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ABSTRACT
Some 74 lines of transgenic mice were screened for insertional mutant 
phenotypes using a two-step breeding strategy. A number of interesting 
developmental mutations were identifed and confirmed as resulting from 
transgene insertional mutagenesis. The further characterisation of two of 
these lines is described.
The Ann line displayed a severe ataxic phenotype, leading to death at an 
early age. Histological analysis of the brains of these mice revealed 
abnormal neuronal patterning in the cerebellum, cerebral cortex and 
hippocampus. The site of transgene insertion was mapped on Chromsome 
4 by a combination of Fluorescence In-Situ Hybridisation (FISH) and 
backcross linkage mapping. The expression of several candidate genes 
mapping close to the transgene was tested. Expression of the mouse 
disabled (mdabl) gene was completely ablated in the brains of Ann 
mutants. Several m utant alleles of this gene have already been described 
that result in a phenotype indistinguishable from that seen in Ann mutants. 
The Ann m utant thus represents a new member of a pre-existing allelic 
series at this locus.
2Male homozygotes of the Ob transgenic line have never been identified. 
That a significant proportion of Ob transgenic males did not breed strongly 
suggested that this line was affected by male sterility. Non-breeding males 
were confirmed as homozygous transgenics by FISH on interphase 
chromosome spreads. Additionally, histological studies showed 
abnormalities in testicular morphology as well as a reduction in a subset of 
spermatogenic cell types. Again the site of transgene insertion was 
m apped by FISH and linkage mapping. No strong candidate genes are 
present around the site of transgene integration on chromosome 8 
suggesting that a novel mutation could be present in the Ob line.
I wish to dedicate this thesis to my parents, 
Kathleen and Alexander Paisley.
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CHAPTER 1: INTRODUCTION
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1.1 The Laboratory Mouse As A  Model System
The study of mouse genetics originated at the beginning of the 20th century 
with the demonstration that Mendel's laws could be applied to mammalian 
species. This was done by Cuenot who, along with two other forefathers of 
the field, Castle and Bateson, conducted their work on mouse coat colour 
phenotypes (reviewed in Mouse Genetics by L. M. Silver [1]).
The small size, short gestation period and prolific breeding rate of the 
mouse, made it an ideal model for the study of mammalian genetics. 
Mouse genetics only really though began to flourish with the advent of 
recombinant DNA technology. Early mouse genetics focused on the 
generation of inbred lines of the Mus musculus sub-species, and the study 
of a small number of 'classical' loci which had a readily identifiable 
phenotype.
The ability to manipulate genes using molecular biology, coupled with 
existing embryology, facilitated the generation, or improvement, of a wide 
range of techniques useful for studying mouse genetics, development and 
cell biology. Mouse genes can now be cloned, sequenced, m apped (both 
genetically and physically) and manipulated in a variety of ways. 
Laboratory mice can now be generated in which genes are deleted, subtly 
changed or missexpressed. This has enabled us to learn much about the 
mouse genome and how it functions, yet despite this a great deal of 
questions remain unanswered. The sequencing of the entire mouse 
genome, which should be completed within the forthcoming months, will 
ensure that further progress proceeds at an astonishing rate.
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1.2 Tools For studying The Mouse Genome  -  Genotype Based Analysis
The original genetics of Mendel investigated naturally occurring, visible 
mutations. Today, the ability to manipulate the mouse genome means that 
both a genetic and a 'reverse genetic' approach can be employed by 
investigators. As well as going from a m utant phenotype to identification 
of the gene involved, one can now, with the DNA sequence of a mouse 
gene in-hand, investigate what the phenotypic effects are of artificially 
manipulating this gene. This can facilitate the elucidation of a gene's wild- 
type function. The technology available for manipulation of the mouse 
genome has evolved so rapidly that alterations ranging from vast 
chromosomal rearrangements to point mutations can now be introduced 
with relative ease.
1.2.1 Gene targeting
The cloning of a gene facilitates the manipulation of that gene by means of 
targeted gene replacement. This involves the replacement of the 
endogenous wild-type gene with a gene copy bearing the desired 
mutation. Gene targeting, as this technology is known, involves the 
manipulation of the mouse genome using embryonic stem (ES) cells in 
culture. Cells bearing an altered genetic code are then used to generate 
mice carrying only the altered copy of the gene of interest.
Derived from the inner cell mass of mouse blastocyst stage embryos, 
embryonic stem (ES) cells can be maintained in culture, where treatment 
with leukaemia inhibitory factor/differentiation inhibitory activity 
(LIF/DIA) allows them  to retain their totipotency [2-4]. On re-introduction 
into mouse embryos these cells contribute to normal embryonic 
development [5]. During culture, ES cells can be subjected to genetic
21
manipulation through homologous recombination with specially designed 
gene-targeting constructs. These constructs contain a region of homology 
to the gene being targeted, which is essential for homologous 
recombination to take place. The homologous region incorporates the 
desired modification that will be introduced into the endogenous gene 
upon successful targeting. When the aim of a targeting experiment is the 
introduction of a null mutation into an endogenous gene, the region of 
homology used in the targeting vector will most often be disrupted with a 
positive selectable marker such as a neomycin resistance cassette. This 
serves two functions. Firstly, expression of this marker can be used to select 
ES clones, into the genomes of which the targeting vector has been 
introduced. Secondly, depending upon the homology region used, the 
selectable cassette will create a null mutation by replacing or interrupting 
the desired segment of the endogenous gene (most often the protein coding 
region of the gene) [6].
In the vast majority of cases, such an exogenous DNA construct, upon 
introduction into an ES cell culture, will integrate randomly into the 
genome of these cells. It has been found that only around 1 in 1000 
integration events take place by homologous recombination [7]. A 
procedure to enrich for homologous recombination events is therefore 
desirable. This is achieved through the incorporation of a negative 
selectable marker (such as the Herpes Simplex Virus Thymidine Kinase 
(HSV TK) cassette) in the targeting vector, outwith the gene homology 
region. This cassette will not be incorporated into the host genome, 
following homologous recombination, allowing selection of targeted ES cell 
clones [6].
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Successfully targeted clones can then be microinjected into the blastocoel 
cavity of a blastocyst stage embryo that is then introduced into a surrogate 
mother [6]. Alternatively, ES cells can be incorporated into a cleavage 
stage embryo by means of aggregation [8]. Being totipotent, ES cells are 
able to contribute to both the somatic and germ cell lineages of the host 
embyo, to generate a chimera [5]. Chimeric mice produced in this manner 
are identifiable through the use of coat colour genetics. ES cell lines are 
generally derived from the 129 inbred strain of laboratory mice, which has 
an agouti (or in the case of the 129/O la substrain, chinchilla) coat colour. 
Chimeric mice display patches of agouti coloured fur (derived from 129 
cells) interspersed with the blastocyst derived colour (often white from the 
BALB/c line or black from the C57BL/6J line). Chimeras are then bred, 
with the aim of passing the targeted genome through the germline to 
produce pure-bred offspring which will be heterozygous for the targeted 
alteration. Crossing of heterozygotes will then generate homozygous 
animals, the phenotype of which can be studied in detail.
The basic gene-targeting technology used to introduce straightforward null 
mutations at a specific gene has been adapted to facilitate the introduction 
of more subtle mutations i.e. point mutations, into an endogenous gene. 
One such method, 'h it and run ' gene targeting, involves a two-step 
recombination strategy [9]. Conventional gene targeting (as described 
above) is used to replace the endogenous gene with a specially designed 
targeting vector. A second, intrachromosomal recombination event (which 
is also selectable), then eliminates the selectable marker and leaves behind 
an engineered copy of the gene.
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Another two-step targeting strategy that can be used to introduce subtle 
alterations to genes is double replacement gene targeting [10,11]. Again, a 
conventional targeting step is used to replace the endogenous gene with a 
targeting vector that includes a marker that is both positively and 
negatively selectable (usually HPRT). A second targeting step is then used 
to replace the newly introduced sequence with an identical copy of the 
original gene except for the subtle alteration of choice. This step is also 
selectable through the loss of the positive/negative selectable marker. An 
advantage this method has over "hit and run ' gene targeting is that 
following the original targeting step, separate mouse lines bearing different 
m utant alleles can be produced by carrying out the second targeting stage 
with different constructs.
An alternative to both of the two-step targeting methods for introducing 
subtle mutations is the generation of transgenic lines w ith the transgene 
consisting of a subtly altered gene copy, on a null genetic background 
generated by conventional gene targeting. This approach can often prove 
more efficient for generation of multiple m utant alleles but does require 
that the expression of the transgene is correctly regulated.
1.2.2 Cre/lox P technology
The ability to study the function of a gene of interest, by introducing a null 
mutation into this gene, is often impeded by the embryonic lethality of the 
m utant mice generated by gene targeting. It is, though, possible to 
introduce mutations into genes in a spatially or temporally restricted 
manner that may enable animals to survive to term  if not adulthood. This 
can be achieved through the use of the bacteriophage Pl-derived loxP 
sequence for site-specific recombination, in conjunction with the Cre
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recombinase enzyme that catalyses the recombination reaction. 
Introduction of the short (23bp in length) loxP sites at the desired location 
is possible through gene targeting in ES cells. To generate a conditional 
null mutation, loxP sites are often introduced flanking the protein coding 
region of the gene of interest. These gene-targeted mice, bearing a so- 
called /floxed/ gene, can then be bred with a transgenic mouse line that 
expresses the Cre recombinase enzyme either in a spatially or temporally 
restricted manner [12]. Cre-mediated recombination of loxP sites will then 
take place, generating a recombined null allele in the offspring produced 
only in the tissues or at the time at which the enzyme is expressed. This 
allows the effects of loss of gene expression only in particular tissues or at 
particular time periods to be studied where, in a conventional gene- 
knockout, the mouse may have died early in embryogenesis.
Cre/loxP technology has also been applied to uses other than the 
generation of conditional knockout mice. The introduction of loxP sites at 
specific chromosomal locations has facilitated the generation of 
chromosomal rearrangements unattainable by means of conventional gene 
targeting. This 'chromosome engineering' has been successfully used to 
introduce defined chromosomal deficiencies, inversions and duplications 
into the mouse genome [13]. Such technology can be applied to create 
useful models of human diseases that involve chromosomal 
rearrangements as well as other tools such as mouse strains carrying 
balancer chromosomes [14]. Another use of the Cre/loxP system is the 
accurate replacement of a specific gene with a gene of choice. In such a 
'knock-in' mouse an endogenous gene can be simultaneously disrupted 
and replaced with another gene. The expression pattern of the introduced 
gene should recapitulate that of the original. 'Knock-in' mice can be useful
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in demonstrating the functional redundancy of closely related genes (e.g. 
the muscle-specific transcription factors myogenin and Myf-5 [15]).
1.3 Tools For Studying The Mouse Genome - Phenotype Based Analysis
In addition to the introduction of specific genetic alterations following the 
isolation of the DNA sequence of a gene, the laboratory mouse also lends 
itself to more traditional genetic investigation where one can progress from 
the discovery of a phenotypic mutation to the isolation of the gene 
responsible for this phenotype. A variety of techniques have been 
successfully used to produce novel mutants without prior knowledge of 
gene sequence. The genes involved in these, as well as the vast number of 
naturally occurring mouse mutants in existence, can then be isolated 
through gene m apping and cloning.
1.3.1 Gene traps
In addition to the targeted alteration of genes, embryonic stem cells have 
successfully been used in the generation of random  mutations by "gene 
trapping'. Upon their introduction to ES cells, gene trap vectors integrate 
into the host genome at random. These vectors are designed so that their 
insertion into an actively transcribed gene can be identified and they can 
then be used as a means to isolate the endogenous gene involved [16]. This 
is achieved through the presence of two genes in the gene trap vector: a 
selectable marker (e.g. neo, encoding resistance to the antibiotic G418) [17], 
that allows the selection of integration events, and a reporter gene (e.g. 
(3-galactosidase), that enables lines carrying a successful gene-trap event to 
be identified [18]. In the generic gene trap vector the reporter gene does 
not have any associated control elements meaning that it will only be 
expressed upon integration of the vector into an exon of a transcribed gene.
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Modification of the basic vector by the addition of a splice acceptor site 
upstream  of the reporter allows expression upon integration of the vector 
into either an intron or an exon [19].
Succesful 'trapping' of a gene in this manner serves multiple functions. 
The endogenous gene will usually be rendered dysfunctional, constituting 
a null mutation. Gene trapped ES cells can be used to generate mouse lines 
in an identical manner to gene targeted ES lines, therefore the phenotypic 
effects of a gene trap mutation can be studied. Furthermore, the inclusion 
of the reporter gene in the gene trap vector means that the expression 
pattern of the 'trapped ' gene can be followed. Finally, the vector itself 
facilitates the cloning of the 'trapped ' gene, often by RACE (rapid 
amplification of cDNA ends); a technique used to amplify unknown 
stretches of cDNA flanking a region of known sequence [20].
Additional modifications to the basic gene trap vector have been 
developed, facilitating the successful isolation of unknown enhancers [21] 
and secreted and membrane-spanning proteins [22] in addition to gene 
coding sequences.
1.3.2 Transgene insertional mutagenesis
A further method of mutating the mouse genome at random  is through the 
production of transgene insertional mutants. DNA constructs introduced 
into the mouse genome either through pronuclear microinjection of 
fertilised eggs [23], electroporation of ES cells [24] or infection with a 
retrovirus based vector [25] integrate randomly into the host genome. It 
has been estimated that in 5 to 10% of transgenics the function of an 
endogenous gene is disrupted [26]. Such mutants are suitable for further
27
characterisation using the transgene sequence as a molecular handle. 
Indeed a variety of interesting mouse mutants have been generated and 
characterised in this way. Transgenic insertional mutagenesis will be 
discussed in greater detail in section 1.6.
1.3.3 Mutagenic agents
Both ionising radiation and chemical mutagens have been used to induce 
germline mutations in the mouse. Whilst exposure to radiation of one of 
the three commonly used types (X-rays, gamma rays or neutrons) 
frequently creates large deletions or other chromosomal rearrangements 
[1], chemical mutagens are available that, upon delivery to the gonads, can 
induce both large and discrete mutations in the mouse germline. 
Furthermore, chemical mutagens have a much higher mutational yield 
than any radiation type tested, making them more suitable for small scale 
screening programmes.
Ethylnitrosourea (ENU) is a chemical mutagen that induces discrete lesions 
which are often point mutations [27]. ENU has been used in a number of 
screens for mutations across the whole genome [28] or at specific 
chromosomal sites [29]. Rapid throughput, whole genome mutagenic 
screens are being carried out using ENU treatment. Such studies usually 
involve screening for detectable dominant m utant phenotypes that are 
expressed in heterozygous animals generated by a single point mutation in 
a gene. The number and variety of dominant m utant phenotypes 
identified in this way can depend upon the screening strategy used to 
identify m utant animals. One such study being carried out by the MRC 
Mammalian Genetics Unit involves the use of the SHIRPA (SmithKline 
Beecham, Harwell, Imperial College, Royal London Hospital, Phenotype
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Assesment) protocol for detecting even the most subtle dominant mutant 
phenotypes with a special emphasis being placed on neurological 
phenotypes [30].
ENU mutagenesis has also been used in screening for recessive point 
mutations in chromosomal regions that have been defined by deletions. 
The existence of mouse strains carrying characterised deletions spanning 
single or multiple genes, allows the expression of recessive mutant 
phenotypes following a single point mutation in one of these genes. ENU 
is now being used to saturate such regions with point mutations (e.g. the t 
region [31]). Unfortunately only a limited number of these regions exist 
throughout the genome. Most deletion complexes available in the mouse 
were generated by X-ray irradiation. It is hoped that the discovery of a 
chemical mutagen, chlorambucil, that induces deletion mutations at a high 
rate in the mouse may lead to an increase in the number of genomic 
regions in the mouse that are defined by deletions [32]. Alternatively, 
Cre/loxP chromosomal engineering can be employed for the same purpose 
[13].
1A Analysing The M utant Resource
1.4.1 Bridging the phenotype gap
With a panopoly of techniques now available for the generation of both 
targeted and random  mutations in the mouse genome, perhaps the major 
bottle-neck in the progression of murine functional genomics rests with the 
phenotypic analysis of the array of mutants which have been, or are being, 
generated.
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Whilst new mutants have been produced at a phenomenal rate, often 
through high throughput, systematic mutagenesis programmes, until 
recently, phenotypic analysis of mutants was only conducted on a mouse 
to mouse basis. A major aim of mouse functional genomics is now the high 
throughput analysis of m utant phenotypes that will in turn provide an 
essential insight into the functions and interactions of a vast number of 
mammalian genes. Such studies, working in tandem with large scale 
mutagenesis programmes of a variety of types, are currently in progress 
[33].
1.4.2 The emergence of microarray technology
Microarray technology is an extremely novel approach to high-throughput 
genomic analysis based upon the ability to spot high numbers (as much as 
10,000) of discrete cDNAs onto a non-porous support (e.g. glass). 
Expression in a test sample of each gene represented on the array can then 
be monitored through hybridisation and fluorescent detection [34].
This technology has a variety of applications including the analysis of 
differential gene expression in disease [35]. In the context of mouse m utant 
analysis, cDNA microarrays have considerable potential for investigating 
the effects of a mutation on the expression of other genes. One could 
envisage using microarray technology on mouse mutants in order to 
identify genes up or downregulated in the mutant, implying their 
interaction in some way with the mutated gene [36]. In this way a clearer 
picture of gene and protein interactions and expression pathways could be 
formulated.
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1.5 Mapping Genes And M utations In The Laboratory Mouse
The m apping of genes and mutations represents an extremely important 
tool in modern mouse genetics. Obtaining the map position of a 
phenotype-causing mutation is often the fist step in the molecular cloning 
of the causative gene. Alternatively, DNA clones of unknown function can 
be associated with characterised m utant phenotypes by means of gene 
mapping. Recently, mapping has been increasingly applied to the 
dissection of complex traits and the identification and cloning of loci 
contributing quantitatively or qualitatively to such traits [37].
Mapping studies can be subdivided into three tiers: chromosomal mapping 
allows the assignment of a locus to a specific chromosme or chromosomal 
segment, whilst linkage mapping involves the ordering of loci through 
recombinational distance. At the highest level of resolution, physical 
mapping is based upon the direct analysis of DNA, either in the form of 
overlapping clones or nucleotide sequence itself.
1.5.1 Linkage mapping in the mouse
Linkage mapping centres upon the premise that meiotic recombination 
takes place at random  sites across the genome and the further two linked 
loci are apart the greater the likelihood of recombination events taking 
place in the intervening region. The frequency of recombination between 
two linked loci therefore provides a measurement of the genetic distance 
between these sites.
In the laboratory mouse, breeding experiments of different types can be 
performed and offspring tested to identify whether parental or 
recombinant combinations of genes being m apped have been inherited.
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For this to be possible it is essential that the loci of interest exist in multiple 
identifiable forms or alleles.
Originally, linkage mapping was carried out only on a small number of 
phenotypically defined loci. The dawn of the recombinant DNA era has 
meant that now polymorphic DNA sequences, such as microsatellite 
markers, can be linkage mapped [38].
An extremely detailed linkage map now exists for the laboratory mouse, 
containing thousands of polymorphic genes and DNA sequences ordered 
across the whole genome, with new markers being added on a daily basis 
[39].
1.5.2 Chromosomal mapping
Chromosomal mapping involves the assignment of loci to a specific mouse 
chromosomal or sub-chromosomal region. Whilst not providing the same 
level of resolution as linkage mapping, chromosomal mapping does 
circumvent the need for mouse breeding excercises.
Individual chromosomes can be defined cytogenetically, according to their 
size and the banding pattern obtained following staining with dyes such as 
Geimsa. If a probe specific to the locus of interest is to hand (e.g. a cDNA 
clone), then fluorescence in situ hybridisation (FISH) can be performed in 
concert with chromosomal banding to allow a sub-chromosomal 
assignment for the locus to be made [40].
The use of somatic cell hybrid lines, containing a portion of a mouse 
chromosome in combination with the complete karyotype of another
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species, allows loci to be assigned to a sub-chromosomal interval [41]. 
Radiation hybrid panels are derived from somatic cell hybrid lines but 
contain even smaller portions of mouse chromosome, allowing a higher 
degree of resolution to be obtained [42].
1.5.3 Physical mapping
Physical maps are concerned with the molecular constitution of the locus of 
interest, and as such provide the highest level of resolution of the various 
mapping strategies. Such maps are usually found as a contiguous series of 
of overlapping DNA clones, or contig. Owing to their greater cloning 
capacity, contigs are usually constructed using YAC (yeast artificial 
chromosome) cloning vectors [43], although BAC (bacterial artificial 
chromosome) and PAC (PI artificial chromosome) vectors have been used 
[44].
The nucleotide sequence of a genomic region can also be considered a form 
of physical map. Indeed, the complete physical mapping of the mouse 
genome is currently underway [45], with the production of contigs 
covering each mouse chromosome facilitating the nucleotide sequencing of 
the chromosome [46].
Positional cloning involves the progression from high-resolution linkage 
mapping, in which markers closely flanking the gene of interest have been 
identified, to the cloning of the sequence separating the two markers 
(chromosome walking) through the construction of a contig. A variety of 
methodologies can then be utilised to isolate the gene in question such as 
exon trapping [47] and CpG island identification [48] as well as direct 
sequencing.
33
1.6 Transgene Insertional Mutagenesis
1.6.1 Making transgenics
The ability to culture mouse eggs and early stage embryos that could 
subsequently develop as normal following re-introduction into the uterus, 
opened the way for the creation of genetically altered mouse lines. The 
generation of adult 'transgenic' mice carrying exogenous DNA, introduced 
by the genetic manipulation of cultured mouse embryos, was first achieved 
through the injection of viral particles into the blastocoel cavity of 
blastocyst stage mouse embryos [49]. Soon after it was discovered that 
microinjection of DNA into fertilized mouse eggs could also be used to 
produce transgenic lines [23]. A variety of techniques are now available for 
making transgenic mouse lines. The most widely used technique is 
microinjection of DNA into the pronudeus of a fertilised oocyte. 
Alternatively, DNA can be introduced into embryonic stem cells that can 
then be microinjected into the inner cell mass of a blastocyst [24]. In both 
cases the genetically altered embryo can then be taken through 
development by re-introduction into a pseudopregnant surrogate mother. 
Founder animals produced in this manner can then be bred in order to 
establish a new transgenic line.
The life cyde of retroviruses makes them ideal candidates for use in 
making transgenics. The double stranded DNA provirus integrates into 
the genome of an infected cell as a single copy without accompanying 
genomic rearrangements [50]. Genetically engineered viruses can thus be 
used to introduce exogenous genes into the genome of pre-implantation 
embryos [25] or ES cells [51], again fadlitating the generation of a 
transgenic founder.
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Transgenic mice have a variety of important applications in modern 
biology. One common use is in the study of regulatory regions controlling 
gene expression. By generating a range of transgenic lines, each bearing a 
different segment of a regulatory region in combination with a suitable 
reporter gene, the effects of each segment upon gene expression can be 
elucidated. In this way the composition of regulatory regions can be 
dissected accurately.
Another reason for making transgenic mouse lines is to determine the 
effects of gene missexpression. This can be achieved by combining the 
gene of interest with regulatory regions that will cause it to be expressed in 
a different tissue, at a different developmental stage or at a different level 
than normal. Any m utant phenotype created through such missexpression 
may provide some insight into the normal function of the gene in question 
[52].
Transgenic technology can also be used to ascertain whether a cloned 
candidate gene is responsible for a m utant disease phenotype. To discover 
if a cloned gene complements a recessive mutation, a transgene rescue 
experiment can be performed. The success of such a test may depend upon 
an accurate recapitulation of the gene expression pattern. The fact that 
gene regulatory regions can sometimes be located hundreds of kilobases 
upstream of a gene can now be overcome by making BAC or YAC 
transgenics in which the transgene may be large enough to encompass all 
regulatory regions [53,54].
Two problems that can hamper transgenic studies arise due to the 
tendancy of microinjected transgene DNA to integrate into the host
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genome at random. Firstly, levels of transgene expression can be affected 
by local chromatin conformation, depending upon the site of insertion, or 
de-novo methylation. This can often cause a reduction in expression or 
silencing of a transgene [55]. Secondly, integration into an endogenous 
gene can occur and may result in the production of a m utant phenotype 
[26]. Care must be taken not to confuse such a mutation with one resulting 
from the expression of the transgene.
1.6.2 Mechanisms of microinjected transgene insertion
Although the integration mechanism of microinjected DNA into the host 
genome is unknown, a number of features of the integration event are 
widely recognised. It is the commonly held view that transgene 
integration into the mouse genome is random  or at least near-random [55, 
56]. Despite the fact that evidence in favour of preferential integration into 
genes or other 'hot spots' does exist it would be premature to eliminate a 
model of random  insertion [26].
In the majority of cases, transgene insertion is thought to take place at a 
single site in the genome, although multiple sites of integration have been 
reported in transgenics generated by iontophoretic techniques [57] or 
pronuclear microinjection (A. Ward, personal communication). A 
transgene can insert as single or multiple copies. Multiple copy arrays are 
normally found with individual transgene units orientated as 'head-to-tail' 
repeats [58]. It has been proposed that such arrays are generated through 
extra-chromosomal homologous recombination between individual 
transgene units. The concatamer formed could then insert into the 
genome, resulting in a multiple copy array with transgene elements 
orientated predominantly in a 'head-to-tail' fashion [59]. Supporting
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evidence exists with an experiment in which microinjection of two MT- 
hGH genes with non-overlapping deletions gave rise to functional 
recombinant hGH copies in transgenic mice [60]. Such a model also 
accounts for the high frequency of incomplete transgene copies found at 
the terminal ends of such arrangements.
Finally, a mechanism of transgene integration into the host genome has 
been suggested that involves the ends of DNA molecules initiating 
integration at the site of randomly generated chromosomal breaks [61]. 
This might explain why the integration efficiency of linear molecules have 
been observed at fivefold that of circular species.
1.6.3 Chromosomal rearrangements associated with transgene insertion
Transgene integration is often accompanied by chromosomal 
rearrangements with deletions [62], inversions [63] or translocations [64] 
frequently occurring at the same site. Surprisingly, novel DNA sequences, 
found neither in the injected DNA nor around the integration site, have 
also been identified in some transgene junctions [55]. Studies of 
breakpoints at naturally occurring chromosomal translocations yield 
similar observations [65], suggesting a common mechanism for both 
phenomena.
The probability of disruption to somatic gene function is likely to be 
increased by the frequent occurrence of chromosomal rearrangements at 
the site of transgene insertion. Such alterations, whilst increasing the 
distance from the transgene itself at which endogenous genes may be 
susceptible to alteration, can also make the identification of these genes 
more difficult.
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Transgene DNA is thought to transmit stably from generation to 
generation without further possibility of rearrangement. Reports have, 
though, shown that rearrangement is possible in rare cases where partial 
deletions and amplifications have been observed [66-69].
1.6.4 Disruption of somatic gene function by insertional mutagenesis
The insertion of transgene DNA into the genome at random  means that the 
disruption of an endogenous gene is a distinct possibility. It has been 
estimated that between 5% and 10% of transgenic mice will display some 
form of transgene insertional mutation through disruption of endogenous 
gene function [26]. This figure is probably an underestimate given the fact 
that a number of dominant insertional mutations probably go unidentified 
due to embryonic lethality. Furthermore, subtle phenotypes may also 
escape detection. Insertional mutants are often generated as a by-product 
of transgenesis studies but have proved useful in the identification and 
characterisation of novel genes and mutants [26]. As well as constituting 
the mutagenic agent, integrated transgene DNA can act as a useful starting 
point for the further characterisation of the m utant locus at the molecular 
level.
1.6.5 Using transgene mutagenesis as a method for identifying new mutants
Transgene insertional mutagenesis has proved to be a useful tool for the 
study of many biological processes by providing a wide variety of novel 
m utant phenotypes and making their relatively rapid characterisation, 
especially at the molecular level, a realistic possibility [26].
On identification of a m utant phenotype in a group of transgenic mouse 
lines, how should one proceed with a more in depth characterisation?
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It is important to acknowledge the possibility for spontaneous mutants to 
appear in such transgenic studies. The in-breeding of lines creates a 
population 'bottle-neck' in which reinforcement of spontaneous, or indeed 
pre-existing m utant alleles, could occur. Therefore, in the characterisation 
of insertional mutants it is important to identify a causal relationship 
between the transgene and the m utant phenotype. The involvement of the 
transgene is important since it provides a possible means for the mapping 
and isolation of the m utant allele.
The ability to use the transgene as a probe for Fluorescent in situ 
Hybridisation (FISH), on Metaphase chromosome spreads, greatly 
improves the ease of m apping the allele in question. Any map position 
obtained this way can be further refined through the use of Simple 
Sequence Length Polymorpism (SSLP) microsatellite markers in association 
w ith a suitable breeding strategy [1]. Once a map position has been 
confidently assigned, it becomes possible to determine if the insertional 
m utant represents a novel allele of a pre-exisiting mouse mutant. The 
Mouse Genome Database, which contains information on greater than five 
thousand m apped genes, provides a means by which possible allelism can 
be determine relatively quickly [39].
With mutation of a novel gene confirmed, the identification and 
subsequent characterisation of this locus can be undertaken using the 
transgene as a molecular tag. Attempts at cloning genomic DNA flanking 
the site of transgene integration can be complicated by the chromosomal 
rearrangements that are often found at this site, not to mention 
complicated arrangements of transgene copies within multiple arrays [55]. 
Nevertheless, successful isolation of flanking sequence can serve as a
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starting point in cloning the wild-type allele by chromosome walking.
1.6.6 The advantages of retroviral transgenics
Production of transgenic lines by retroviral infection is somewhat more 
straightforward than the technically demanding technique of pronuclear 
DNA microinjection. Retroviral insertion into the host genome can be 
accomplished simply through the incubation of pre-implantation embryos 
or ES cells w ith virus-producing fibroblasts [25]. Furthermore, retroviruses 
integrate as single copies and, as often happens with microinjected DNA, 
integration is not accompanied by chromosomal rearrangements [25]. This 
presents distinct advantages for the use of retroviral transgenesis in the 
production of insertional mutants, since cloning of endogenous flanking 
sequence is generally more straightforward than in the case of injection 
transgenesis [70].
Retroviral transgenics do have disadvantages including the generation of 
mosaic founder animals at a higher rate than the 30% estimated in 
transgenics generated by pronuclear microinjection [71]. This results from 
infection taking place after the beginning of cell division and necessitates 
additional breeding steps in order to obtain pure-bred transgenics.
1.7 A  systematic screen in the mouse fo r  transgene insertional m utants
1.7.1 Background
Genomic imprinting describes the phenomenon whereby a number of 
genes are subject to monoallelic expression dependant upon their pattern 
of inheritance. Different allelic expression of Igf-2 and H19 is suspected to 
involve a number of regulatory elements at these loci. In an attem pt to
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elucidate the mechanisms behind this imprinting, over 70 lines of 
transgenic mice were generated [72]. Using the pronuclear microinjection 
m ethod, individual transgenic lines were founded in Oxford, with one of 
eight linear DNA constructs. The basic transgene construct consists of the 
Firefly (Photinus pyralis) ludferase coding sequence, coupled to the P3 
prom oter region of the murine Igf-2 gene and in seven of the constructs, 
one or more of regulatory sequences from the Igf-2/H19 locus (see section 
3.1.1). The inclusion of these regions was designed to facilitate the 
dissection of their functions in genomic imprinting, in isolation from their 
normal genomic environment and also, importantly, in vivo.
Bearing in m ind the fact that levels of transgene expression can often be 
affected by the local chromosomal constitution, each construct was used to 
generate multiple, separate, transgenic lines. As determined by Southern 
blotting and breeding analysis, each line represented integration of one or 
more transgene copies at a single genomic site.
Given a documented frequency of between 5% and 10% of transgenics 
being insertional mutants [26], the observation of a number of m utant 
phenotypes was expected. This expectation was realised upon Caesarian 
rederivation of most of the lines during their transfer from Oxford to Bath.
During this procedure a number of developmental abnormalities were 
observed which otherwise might have escaped detection due to peri-natal 
lethality or canabalism by parents. As a result, it was decided that a screen 
for other developmental abnormalities, within this mouse population, be 
carried out.
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1.7.2 Rationale of this project
A strategy to screen for insertional m utant phenotypes in this population 
was developed involving two different types of mouse cross. It is normal to 
expect the majority of mutations in developmentally important genes to be 
recessive. To test for visible mutations in homozygous offspring, male and. 
female mice, hemizygous for the transgene were thus intercrossed. To 
detect homozygous mice a second type of cross was utilised. In this case 
transgenic offspring were backerossed against non-transgenic animals. 
Crossing of a test animal homozygous for the transgene would produce 
litters where every pup is transgenic. If homozygous animals were found 
not to have a visible phenotype, this line was eliminated. If homozygotes 
displayed a m utant phenotype or if an abnormally low number of 
homozygous animals were identified the line would be subjected to further 
analysis.
In this way a number of transgenic lines bearing putative insertional 
mutations were found to display visible recessive phenotypes, whilst 
putative embryonic lethal, variably penetrant and sex-linked mutations 
have also been identified. Following confirmation that transgene 
insertional mutagenesis was the basis of the mutation in the mutants 
displaying visible reccesive phenotypes, these lines were characterised 
both at the phenotypic and molecular levels. Attempts to elucidate the 
physiological basis of the m utant phenotypes involved histopatholgical 
analysis. The inserted transgene provided a vital handle on the molecular 
basis of the mutations and facilitated gene mapping and attempted cloning 
exercises.
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This thesis details the screen for transgene insertional mutations and the 
further characterisation of two lines found to bear recessive mutant 
phenotypes: Ann; a cerebellar ataxia mutant, and Ob; which exhibits male 
sterility.
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Transgenic mice were generated in Oxford using FI zygotes resulting from 
crosses between C57BL/6J males and CBA/Ca females (hereafter 
abbreviated to F1(C57/CBA)). Transgenic lines were maintained by both 
incrossing of transgenic mice and outcrossing of transgenic to non- 
transgenic F1(C57/CBA) mice. Stocks of F1(C57/CBA) and C57BL/6J 
were maintained in the animal unit in Bath.
2.1.2 Other materials
General laboratory chemicals used were of the Analytical Reagent grade 
(unless otherwise stated) and were purchased from BDH, Fisher or Sigma.
2.2 General methods
Molecular biology methods were performed according to Sambrook et al 
[73], except where stated otherwise.
2.2.1 Production of electrocompetent E.coli
A modified version of [74, 75] was used. A single, well isolated, bacterial 
colony was picked from a SOB agar (2% bacto tryptone, 0.5% bacto yeast 
extract, 0.05% NaCl, 2.5mM KC1,1.5% agar) plate and dispersed in 1ml of 
SOB (2% bacto tryptone, 0.5% bacto yeast extract, 0.05% NaCl, 2.5mM 
NaCl) by vortexing. Using a sterile loop, 50ml of SOB was innoculated 
with this suspension and cultured in a 500ml flask at 37°C, with shaking, 
for no greater than 12 hours. Two 4ml aliquots of this culture were used to 
seed 2x 400ml of SOB in 1 litre flasks. These cultures were incubated at 
37°C with agitation (approximately 200rpm) for one hour, after which 1ml 
aliquots of culture were removed at regular intervals, and the optical
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density measured at 550nm. Cultures were incubated until an optical 
density of 0.75 (corresponding to a density of around 3-6xl08 cells/ml) was 
reached, following which, the remaining culture was transferred into 4x 
250ml centrifuge pots. Cells were pelleted by centrifugation at 4,500rpm at 
4°C in a Sorvall GSA rotor (Sorvall) using an RC-5B (Sorvall) centrifuge. 
Supernatants were decanted and the centrifuge pots placed on ice in a cold 
room (4°C). Pellets were gently resuspended in 200ml of chilled, sterile, 
10% glycerol solution, using a 10ml pipette. Cells were again pelleted by 
centrifugation, supernatants decanted and pellets resuspended, all as 
before. After a further centrifugation step (as before), as much supernatant 
as possible was decanted and the cell pellet resuspended in any remaining 
supernatant (approximately 3ml in total). The cell suspension was 
transferred in 40pl aliquots to 0.5ml microfuge tubes, on ice, and snap 
frozen in liquid nitrogen.
2.2.2 Transformation of electrocompetent E.coli
For each transformation a 40pl aliquot of electrocompetent E.coli was 
thawed on ice and ln g  of purified plasmid DNA solution, in a volume of 
2(xl, added. This mixture was incubated on ice for 45 seconds and then 
transferred to a 1mm electroporation cuvette. Each cuvette was pulsed at 
1.25kV (12.5kV/cm) using a Bio-rad electroporator. 1ml of warm  SOB +Mg 
medium (SOB, lOmM MgCl2) was immediately added to each cuvette and 
the bacterial suspension dispersed by pipetting. The bacterial suspension 
was removed from the cuvette and incubated at 37°C, w ith shaking, in a 
15ml propylene Falcon tube for 1 hour, following which lOpl and 100pl of 
suspension were spread onto LB agar plates (20}xg/ml ampicillin). Cells 
were cultured overnight at 37°C.
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2.2.3 Small scale purification of plasmid DNA
A single, well isolated, bacterial colony was picked from an LB agar plate 
and inoculated into 1.5ml of LB medium containing the appropriate 
antibiotic in a 15ml Falcon tube. Cells were cultured overnight in a shaking 
incubator at 37°C and plasmid DNA extracted using the Wizard Miniprep 
SV kit (Promega) according to the manufacturers instructions for the spin 
protocol.
2.2.4 Large scale purification of plasmid DNA
A single, well isolated, bacterial colony was picked from an LB agar plate 
and innoculated into 250ml of LB medium containing the appropriate 
antibiotic in a 1L glass flask. Cells were cultured overnight in a shaking 
incubator at 37°C and then pelleted by centrifugation at 4,500rpm at 4°C in 
a Sorvall GSA rotor using an RC-5B centrifuge. The supernatant was then 
discarded and the cell pellet resuspended in 9ml of a 50mM glucose/50mM 
Tris pH  8.0/10mM 0.5M EDTA solution. Following the addition of 18ml of 
0.2M NaOH/1%  SDS the contents of each tube were mixed using a 'head- 
over-heels' motion and then incubated on ice for 5 minutes. 9ml of 3M 
Sodium Acetate (pH 5.0) were then added and the tubes again mixed in the 
same manner prior to a further 10 minute incubation on ice. Tubes were 
then spun at 7,000rpm for 10 minutes at 4°C in a Sorvall GSA rotor using 
an RC-5B centrifuge. Supernatant was then collected into a fresh tube and 
21.6ml isopropanol added before further mixing and a 5 minute incubation 
on ice. After tubes had again been spun at 7,000rpm for 5 minutes at 4°C, 
the supernatant was discarded and the pellet resuspended in 2ml of TE pH
8.0. The DNA solution was then incubated with 2pl of lOm g/m l RNAase 
A (Sigma) at 37°C for 30 minutes. The solution was then transferred to a 
50ml glass Corex tube and 2ml of Phenol (Sigma) added prior to vortexing
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and centrifugation at 10,000rpm for 10 minutes at 4°C in an RC5-B 
centrifuge, using an SS34 (Sorval) rotor. The supernatant was then 
carefully transferred to a fresh Corex tube and 2ml of Chloroform added. 
Tubes were vortexed and spun as before and the supernatant again 
transferred to a fresh Corex tube. 200pl of 4M LiCl and 5ml of ice cold 
absolute ethanol were added and DNA precipitated at -70°C for 3 hours. 
Tubes were then spun at 10,000 rpm  for 10 minutes at 4°C and the 
supernatant discarded, the DNA pellet washed with 70% ethanol and dried 
under vacuum. The pellet was then resuspended in 200jxl of TE pH 8.0.
2.2.5 Purification of genomic DNA from mouse biopsy
This was carried out according to Hogan et al[76] (with modifications) on a 
5-15mm tail biopsy either untreated or having previously been processed 
for luciferase assay (see section 2.2.17). Tail lysis buffer (50mM Tris.HCl 
pH  8.0, lOOmM EDTA, lOOmM NaCl, 1% SDS) was added to give a total 
volume of 525pl followed by the addition of proteinase K (Boeringher 
Mannheim) to a concentration of 285pg/ml. Samples were incubated for at 
least 12 hours at 55°C after which they were treated with 0.7pg/ml RNase 
A for 1 hour at 37°C. NaCl was added to 1.25M, samples briefly mixed by 
inversion, and an equal volume of chloroform/isoamyl alcohol 24:1 
(vol:vol) added prior to gentle mixing at room temperature for 2 hours. 
Samples were microfuged (i.e. subjected to centrifugation in a bench top 
Heraeus centrifuge with 24-place, 1.5ml tube, rotor) for 10 minutes and the 
upper, aqueous, layer transferred to a fresh tube. An equal volume 
(approximately 700pl) of propan-2-ol was added and samples mixed by 
inversion to precipitate the DNA. Samples were microfuged for 10 
minutes causing the precipitate to form a pellet, allowing the supernatant 
to be removed. Pellets were washed at 4°C for 1 hour in 300pl ice-cold 70%
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ethanol. After brief centrifugation the ethanol was rem oved and the pellet 
air dried. The pellet was resuspended in 50pl TE (Tris.HCl pH  8.0, ImM  
EDTA) overnight at 4°C.
2.2.6 Agarose gel electrophoresis of DNA
Unless stated otherwise, DNA samples were electrophoresed on a 1% 
agarose (United States Biochemical) gel containing 0.5pg/m l ethidium 
bromide at 80V for a suitable length of time (usually 1 - 3  hours). DNA was 
visualised on a UV lightbox.
2.2.7 Quantitation of DNA
Concentrations of purified genomic DNA, plasmid DNA and DNA 
fragments were estimated by comparison with DNA markers (lOObp and 
lkb ladders, Promega) of known concentrations, under UV light, following 
agarose gel electrophoresis (section 2.2.6).
2.2.8 Restriction endonuclease digestion of DNA
For isolation of DNA probe fragments, lp g  of plasmid DNA was used, 
whereas for digestion of genomic DNA for Southern blotting 
approximately lOpg of purified genomic DNA was used. DNA was 
digested with greater than 10 units of the desired restriction endonucleases 
(Promega) in a lx  concentration of the recommended restriction 
endonuclease buffers (Promega), for at least 12 hours at the working 
temperature for the particular enzyme in use.
2.2.9 Purification of DNA from agarose gels
Endonuclease digested plasmid DNA was electrophoresed on an agarose 
gel (section 2.2.6) and the appropriate DNA fragment excised with a scalpel 
blade on a UV lightbox. The DNA fragment was purified into 30pl of dHzO
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using the QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturers protocol.
2.2.10 Southern blotting
Genomic DNA samples (5-15pg) were digested overnight with the 
appropriate restriction endonucleases and electrophoresed on a 1% agarose 
gel containing 0.5pg/ml ethidium bromide. Transfer of DNA onto 
Hybond-N (Amersham) membranes was performed under high salt 
denaturing conditions according to standard procedures [73]. Following 
transfer, DNA was cross-linked to the membrane using a UV crosslinker 
(UVP, CL-1000) by exposure to 12,000 p j/cm 2 ultraviolet radiation.
2.2.11 Isolation of brain total RNA
Total RNA was extracted using TRI reagent (acid guanidinium thiocyanate 
phenol chloroform [77], Sigma) according to the manufacturers 
instructions. All equipment used for RNA isolation was soaked in DEPC- 
treated H O  for a minimum of 1 hour prior to use.
Animals were sacrificed and 50-100mg of brain tissue dissected and placed 
immediately in 1ml of TRI reagent on ice. Following homogenisation using 
the 0.1-0.5ml dispersing tool of an Ultra-Turrax T8 homogeniser (IKA- 
Labortechnik), samples were centrifuged at 12000g for 10 minutes at 4°C. 
The supernatant was transferred to a fresh tube and allowed to stand at 
room temperature for 10 minutes prior to addition of 0.2ml of chloroform. 
The tube was then shaken vigorously and left standing at room 
temperature for a further 15 minutes. After centrifugation at 12000g for 15 
minutes at 4°C, the upper, aqueous phase was removed to a fresh tube and 
1/10 volume of propan-2-ol added. The mixture was again shaken and 
then left standing at room temperature for 5 minutes. The tube was
50
centrifuged at 12000g for 10 minutes at 4°C and the supernatant removed. 
To this, an equal volume of propan-2-ol was added in order to precipitate 
the RNA. After mixing, tubes were allowed to stand at room temperature 
for 10 minutes and then centrifuged at 12000g for 10 minutes at 4°C in 
order to pellet the RNA. The supernatant was removed and the pellet 
washed with 1ml of 75% EtOH. Tubes were briefly centrifuged again and 
the supernatant extracted, following which the pellet was allowed to air- 
dry at room temperature for 10 minutes. The pellet was re-dissolved by 
incubation in a suitable volume of DEPC-treated HzO at 55°C for 15 
minutes with occasional pipetting using a Gilson pipettman. Samples were 
incubated with 10 units of Rnasin ribonuclease inhibitor (Promega) at 37°C 
for 30 minutes prior to use.
2.2.12 RNA quantitation
The concentration of RNA samples was quantified by measuring the 
optical density (OD) of the RNA sample (diluted 1:1000 in DEPC-treated 
H20 ) at a wavelength of 260nm. The RNA concentration of the samples 
was calculated based on 40m g/m l of RNA giving an OD reading of 1.0 at 
260nm.
RNA was also checked for integrity by electrophoresis on 1% agarose gel 
for 15 minutes at 100V (section 2.2.6).
2.2.13 Northern blotting
As with RNA isolation, all equipment used in Northern blotting was 
soaked in DEPC-treated HjO for a minimum of 1 hour prior to use. 
Northern blotting was carried out using a modified version of the standard 
protocol [73]. A 1.2% agarose gel was prepared by dissolving 4.2g of 
agarose in 304ml of DEPC-treated b^O. The agarose was incubated at 65°C
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and 35ml lOx MOPS running buffer (200mM MOPS (3-[N-Morpholino] 
propanesulfonic acid) (Sigma) pH  7.0, 50mM Na Acetate, lOmM EDTA) 
and 10.5ml 37% formaldehyde (Sigma) added, following which the gel was 
immediately poured. RNA samples were prepared by adding the desired 
amount of RNA solution to 5pi lOx MOPS running buffer, 8.75pl of 37% 
formaldehyde, 25pi formamide (Sigma) and making the volume up to 50pl 
with DEPC-treated H^O. This mixture was incubated at 55°C for 15 
minutes and 5pl 5x Ficoll loading buffer added. Samples were loaded onto 
the gel and electrophoresed for 18 hours at 50V in lx  MOPS running buffer. 
The gel was blotted onto Hybond-N membrane by capillary blotting in the 
same manner as for Southern blots (section 2.2.10). RNA cross-linking, 
probe hybridisation and membrane stripping were also carried out exactly 
as described for Southern blot membranes (section 2.2.10 and 2.2.15).
2.2.14 Radiolabelling of DNA probes
10-50ng purified probe DNA was labelled with redivue a 32P-dCTP 
(Amersham) using the High-Prime labelling kit (Boeringher Mannheim) 
according to the manufacturers instructions, at 37°C for 30min. Following 
incubation, unincorporated deoxyribonucleoside-triphosphates were 
removed by spinning the labelling mixture, made up to lOOpl with TE pH
8.0, through a 1ml Sephadex G-50 (Sigma) column (packed and pre­
equilibrated with TE pH8.0) at 1200rpm for 4min. A further lOOpl of TE pH  
8.0 was applied to the column which was spun as before and the eluates 
pooled. This labelled probe solution was denatured prior to use by boiling 
at 100°C for 5 minutes.
2.2.15 Hybridisation of radiolabelled DNA to Southern and Northern blots
Blotted and cross-linked membranes were prehybridised in a rotisary oven, 
at 65°C for 2 hours in 30ml of 'Church and Gilbert' hybridisation buffer
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(500mM Na2H P 04 pH  7.2, ImM EDTA, 7% SDS, 1% BSA, lOOpg/ml 
sonicated salmon sperm DNA) [78]. Following this period, denatured, 
radiolabelled probe DNA was added to the hybridisation mixture and 
filters incubated for at least 12 hours at 65°C. Filters were then washed 
twice at 65°C for 15 minutes each in 40mM Na2H P 04 pH  7.2, ImM  EDTA, 
5% SDS followed by two 1 hour washes in 40mM Na2H P 04 pH  7.2, ImM 
EDTA. After a brief rinse in 40mM Na2H P 04 pH  7.2, filters were wrapped 
in Saran wrap (GRI) and placed in an autoradiography cassette (including 
intensifying screens) with either pre-flashed blue sensitive X-ray film (GRI) 
or with Kodak BIO-Max film (Sigma). Following incubation at -80°C for a 
suitable exposure time, films were developed using a Compact x2 (X- 
ograph) X-ray processor.
Membranes were stripped by submerging in boiling 0.1X SSC/1% SDS for 
a minimum of 5 minutes.
2.2.16 Polymerase chain reaction
All PCR reactions were carried out in a total volume of 20pl consisting of 
72mM Tris.HCl pH  9.0, 20mM (NH4)2S 04, 0.01% Tween-20 (Reaction buffer 
IV, Advanced Biosciences), 1.5mM, 3mM or 4.5mM MgCl2 (Promega), 
200pM dATP, 200jjM dCTP, 200pM dGTP, 200pM dTTP (Amersham 
Pharmacia), 1U "Red Taq " DNA polymerase (Sigma) and 133nM of each 
primer.
For reactions with microsatellite PCR primers, 5pil (approximately 25ng) of 
genomic DNA (prepared as above), which had been diluted 1:150 in dHzO, 
was added to each reaction. For reverse transcriptase PCR reactions, lp l of
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a 20pl reverse transcriptase reaction mixture was added, along with 5|il of 
dH20 ,  to each PCR reaction.
All PCRs reactions were performed on a PTC-100 thermocycler (MJ 
research) according to the recommended protocol from the Whitehead 
Institute [79] for microsatellite primer pairs: 2 minutes at 95°C followed by 
30 cycles of 45 seconds at 94°C, 45 seconds at the annealing temperature 
specified for each primer pair and 60 seconds at 72°C followed by a final 
extension of 7 minutes at 72°C and cooling to 4°C.
2.2.17 Luciferase assay
This was performed essentially according to W ard et al(l997) [72] on a 
small tail biopsy (2-4mm) taken from pups up to 7 days post partum. 
Following storage at -20°C, thawed material was added to lOOpl of 
luciferase assay cell lysis buffer (Lysis buffer 4, LabTech), vortexed, and 
then re-frozen at -20°C for at least 30min. lOpil thawed lysates were then 
plated, in duplicate, on a white, 96-well microtitre plate. Samples were 
assayed for luciferase activity using 50pl Genglow-1000 luciferase assay 
substrate (LabTech) in either an Anthos Lucy 1 luminometer (LabTech) or 
an E.G. & G. Berthold Autolumat LB953 luminometer (Berthold). Light 
emission was counted for 10s in each case. A mean reading of greater than 
0.3 relative light units constituted a positive result for luciferase activity. 
Genomic DNA was prepared from biopsy samples giving readings below 
this value and genotyping was repeated by Southern blotting.
2.2.18 Preparation of metaphase chromosome spreads
This protocol was adapted (by Dr W. R. Bennett) [80] from that used in the 
MRC Hum an Genetics Unit, Edinburgh (M. Lee, pers. comm). Mice were 
sacrificed and spleens dissected into PBS. Following transfer into a 50mm
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tissue-culture dish containing 5ml of RPMI-1640 with Glutamax 11 (Gibco- 
BRL) medium, cells were extruded from spleens by piercing w ith a 26 
gauge needle and then, whilst holding the specimen steady with the 
needle, another needle used to squirt medium into the spleen. Care was 
taken not to suck cells back through the needle. Using 10ml of medium, as 
many cells as possible were flushed out and pooled. Cells were then 
pelleted by centrifugation at 250g for 6 minutes. It was found that 
splenocytes proliferate more readily and yield more metaphase 
chromosome spreads when spleens from two or more animals were 
pooled, only spleens from animals of the same genotype were pooled. 
Supernatant was removed and cells resuspended in 5ml lymphocyte 
culture medium (RPMI-1640 with Glutamax 11, 15% fetal calf serum 
(Gibco-BRL) and O.lmg/ml gentamicin sulphate (Sigma). Two 5ml 
cultures were set up per spleen in round-bottomed, 15ml snap-cap 
polystyrene tubes (Falcon), one consisting of 1ml of cell suspension plus 
4ml lymphocyte culture medium, the other; 2ml cells plus 3ml medium. 
Lipopolysacharride (from Salmonella enteriditis, Sigma #L-6011) was added 
to each culture at 50|xg/ml. Cultures were incubated at 37°C (5% C 0 2) with 
tube caps left loose to allow gas exchange. One 1ml and one 2ml culture 
was incubated for 44 hours whilst similar cultures were incubated for 46 
hours. In a subset of cultures ethidium bromide was added at a 
concentration of lOpg/ml two hours before harvesting. This acts as an 
intercalating agent between DNA strands therefore decelerating 
contraction of metaphase chromosomes, thus yielding more elongated 
metaphase chromosomes. Following incubation, cells were spun at 250g 
for 6 minutes and the supernatant removed. Cells were resuspended in 
hypotonic 75mM KC1 solution, the first 1ml being added dropwise, with 
constant agitation, and then carefully overlaid with a further 9ml. Cells
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were incubated at room temperature for lOmin prior to further 
centrifugation at 250g for 6 minutes, and the supernatant removed. Freshly 
made fixative (3:1, methanol:glacial acetic add) was added, for the first 
lm l, dropwise, with constant agitation to prevent cell clumping, and the 
remaining 9ml gently overlaid. Cell suspensions were incubated overnight 
at 4°C. The following day, cells were spun at 250g for 6 minutes, fixative 
removed, and cells resuspended in 10ml fixative. This was repeated except 
the cells were resuspended in 0.1-0.5ml of fixative.
Glass microscope slides (Raymond Lamb) were deaned thoroughly, first 
with hot soapy water, and then by soaking in absolute ethanol: 
concentrated HC1,1:1 (vol:vol). Slides were washed in running tap water, 
rinsed in dH^O, and stored in industrial methylated spirit (IMS) with a few 
drops of HC1 added. Just prior to use, slides were transferred to dH^O for 5 
minutes. They were then removed from the water and wiped once with a 
piece of tissue moistened in dP^O. Only slides showing a uniform thin film 
of water were used. Spreads were made by applying lOpl of cell 
suspension directly to the slide using a Gilson Pipettman. Slides were then 
air-dried at room temperature and then placed under vacuum, at room 
temperature, for at least 48 hours. These slides were then ready for G- 
banding and FISH experiments, although it was found that optimal G- 
banding was obtained if the slides were left at room tem perature for 
around 14 days following vacuum treatment. This is in accordance with 
the published observations of E.P Evans [76].
2.2.19 Giemsa banding of metaphase chromosome spreads
Giemsa (G-) banding was performed according to standard protocols with 
modifications [76]; [80]; [81]. to prepare Giemsa stock, 7.63g Giemsa
56
powder (BDH) was dissolved in 500ml glycerol by incubation at 50°C for 
30 minutes, with occasional mixing, and allowed to cool prior to addition 
of 500ml methanol. This stock solution was filtered with W hatmann 3MM 
paper and stored at room temperature. Working Giemsa solution was 
prepared by addition of 1ml stock to 50ml lOmM sodium phosphate buffer 
pH 6.8.
Following aging, slides were incubated in 2x SSC at 60°C for 60min in a 
glass Coplin jar. After cooling to room temperature and a brief 
equilibration in PBS, slides were incubated for between 5 and 20 seconds 
(optimised for each set of slides) in fresh trypsin solution. This was made 
by diluting 0.25ml Difco Bacto-trypsin stock (dissolved in dH20  and stored 
at -20°C) (Difco Labs #0153-60-2) in 50ml PBS. After a brief rinse in lOmM 
phosphate buffer pH  6.8, slides were transferred to working Giemsa 
solution at room temperature for 15 -  20 minutes. Slides were then rinsed 
in deionized dH20  and air dried prior to documentation of G-banded 
spreads (see section 2.2.22).
Prior to FISH, slides were prewashed with xylene and then 1:1 
xylene:ethanol for lm in each, then destained with two 5min washes in 3:1 
methanokglacial acetic acid. Spreads were refixed in 4% 
paraformaldehyde in PBS for 10 minutes followed by four 5 minute washes 
in PBS, a brief rinse in dH20  and air-drying. Slides were then used for 
FISH within 24 hours.
2.2.20 Labeling of FISH probes
FISH DNA probes were labelled according to a modification of Wilkinson 
et. al. [81] For biotin labelled probes a nick translation mix was assembled
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on ice containing 500ng purified probe DNA (6pl), 0.3mM dATP, dCTP, 
dGTP (Amersham Pharmacia), Bio-16-dUTP (Boeringher Mannheim) (2.5pl 
of each), nick translation salts (0.5M Tris.HCl pH  7.5; 0.1M M gS04; ImM 
dithiothreitol; 500pg/ml BSA fraction V (all Sigma)) (2pl) and lp l of Rnase- 
free Dnase 1 (Amersham Pharmacia) freshly diluted 1:500 in ice-cold dH ,0. 
The reaction mix (total volume 19pl) was spun briefly and lp l of E. coli 
DNA polymerase I (Sigma) added (final reaction conditions: 50mM 
Tris.HCl pH7.5, lOmM M gS04, O.lmM DTT, 50pg/m l BSA, 62.5mM dATP, 
62.5mM dCTP, 62.5mM dGTP, 62.5mM bio-16-dUTP. This mixture was 
incubated at 15°C for 90min and then the reaction was stopped by 
incubation at 65°C for 10 minutes following the addition of 2pi 0.2M EDTA 
and lp l 5% SDS. TE pH  8.0 was added to give a total volume of lOOpl and 
unincorporated deoxyribonucleoside-triphosphates removed using a 1ml 
Sephadex G-50 column (as section 2.2.14). 5pl of lOm g/m l sheared salmon 
sperm DNA (Sigma), 50pl of 3M NH4 acetate pH4.6 and 500pl of ice-cold 
absolute ethanol were added to the 200pl of eluate and the probe DNA 
precipitated overnight at -20°C. The DNA was pelleted by centrifugation 
at 12000g for 10 minutes and the supernatant removed. After washing 
with 1ml of 70 EtOH, the pellet was dried and re-dissolved in 50pl of TE 
pH  8.0.
Labelling of DNA probes with digoxigenin was performed identically to 
the biotin labelling procedure except that the bio-16-dUTP was substituted 
for dig-11-dUTP (Boeringher Mannheim).
2.2.21 FISH of chromosome spreads
FISH was carried out according to a modified version of the protocol used 
in the MRC Hum an Genetics Unit, Edinburgh [80]. Slides which had not
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been G-banded required a pre-treatment step with RNase in which they 
were equilibrated for 5 minutes at room temperature in 2x SSC, followed 
by incubation in O .lmg/ml Rnase (Sigma) at 37°C for 1 hour. Previously G- 
banded slides did not require this step.
Probe preparation was carried out in advance, or in the case of non G- 
banded slides, during the RNase treatment step. For each slide, 50ng of 
probe DNA was added to 2pg of C0t-1 DNA (Gibco-BRL) and 2 volumes of 
absolute ethanol, and dried to a pellet under vacuum. Approximately 30 
minutes prior to using on slides, 15jxl of FISH hybridisation mixture (50% 
formamide (Ultra grade, Sigma), 2x SSC, 1% Tween-20 (Sigma) and 10% 
dextran sulphate (Sigma) was added to the probe DNA pellet. This 
mixture was incubated at 37°C for 15 minutes and vortexed in order to 
dissolve the probe DNA, prior to further incubation at 37°C. Just prior to 
use, the probe DNA was denatured at 70°C for 5 minutes followed by 
incubation at 37°C for a further 30 minutes to allow pre-annealing of the 
C0t-1 DNA to any repetitive sequence elements in the probe.
Slides were equilibrated in 2x SSC for 5 minutes, at room temperature, and 
then dehydrated by passing through 70%, 80% and 100% absolute ethanol 
for 2 minutes each and air-dried under vacuum. Dried slides were 
incubated at 70°C for exactly 2 minutes and then transferred to pre­
warmed denaturation solution (70% formamide, 2xSSC) at 70°C for exactly 
2 minutes. Slides were then quickly passed into ice-cold 70% absolute 
ethanol for 2 minutes before dehydration in 90% and 100% absolute 
ethanol at room  temperature as before. Slides were then dried under 
vacuum.
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15|il of hybridisation cocktail was pipetted onto a 22x22mm coverslip 
(stored in IMS) placed on a hotplate. Slides which had been pre-warmed 
on the hot-plate for no more than 2 minutes were then used to pick up the 
probe-carrying coverslip. Tip-Top rubber cement (Cat#5059128, Rema Tip- 
Top UK, Westland Square, Leeds LS11 5X5) was used to seal the edge of 
the coverslip, and slides were incubated overnight at 37°C.
Following overnight hybridisation, the Tip-Top rubber seal was removed 
carefully and coverslips allowed to fall off by immersion in 2x SSC at room 
temperature. Slides were washed in pre-warmed 50% formamide, 2x SSC, 
at room temperature, four times for 3 minutes each wash. After four 
further 3 minute washes in 2x SSC at 45°C, and four 3 minute washes in 
O.lx SSC at 60°C, slides were equilibrated in SSCT (4x SSC, 0.1% Tween-20) 
at room temperature for 10 minutes.
SSCTM blocking buffer was prepared by dissolving 5% powdered milk 
(Sainsburys) in SSCT and spinning at 300g for 10 minutes, after which 
clarified blocking solution was removed. Fluorescent antibodies were 
prepared by addition to clarified SSCTM in the correct concentrations, 
following which the solution was spun at 15000g for 10 minutes and the 
supernatant removed and stored at 4°C until required.
All antibody incubations were carried out with 50pl of antibody solution 
under a coverslip, at 37°C, in a humidity chamber. After incubations, 
slides were washed three times for 2 minutes in SSCT at 37°C. For 
detection of biotinylated probes with FITC labelled antibodies, slides were 
incubated w ith 50pl of SSCTM for 30 minutes at room temperature, 
followed by incubations with a 1:500 dilution of avidin FITC (Vector) for 30
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minutes, then a 1:100 dilution of biotinylated anti-avidin (Vector) for 30 
minutes and finally a further 30 minute incubation with avidin FITC, again 
diluted 1:500. For detection of digoxigenin-labelled probes with FITC 
antibodies, slides were incubated firstly in SSCTM for 30 minutes at room 
temperature, and then in a 1:15 dilution of sheep anti-digoxygenin-FITC 
(Boeringher Mannheim), followed by anti-sheep FITC (Vector), diluted 
1:200.
After completion of antibody incubations and final washes, slides were 
incubated in the dark for 5 minutes in PBS containing 0.25pg/ml DAPI (4,6- 
diamidino-2-phenylindole) and then washed twice for 5 minutes each in 
PBS. Slides were m ounted in Vectashield m ountant (Vector) and coverslips 
sealed w ith clear nail varnish (Boots).
2.2.22 Image capture of chromosome spreads
Slides were examined using a Leica DMRB microscope equipped with 
epifluorescent illumination and the appropriate filter blocks. Spreads were 
located at x200 magnification and then examined in more detail at xlOOO 
using an oil immersion xlOO objective. Image capture was carried out 
using a cooled CCD camera (Hamamatsu) linked to a PC equipped with a 
frame grabber card. The Image Pro Plus V3.0 software (Media Cybernetics) 
was used to capture images and process them for colour and brightness. 
False colouring and merging of fluorescent images was done using 
Photoshop V5.0 software (Adobe).
Following G-banding, images of multiple metaphase chromosome spreads 
were captured and their respective locations recorded using the X-Y stage 
ruler. This allowed relocation of the same spreads following FISH. It was
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found that by setting up the microscope for Kohler brightfield illumination 
but using the phase ring at position 1 rather than brightfield, more detailed 
G-banding could be obtained. A decrease in numerical aperture, resulting 
in both increased contrast and depth of field is thought to be responsible 
for this phenomenon (W. Bennett, pers. comm.).
2.2.23 Processing, embedding and sectioning of tissue samples
This was performed according to standard procedures [82]. Tissue blocks 
were fixed in 4% Paraformaldehyde in PBS for 12 hours with one change of 
fixative (unless stated otherwise). Fixed tissues were processed using a 
Leica autom ated processing machine. Samples were rehydrated by passing 
through 70%, 80%, 90%. 95%, 100% and 100% EtOH, for a period of 30 
minutes or 1 hour (dependent on sample size) in each solution. Tissues 
were cleared by passing through xylene twice (30 minutes or 1 hour per 
change) and then incubated in paraffin wax at 60°C for 1 hour prior to 
embedding in paraffin wax.
Wax blocks were trimmed and tissue sections cut at 7pm using a Leica 
microtome. Sections were floated on a water bath and transferred onto 
slides previously treated with TESPA (3-aminopropyltriethoxysilane) 
(Sigma), as per the standard protocol. Following air-drying, slides were 
suitable for staining.
2.2.24 Haematoxylin and eosin staining of processed tissue samples
This was performed using a modification of the standard procedures [82]. 
Slides were dewaxed in two 2 minute changes of Histoclear (National 
Diagnostics) then rehydrated by passing through 100%, 100%, 95%, 90%, 
70% and 50% EtOH for 2 minutes in each solution, followed by 1 minute in 
dHzO and 20 minutes in Mayer's haematoxylin (Raymond Lamb).
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Following a brief rinse (30 seconds) in dH20  and washing under cold 
running tap water for 5 minutes, slides were passed through 50%, 70% and 
100% EtOH for 2 minutes in each solution. Slides were then stained for 20 
minutes in Eosin Yellow (0.1% in 100% EtOH) and passed through two 
changes in 100% EtOH (2 minutes each) and two changes of Histoclear (2 
minutes each). Slides were then mounted under coverslips with DPX 
mountant (BDH).
2.2.25 Documentation of stained sections
Slides were viewed using bright field illumination on either a Leica DMRB 
or Nikon Eclipse E800 microscope. Images were photographed using 
Kodak Ektachrome 64 film.
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3.1.1 74 lines of transgenic mice used in this study were generated by 
microinjection of one of eight DNA constructs into the pronuclei of fertilised 
mouse eggs.
The Igf-2 and HIS  loci are closely linked on mouse chromosome 7 but are 
differentially expressed depending upon parental origin, Igf-2 normally 
being expressed from the paternally inherited allele [83] and H19 from the 
maternally inherited allele [84].
Studies were initiated to elucidate the function of five regulatory elements 
located in the Igf-2/H19 region (see Fig 3.1) that might have a role in 
genomic imprinting and gene expression at this locus. To eliminate any cis 
interactions with other domains in this region it was decided to study the 
function of these elements in isolation from their normal genomic 
environment. This can be most easily achieved by using injection 
transgenesis to make multiple transgenic lines for each DNA construct.
Eight different constructs were used, each based on the 153bp, Igf-2 P3 
promoter region upstream  of a luciferase reporter cassette; consisting of the 
firefly (Photinus pyralis) luciferase gene and an adjoining SV40 small t 
intron/polyadenylation signal, which ensures correct expression of the 
reporter in mammalian cells [85]. The remaining seven constructs 
contained various combinations of four Igf-2/H19 regulatory regions, 
attached to this basic reporter construct (see Fig.3.2).
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Fig. 3.1. The Igf-2 and H19 loci and regions used to make the transgene constructs.
These include the differentially methylated region (DMR), the Igf-2 P3 promoter, the 
centrally conserved domain (CCD), and the H19 promoter and enhancer (H19 PROM /H19 
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Fig. 3.2. Constructs used to make transgenic mice.
Note that the initial letter of each line corresponds to the construct used. Genomic regions 
used include the differentially methylated region (DMR), the centrally conserved domain  
(CCD) and the H 19  promoter and enhancer elements. Each construct contained the Igf-2 P3 
promoter and a luciferase reporter gene (Luc) (figure adapted from Bennett [80]).
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Constructs were linearised and then microinjected into one pronucleus of a 
fertilised mouse egg derived by crossing a C57BL/6J male with a CBA/Ca 
female.
Each construct was assigned a letter of identification and used to generate 
multiple transgenic founders, the name of the associated line being derived 
from the sex of the founder and the letter of the construct used. For 
example, the Ann line was derived from a female founder carrying an 'A ' 
construct transgene.
Most lines were tested for transgenicity by performing a luciferase assay on 
a tail biopsy. Lines that did not express detectable levels of luciferase were 
genotyped by Southern analysis using a transgene specific probe. Southern 
blotting was also employed to confirm that each transgenic line 
represented an integration event of one or more transgene copies at a 
single position in the mouse genome.
In this way 74 lines of transgenic mice were generated with multiple lines 
being derived from one of eight DNA constructs and each representing a 
unique transgene integration event.
3.1.2 A systematic screen for insertional mutants
The mouse lines used in this study were derived in Oxford and 
subsequently transferred to Bath. Stocks in Oxford had been exposed to a 
variety of common mouse viruses and in order to satisfy house rules in 
Bath every line was re-derived by Caesarian section prior to entering the 
animal facility there. Foster mothers subsequently raised litters delivered 
in this way. It was during this procedure that a number of developmental
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abnormalities were observed which might have otherwise escaped 
detection due to peri-natal lethality or cannibalism by parents. It was 
postulated that some of these phenotypes may have arisen by transgene 
insertional mutagenesis. This is a well-known phenomenon, and screens 
for insertional mutants have previously been conducted on large series of 
transgenic mice [26]. In order to identify possible insertional m utant 
phenotypes it was decided to initiate a systematic screen on the transgenic 
lines generated. This study is ongoing and is based around a two-step 
breeding strategy.
In order to identify recessive as well as dominant mutations it was 
necessary to generate animals that were homozygous for the transgene by 
intercrossing hemizygous transgenic mice. Such a strategy also facilitated 
the identification of embryonic or peri-natal lethality in homozygous 
animals that would upset the normal 1:2:1, homozygous 
transgenic:hemizygous transgenic:non-transgenic ratio of offspring types 
expected from such a cross. Sex-linked mutations would also be 
identifiable in that a sex-linked phenotype will be apparent in 100% of the 
transgenic male offspring from such a cross but only 50% of the transgenic 
female offspring. Detection of sex-linked embryonic lethality was also 
possible through the generation of a sex-ratio distortion of transgenic 
offspring from such crosses.
The need for the second breeding step in this strategy becomes apparent 
when considering the difficulties in distinguishing hemizygous and 
homozygous transgenic animals. Both the luciferase and Southern blot 
genotyping assays allow only the discrimination of transgenic from non- 
transgenic mice, but not the unambiguous distinction of hemizygous from
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homozygous transgenic animals. Backcrossing a known transgenic, 
generated by hemizygous intercrossing, against a non-transgenic 
F1(C57/CBA) (resulting from a C57BL/6J against CBA/Ca cross), and 
analysing the genotypes of the offspring, allowed the exact genotype of the 
transgenic parent to be determined. A hemizygous parent should produce 
an equal number of both transgenic and non-transgenic offspring, whereas 
a homozygous parent will produce offspring that are all transgenic. 
Animals being tested in this manner were bred until it had been 
determined, with statistical significance, whether they were homozygous 
or hemizygous. Confirmation of homozygosity required a transgenic 
animal, upon backcrossing against an F1(C57/CBA) partner, to produce at 
least 11 transgenic pups without any non-transgenics (p<0.001, using the %2 
test, see section 3.2.2). The identification of at least one homozygous mouse 
of each sex bearing no detectable phenotype was deemed enough to 
eliminate this line from further testing.
Thus, the coupling of such genetic testing for homozygosity, with the 
intercross strategy for the detection of post-natal defects, facilitated the 
screening of a large number of transgenic lines for a variety of putative 
transgene insertional m utant phenotypes.
3.1.3 Drawbacks of such a screening strategy
By means of hemizygous intercrossing, lines producing obvious defects 
could be quickly ear-marked for further investigation. Genetic testing for 
homozygosity was required to eliminate remaining lines from the screen 
and in the majority of lines in which no insertional mutation was present, 
both male and female homozygotes were identified within the first few 
animals tested. A noticeable shortcoming in this screening strategy was the
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difficulty encountered when a putative insertional mutation generated a 
phenotype other than an obvious post-natal defect such as embryonic 
lethality or sterility. In such cases it became necessary to subject large 
numbers of transgenic animals to genetic testing for homozygosity until 
numbers sufficient to provide statistical significance had been bred. 
Obviously such a strategy requires considerable effort and financial costs, 
meaning that further genetic testing of lines following the identification of 
single homozygotes of each sex, stretched beyond the scope of the study. 
As a result, it is possible that more subtle phenotypes may have been 
missed. The nature of this strategy also creates difficulties in identifying 
and characterising m utant phenotypes that display variable penetrance or 
expressivity (although at least two of the identified m utant lines are 
suspected to have variably penetrant phenotypes, see below). This 
problem was accompanied by the fact that transgenic mice were generated 
on a mixed genetic background that became less uniform with each 
additional breeding step. This could have interfered with the 
reproducibility of variably penetrant phenotypes, which are affected by 
differences in genetic background.
Finally, the generation of transgenic mice from a single founder and the 
inbreeding required by this screening strategy meant that the fixation of a 
non-transgene-related, spontaneous m utant phenotype in the mouse 
population was a realistic possibility. Prior to conducting further 
characterisation it was necessary to eliminate this as the source of mutation 
in putative insertional m utant lines by confirming that the transgene and 
phenotype were co-segregating and closely linked.
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3.2 Materials And Methods
3.2.1 Intercross strategy to identify recessive mutant phenotypes
Within each line, mice previously identified as being transgenic were bred 
and a tail biopsy taken from all progeny at between 4 and 7 days of age 
and used for genotyping. Offspring were kept under observation for 
possible m utant phenotypes.
3.2.2 Backcross strategy to identify mice homozygous for the transgene
To determine whether transgenic mice derived from a hemizygous 
intercross were homozygous or hemizygous for the transgene, they were 
bred with a wild-type (usually F1(C57/CBA)) mouse. Offspring were 
culled at birth and a tail biopsy taken and genotyped. This was carried on 
until enough progeny had been tested to confirm whether the transgenic 
parent was hemizygous or homozygous. The number of progeny tested 
was determined by %2 analysis, taking the null hypothesis to be that the 
transgenic parent is hemizygous. In this case equal numbers of transgenic 
and non-transgenic progeny should be born. For a %2 test to have 
significance the expected numbers in each class must be at least 5, meaning 
that a minimum of 10 progeny must be tested. If 11 offspring are tested 
and all are found to be transgenic, performing a %2 test will give a P value 
of < 0.001, in other words there is a likelihood of less than one in a 
thousand that the transgenic parent is hemizygous. Thus 11 or more 
progeny were tested before the genotype of the transgenic parent was 
confirmed as homozygous. The identification of one or more non- 
transgenic offspring confirmed the parental genotype as hemizygous.
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3.2.3 Genotyping
Progeny were genotyped in duplicate by luciferase assay on a tail biopsy 
sample. In the event that an assay proved inconclusive, especially in lines 
expressing lower levels of luciferase, genotyping was performed by 
Southern analysis on genomic DNA derived from biopsy material (see 
section 2.2.17). Southern blot probes were selected based on the criteria 
that they could hybridise to both the transgene and a sequence endogenous 
to the mouse genome. This facilitated the detection of both an endogenous 
band, confirming a successful assay and, in the case of a transgenic sample, 
a transgene specific band.
3.2.4 Caesarian rederivation
Timed matings were set up in Oxford between transgenic animals and 
either wild-type F1(C57/CBA) or transgenic partners. Pregnant mothers 
were transported to Bath and sacrificed on day 18.5 of gestation by cervical 
dislocation. The mother's body was dipped in 70% EtOH and the uterus 
carefully dissected out and rinsed in sterile PBS at 37°C. The foetuses were 
dissected out by a second person and passed to a third who revived the 
pups and transferred them to a foster mother. Mice that had given birth 
that day or one day previously were chosen as fosters and their own litter 
removed up to four hours beforehand.
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3.3 Results
3.3.1 An overview of screen to date
Of the original 74 transgenic lines generated, homozygous animals in both 
sexes were bred in Oxford for 21 lines (see Table 3.1) 19 of which were not 
transferred to Bath. A further 14 lines either failed to breed in Oxford or 
were not successfully re-established in Bath and became extinct. During 
the Caesarian re-derivation of lines in Bath a number of abnormalities were 
discovered (see Table 3.2). The 41 transgenic lines successfully re-derived 
in Bath were also put through the two-step breeding strategy already 
described in section 3.1.2, in order to screen for recessive developmental 
abnormalities (see Table 3.1)
In summary (see Table 3.3), 45 lines were readily bred to homozygosity for 
the transgene in both sexes, allowing their elimination from the study. An 
additional 6 lines were bred extensively but either failed to yield breeding 
homozygote male or female animals, or homozygotes with manifest 
m utant phenotypes. Three lines have post-natal phenotypes confirmed as 
being associated with transgene insertion (Ann, Harry and Holly (although 
occasional homozygous mutants have bred for this line)) and have been 
further characterised [80], 2 lines have suspected embryonic lethality 
phenotypes (Antonio and Ingrid) and the remaining line has suspected 
embryonic lethality with variable penetrance such that some putative 
homozygotes are born and display growth retardation and subsequently 
die before reaching the age of sexual maturity (Gertrude). In 12 lines, 
either male or female homozygotes were never identified. In the 4 lines in 
which no female homozygotes were bred, insufficient animals were tested 
to allow for statistical significance and these lines displayed no evidence of
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any m utant phenotype. Testing of females in one of these lines (Quark) is 
ongoing, but the remaining three lines are now extinct (Ian, In and 
Tarquin). Similarly, in 4 of the 8 lines in which no male homozygotes were 
identified, the num ber of animals tested was insufficient and no mutant 
phenotype was apparent. All 4 of these lines are now extinct.
In one of the remaining lines in which male homozygotes were never 
identified, Ob, a male infertility phenotype has been characterised (see 
Chapter 8). A total of 36 transgenic males were set up for genetic testing by 
backcross mating. Of these, only 23 animals bred, all of which were 
confirmed as hemizygous for the transgene. The remaining 13 animals 
(36% of the total set up) failed to breed. In a second line -  Grace (now 
extinct), male infertility seemed probable. Again, a noteable proportion of 
transgenic males set up for genetic testing failed to breed (6 of 26, 30%) 
whereas female homozygotes were readily identified (4 of 14 transgenic 
females tested). Another line (Axe) shows evidence of embryonic or 
perinatal lethality. Although only one female has been tested, no 
homozygotes animals have been identified amongst a total of 23 transgenic 
animals tested (the probability of this happening by chance is <0.001, as 
determined by %2 analysis). The Titus line exhibits a post-natal lethality 
phenotype that affects approximately one third of offspring from 
transgenic intercrosses (see Table 3.4). Here again, the identification of 2 
female homozygotes might reflect a variability of phenotypic penetrance.
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Numbers bred to date.
6 9
tg/tg tg/+ tg /tg tg /+
Alicia Yes N o N o 3 8 1 10
Alison N o N o N o 2 0 2 1
Amanda Yes N o N o 1 2 1 4
Anabella N o N o N o 0 1 0 2
Andrew N o N o N o 0 2 0 2
Ann Yes N o Yes See Chapter 5
Antonio Yes N o N o 0 15 0 16
April N o N o N o 0 2 0 2
Archy Yes No N o 1 8 3 2
Arramis N o No N o 1 0 1 1
Axe Yes Yes N o 0 22 0 1
Ayah Yes N o N o 0 7 0 8
Azure Yes N o N o 3 7 6 8
Edmond N o N o N o 0 1 1 2
Edna N o N o N o 1 0 2 0
Edy N o N o N o 1 0 1 4
Elaine N o N o N o 1 0 2 0
Eleanor N o N o N o 0 0 0 0
Ellen N o N o N o 1 1 1 1
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Elly N o N o N o 2 0 2 0
Elton N o N o N o 0 1 1 1
Elvis Yes N o N o 2 11 1 7
Erasmus N o N o N o 1 0 1 1
Eric N o N o N o 0 1 0 2
Ethel Yes N o N o 2 2 1 6
Eva Yes Yes N o 1 8 2 5
Gentian N o N o N o 2 3 2 11
George N o N o N o 2 2 3 13
Gertrude Yes N o N o 0 15 0 16
Grace N o N o N o 0 26 4 10
Graham N o N o N o 2 1 2 7
Hamish Yes Yes N o 3 5 2 3
Hank N o N o N o 2 0 2 2
Harold Yes Yes N o 1 5 8 4
Harry Yes N o Yes W.R. Bennett, PhD thesis[80]
Hector N o N o N o 1 2 2 2
Heidi N o N o N o 0 3 0 7
Helen N o N o N o 0 0 0 0
Helga Yes N o N o 1 12 1 7
Holly Yes N o Yes W.R. Bennett, PhD thesis [80]
Homer N o N o N o 1 1 2 2
H ugo N o N o N o 0 4 3 3
Hum phrey N o N o N o 2 2 1 0
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Ian Yes Yes N o 1 3 0 0
Ibadan Yes N o N o 1 1 1 6
Ice Yes Yes N o 1 0 2 2
Id Yes Yes N o 0 1 0 0
If Yes N o N o 2 2 3 5
111 Yes N o N o 2 4 1 0
In Yes Yes N o 1 2 0 3
Ingrid Yes Yes N o 0 9 0 15
Isac Yes N o N o 1 0 1 1
Oat N o N o N o 2 2 3 1
Ob Yes N o Yes 0 23 1 7
Oc Yes Yes N o 1 6 1 3
Odd Yes Yes N o 2 4 1 4
Oh N o N o N o 2 6 3 4
Oil Yes Yes N o 1 0 1 7
Ok Yes N o N o 1 3 2 5
On N o Yes N o 0 7 3 1
Ost Yes Yes N o 1 6 4 0
Ovid Yes N o N o 3 9 3 4
Owl Yes Yes N o 1 4 1 0
Tarquin Yes N o N o 1 0 0 1
Tessa N o N o N o 1 0 2 1
Theresa N o N o N o 2 1 1 1
Tiberius N o N o N o 0 0 0 0
Tilly Yes N o N o 3 3 1 1
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Tim Yes N o N o 1 0 1 2
Titus Yes N o N o 0 32 2 3
Tracy Yes N o N o 2 0 1 4
Tutu N o N o N o 0 1 0 2
Quark Yes N o N o 1 4 0 3
Quasar Yes N o N o 2 14 1 19
Table 3.2. Abnormalities discovered during Caesarian sectioning
Line Defect
Axe 1 craniofacial defect - lower jaw severely affected
Eva 2 "big-skulls" - grossly expanded crania
Hamish 2 exencephalies
Harold 1 exencephaly
Ian 1 execephaly, 2 omphalocoel, 1 "puffer"-fluid-filled thoracic region and 
pale appearance
Ice 1 "thalidomide" - stunted limbs
Id 1 "thalidomide"
In 1 hindleg deformity
Ingrid 1 "thalidomide"
Oc 1 hindlimb deformity - "paddle-limb"
Odd 1 hindlimb deformity - "flipper foot"




Table 3.3. Summary of data derived from screening program
Number of lines Breeding status Defects
45 d  and 9 bred to hom ozygosity None
7
(Does not include 10 
lines where too 
few /n o n e  were tested 
prior to extinction).
N o d  or 9 hom ozygotes or 
hom ozygotes with manifest mutant 
phenotypes.
3 lines, post-natal phenotypes 
(Ann, Harry, Holly).
1 line, partially penetrative, 
growth retardation/embryonic 
lethality (Gertude).
3 lines, suspected embryonic 
lethality (Antonio, Ingrid, 
Ayah).
4 Only d  bred to hom ozygosity Probably none (Ian, In, Tarquin 
extinct, Quark -  still 
breeding).
8 Only 9 bred to hom ozygosity 1 line, d  infertility (Ob).
1 line, probable d  infertility 
(Grace -  extinct).
1 line, possible d  embryonic 
lethal (Axe).
1 line, possible partially- 
penetrative post-natal lethality 
(Titus).
4 lines, probably none 
(Edmond, Elton, Hugo, On).
Table 3.4. Titus breeding data.
Sex/genotype Total number of 
animals
Post natal deaths % of total animals 
displaying transgene 
specific abnormality
d  - transgenic 37 13 35
d  - non-transgenic 15 2
9 - transgenic 35 10 29
9 - non-transgenic 14 0
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3.4 Discussion
3.4.1 The screen has identified several lines displaying reproducible 
developmental abnormalities
The screen successfully identified 4 lines that display reproducible 
developmental abnormalities (see Table 3.5). These lines have subsequently 
been confirmed as bona-fide transgene insertional mutants and have been 
subjected to further investigation.
A defect in the Ann line was first observed in litters derived from 
hemizygous intercrosses in Oxford. A number of pups displayed 
progressive ataxia and tremor from around twelve days. These mice were 
also subject to gradual weight loss and worsening paralysis, and eventually 
died between 19 and 25 days old. Following successful re-derivation in 
Bath, it was decided to further investigate this line as a putative insertional 
mutant. The outcome of these investigations will be presented in Chapters 
4 -7 .
In one early Harry litter generated by a hemizygous intercross in Oxford, 
two transgenic stillborn pups showed extreme ventral curvature, small size 
and highly abnormal skin texture and colour. Further hemizygous 
intercrosses, both in Oxford and, following successful re-derivation, in 
Bath, reproducibly generated "piebald" transgenic pups in which 
homozygous mutants display a white coat colour spotting and lethal 
megacolon phenotype that most likely results from a neural crest defect. 
This line was selected for further investigation and subsequently the 
m utation was confirmed as being linked to the integrated transgene at a 
site in mouse Chromosome 15 [80]. The position of the transgene was
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m apped close to an existing coat colour mutation, dom (dominant 
megacolon), which apart from being dominant, exhibits an almost identical 
phenotype to that of Harry. The dom phenotype results from a mutation in 
the sox-10 gene and represents a mouse model for the human 
Waardenburg-Shah syndrome [86]. Northern analysis of Harry mutant 
mRNA revealed no abnormalities in sox-10 transcripts and to date it is not 
certain whether Harry represents a new allele of the sox-10 gene or a novel 
m utant of a gene located nearby [80].
The Holly line consistently gave small litters during hemizygous 
intercrossing in Oxford. Furthermore, three transgenic pups re-derived by 
Caesarian section in Bath, despite appearing normal at birth, displayed 
progressively worsening comeal opacity from about two weeks of age. 
This line was also chosen for further investigation and the mutation was 
confirmed as being linked to the transgene. Through FISH and linkage 
mapping the integration site was identified at the proximal tip of 
Chromosome 1. A number of possible, but not obvious, candidates were 
known to map in this region and Northern analysis was used to eliminate 
one gene, Eyal before another, the col9al collagenase gene was found to 
display aberrant expression in developing Holly m utant eyes. Holly does 
not represent a null mutation of the col9al gene but may instead be a 
mutation affecting expression in some tissues [80]. With further 
investigation Holly was found to represent a useful mouse model for the 
hum an disease, closed angle Glaucoma.
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Table 3.5. Transgene insertional mutant ines identified by screen
Line Phenotype Chromosome M apping Gene
Ann Cerebellar ataxia 4 See Chapter 5 m Dabl
Harry Neural crest defect 15 W.R.Bennett SoxlO
H olly Cataracts /  gluacoma 1 W.R.Bennett Col9al (C oll9?)
Ob Male sterility 8 See Chapter 8 unknown
Although investigations thus far have not progressed to the advanced 
stage reached for the three lines mentioned already, work done on the Ob 
line strongly suggests another recessive mutant phenotype. To date no 
homozygous male mice have been identified and approximately one third 
of male transgenic offspring generated by transgenic intercrossing failed to 
breed. Homozygous females were readily identified, implying a recessive 
male sterility phenotype in this line. Further characterisation of the Ob line 
will be detailed in Chapter 8.
3.4.2 A variety of abnormalities were observed during Caesarian re-derivation
As stated, breeding studies conducted in Oxford allowed the elimination of 
19 transgenic lines, whilst a number of other lines failed to breed and 
became extinct. It was attempted to re-derive the remaining lines in Bath 
by Caesarian sectioning (see section 3.2.4), and in the majority of cases this 
proved successful. A number of abnormalities were observed in pups 
during sectioning (as summarised in Table 3.3).
Noticeably, a high proportion of the abnormalities observed in pups 
during Caesarian sectioning could all be grouped into four classes which 
may be interrelated. Pups from In, Ice, Ingrid, Id, Oc and Odd displayed 
some form of limb deformity (fused digits, stunted or absent fore-limbs) 
whilst abnormal Owl, Ian and On pups were termed "puffer" mutants to
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describe a fluid-filled thoracic cavity. A number of Ian, Harold and 
Hamish pups displayed exencephaly. And finally pups from the Ian, Oil 
and Ost lines presented either omphalocoele or sacro-lumbar defects. All 
four classes of m utant could be encompassed within the sphere of Neural 
Tube Defects (NTDs) that result from a failure of the neural tube to close at 
various sites along its length. Of these, the Ian line proved difficult to 
maintain and became extinct, thereby curtailing follow-up studies, whilst 
subsequent breeding indicates that the Ingrid and Axe lines are suspected 
recessive embryonic lethal mutants.
A correlation has previously been shown between exencephaly, limb 
defects, omphalocoele and lower spinal defects and a failure of the neural 
tube to close but in the case of the thoracic oedema observed in a number 
of animals this correlation is rather more tentative. One possibility is that a 
failure of neural tube closure could prevent colonisation of the cardiac 
outflow tract by neural crest derivatives [87], although this hypothesis is 
rather questionable.
It is remarkable that such defects in independent transgenic lines are, in a 
number of cases, highly similar. Furthermore these presumptive neural 
tube defects arise only in lines derived from three of the eight transgene 
constructs, each of which have the CCD (centrally conserved domain) [88] 
enhancer element in common. These strands of evidence may suggest that 
the proposed neural tube defects are derived not from transgene 
insertional mutagenesis but rather from some effect associated with the 
CCD. It has been proposed that the CCD acts as a mesoderm-specific 
enhancer for the Igf-2 gene. High expression of CCD-driven reporter genes 
in mesodermally derived tissues, such as the notochord, may disrupt the
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development of the Neural Tube, a process which is known to be highly 
sensitive to interference. Alternatively, multiple copies of the CCD 
enhancer could affect the expression of other genes by binding high 
concentrations of transcription factors required for normal development of 
the Neural Tube.
It m ust be stated that these Neural Tube defects, along with a variety of 
other m utant phenotypes discovered during re-derivation in the Axe, Eva, 
Hamish and Harold lines have never been recapitulated during subsequent 
breeding. It is possible that a number of these phenotypes could have 
resulted from careless handling during sectioning. Alternatively, 
perturbation of normal development could have arisen sporadically and be 
totally unrelated to insertion of the transgene. This would be 
unexceptional since during any normal pregnancy a proportion of mouse 
embryos will not reach full term and will be resorbed at some stage during 
gestation.
3.4.3 Several other lines may represent additional mutant phenotypes
Although not confirmed as definite transgene insertion mutants, a number 
of lines did display phenotypic an d /o r breeding abnormalities suggestive 
of a m utant phenotype.
During hemizygous intercrossing in Oxford it was reported that a number 
of Gertrude pups, despite appearing normal at birth, typically died after 7 
to 10 days by which time they weighed 30% to 40% less than their siblings. 
This phenotype was never reproduced during extensive breeding in Bath, 
although a num ber of pups were observed which were markedly smaller 
than their siblings for the first two weeks but caught up in size thereafter.
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Genetic screening of this line via backcross mating was unable to identify 
any homozygous animals, although a large number of hemizygotes of both 
sexes were bred (15 males and 16 females). This data correlates with an 
embryonic lethality mutation, although the fact that a number of putative 
homozygotes were born but died shortly thereafter suggests a partially 
penetrant phenotype. The difficulties in studying this line were 
compounded by the fact that Gertrude mice were particularly poor 
breeders, with transgenic mice frequently failing to produce litters.
Two further lines may also represent recessive embryonic lethal mutants. 
In both the Antonio and Ingrid lines, no homozygous animals of either sex 
were ever identified. Sufficient male and female hemizygotes were bred 
(Antonio: 15d, 169, Ingrid: 9c?, 159 to strongly suggest recessive embryonic 
lethality in both lines. In future it will be necessary to analyse intercross 
litters in-utero in order to characterise when the loss of homozygotes occurs 
and to determine whether there is an obvious cause of death.
Similar to the situation in the Ob line, breeding of Grace male homozygotes 
proved impossible, despite the identification of 20 hemizygous male 
animals (and both hemizygous and homozygous females (the 28% 
observed correlates well with the 1/3  expected)). Of the 26 male transgenic 
animals set up for backcross testing, 6 did not breed (30% of male 
transgenics). This is suggestive of recessive male sterility in this line, 
although further characterisation was prevented by its extinction.
Despite the identification of 22 Axe hemizygous male animals, no 
homozygous males were ever bred. Of two Axe females tested, one 
hemizygote and one homozygote were identified. Since all animals tested
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bred successfully, sterility in homozygote males seems improbable. This 
data could therefore be explained either by a sex-linked, embryonic-lethal 
phenotype or by variably penetrant embryonic-lethality affecting both 
sexes. Further genetic testing of Axe transgenic females would be required 
to confirm either of these possibilities. As for the Antonio and Ingrid lines, 
Axe intercross litters should also be examined in-utero.
In the Titus line approximately one third of offspring generated by 
hemizygous intercrossing die at, or shortly after, birth (see Table 3.4). The 
identification of two female, but no male homozygotes may again reflect 
variable penetrance of this phenotype, although further genetic testing of 
transgenic females would be required to confirm this.
3.4.4 Numbers of mutants are comparable with those of similar studies
With Ann, Harry, Holly and Ob the only lines confirmed as subject to 
transgene insertional mutagenesis thus far, and taking into consideration 
that only 63 of the original 74 transgenic lines have been subjected to 
extensive breeding analysis, we can calculate the overall frequency of 
transgene insertional mutagenesis in this series of mice to be at least 6.3%. 
However, at this stage it may be safer to consider this as the frequency of 
readily detectable mutants, since a number of putative mutations of a less 
obvious nature (including possible embryonic-lethal phenotypes) are still 
awaiting confirmation. Two such previous studies reported ratios of visible 
mutation at 3% (in a series of 200 transgenic lines) [26] and 1.5% (139 
transgenic lines) [55]. The figure for this study of at least 6.3% is higher 
than, but still in keeping with, those of the other studies. Overall 
frequencies of transgene insertional mutation, including prenatal lethal as 
well as visible phenotypes, have been estimated at between 5% and 10%
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[55, 89, 90]. These figures suggest that identification of further insertional 
m utant lines in this screen is not unlikely, and indeed, if the remaining six 
putative insertional mutants are included in calculations, an overall figure 
of 16% for transgene insertional mutagenesis is reached. This is in keeping 
with figures obtained in the previous such studies.
3.4.5 A high proportion of mutants found in such screens have previously 
been identified
One noticeable facet of the screen as a whole is that a high proportion of 
the visible insertion mutants generated have arisen through re-mutation of 
classical lod. This statement is true both for the Harry line, which is 
probably a new allele of the dom locus, and, as we shall see in Chapters 4 to 
7, the Ann line. These findings are not uncharacteristic with a notable 
review of transgene insertional mutation stating that; of 23 visible, viable, 
transgenic mutations described, 13 were at previously known loci [26].
Obviously the screening strategies employed contribute greatly to these 
findings in that they favour genes which can be m utated to produce viable 
animals with visible abnormalities. The high frequency of re-mutation of 
classical loci does suggest that a significant proportion of such genes have 
already been mutated. It may therefore be advisable for future 
mutagenesis studies to be refined so that screening for embryonic lethal 
mutants, or more subtle phenotypes, is more rigorous. Indeed such 
problems are now being addressed with the utilisation of the SHIRPA 
protocol for detecting subtle neurological defects in a large-scale ENU 
mutagenesis-screening program  currently being conducted [91]. Such 
strategies may well be beyond the scope of studies such as ours, where 
transgenic experiments were initiated with a completely separate aim and
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the discovery of mutations was purely serendipitous. However, such 
studies, despite perhaps lacking the scale and depth of specific mutational 
screening programmes, have led to the functional characterisation of 
several mouse genes.
3.4.6 Are such visible mutation rates consistent with insertional mutagenesis 
being completely random?
It is the widely held view that transgene integration into the mouse 
genome is random  or at least near-random. It has however been estimated 
that if this was the case then the rate of visible mutation in transgenic mice 
should be 0.3% [26]. Our findings along with those of two similar studies 
suggest that this figure is somewhat less than that observed. Although 
limited evidence is available, non-random integration of transgenes into 
genes or other mutational 'hot-spots' could explain this apparent disparity.
3.4.7 Conclusion
Screening of the original cohort of luciferase transgenic mice is still 
incomplete, however, several putative transgene insertional mutants have 
been identified. Of these, four have been characterised in some detail, 
including confirmation of co-segregation of the phenotype with the 
transgene. The Harry and Holly lines have been described previously [80] 
whilst the Ann (Chapters 4 - 7 )  and Ob (Chapter 8) lines are the subject of 
this thesis.
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4.1.1 Identifying the physiological basis of the Ann phenotype
Ann m utant animals have a severe deficit in locomotion, but the 
physiological basis for this could be one of several possibilities that fall into 
at least three broad catagories:
The inability of mutants to walk without reeling to one side might be 
attributable to the wasting or weakness of skeletal muscle, which is 
symptomatic of a neurogenic or myopathic disorder. A neurogenic disease 
could be of either a motor neuron disease type, in which the nerve cell 
bodies of motor neurons are primarily affected, or a peripheral 
neuropathy, in which the motor axon is primarily affected. Myopathic 
disorders result from muscle fibre degeneration. Alternatively, an inability 
to plan or execute movements properly could be the basis of the Ann 
disorder and if so, might originate in one of the higher structures that exert 
some form of control over voluntary movements such as the motor cortex, 
cerebellum and upper motor neurons.
Such a broad range of possibilities presents a difficult challenge in the 
identification of the physiological basis of the Ann m utant phenotype. The 
identification of any pathological changes in Ann m utant mice would 
provide an invaluable handle on the exact nature of the disorder.
4.1.2 The motor unit
The term 'm otor unit' was first used to define the basic unit of motor 
function i.e. a motor neuron and the muscle fibres it innervates (discussed 
in [92]). A closer examination reveals that a motor unit can be subdivided 
into four functional components: the motor neuron cell body, the motor
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axon, the neuromuscular junction (NMJ) and the muscle fibres innervated 
by the motor neuron.
Motor nuclei are located in the ventral horns of the spinal cord where they 
synapse with both afferent neurons and neurons of descending pathways, 
as well as spinal intemeurons. Consequently both voluntary and reflex 
movements are facilitated through innervation of skeletal muscle by motor 
neurons. Action potentials are transmitted along the myelinated motor 
axon to the NMJ, which is the synapse between motor neurons and 
individual skeletal muscle fibres. The action potential generated at the 
NMJ is rapidly propagated throughout the length of the fibre and 
facilitates its mechanical contraction.
Skeletal muscle fibres are elongated, multinucleate cells, consisting of 
myofibril bundles enclosed in a membrane called the sarcoplasmic 
reticulum. A single muscle fibre is usually innervated by only one motor 
axon, although a single motor neuron can innervate more than one muscle 
fibre.
4.1.3 Myopathic disorders
Most diseases of the motor unit are characterised by weakness and wasting 
of skeletal muscles. If muscle becomes dysfunctional and denervation is 
not the cause, then the disorder is said to be myopathic. The muscle 
weakness observed in most inherited myopathies arises from the 
degeneration of muscle fibres, although in other cases a biochemical or 
some other defect in muscle fibres may be responsible.
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The best-characterised inherited myopathies belong to the muscular 
dystrophy group of diseases, and all involve the degeneration of muscle 
fibres. The commonest muscular dystrophy, Duchenne muscular 
dystrophy (DMD) is a fatal, X-linked, myopathic disease affecting 1 in 3300 
boys. DMD, along with an associated disease, Becker muscular dystrophy, 
is caused by mutation of the large membrane-associated protein, 
dystrophin (reviewed in Hoffman and Kunkel, 1989) [93].
Several of the proteins involved in other muscular dystrophy types co- 
localise with this protein in the dystrophin associated glycoprotein 
complex (DAGC). This complex is thought to be important in anchoring 
muscle cells to the extracellular matrix and in so doing protect the 
sarcolemmal membrane from the mechanical stresses that develop during 
muscle contraction. Disruption of this linkage has been proposed as the 
basis of the muscle fibre degeneration common to the different forms of 
muscular dystrophy (see Fig. 4.1) [94,95].
A pattern of muscle fibre degeneration and regeneration is observed in 
these diseases resulting in characteristic pathological features. 
Regenerating muscle fibres are typically of small-calibre and have centrally 
located nuclei. Necrotic fibres are also evident as is the accumulation of 
macrophages. Eventually in dystrophic muscle, myofibres are replaced by 
connective tissues. Additionally, elevation of serum creatine kinase levels 
is indicative of the breakdown of the sarcoplasmic membrane. Mouse 
models for a number of the muscular dystrophy types are already in 
existence with the gross phenotypes of several bearing strong similarities 
to the Ann m utant (see Table 4.1).
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A mouse mutant lacking dystrophin, the mdx mouse, was shown to exhibit 
the severe muscle pathology characteristic of DMD during the first 6 weeks 
of life. Thereafter the muscles of mdx mice recovered by virtue of 
substantial muscle regeneration, and these mice subsequently led 













Limb Girdle Muscular 
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Fig. 4.1. The components of the Dystrophin-associated glycoprotein complex.
The com plex provides a physical linkage between the muscle cell cytoskeleton and the 
extracellular matrix. Loss of a number of these proteins is associated with a variety of 
Muscular Dystrophy disease types, as indicated. Figure adapted from Novocastra 
Laboratories Ltd. Product range 2000 catalogue.
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Table 4.1. Mouse models of muscular dystrophy diseases
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This has limited the effectiveness of the mdx mouse as a model for DMD
[108]. The explanation for the phenotypic differences between mdx and 
DMD was subsequently attributed to the dystrophin related protein, 
utrophin. The expression of utrophin was found to be upregulated in mdx 
muscle where it functionally compensates for the dystrophin deficiency
[109]. This was confirmed by the generation of mdx:utrrih double mutants, 
which displayed progressive DMD-like clinical and pathological changes, 
thus providing a more accurate model of DMD than the mdx mouse [98, 
99]. Double mutants are subject to a marked reduction in size, a waddling 
gait, progressive dorsal-ventral curvature of the spine and eventual death. 
Although differing in the time course of disease progression (onset at 4 to 6 
weeks, death by 20 weeks) many of these gross phenotypic features are 
extremely similar to those of Ann.
The superficial similarities between the Ann m utant and a number of 
mouse models for various muscular dystrophies suggests that the nature of 
the disorder in Ann mutants may be myopathic in origin, and could be of 
the muscular dystrophy type. An obvious way to test this suggestion 
would be to carry out a histological examination of Ann m utant muscles in 
order to look for any characteristic muscular dystrophy disease pathology.
4.1.4 Motor neuron diseases
The hum an motor neuron diseases are a heterogeneous group of 
syndromes that have the common features of progressive degeneration of 
motor neurons and denervation atrophy of skeletal muscle. Motor neuron 
diseases may be sporadic or inherited, with clinical observation alone often 
insufficient to distinguish the two categories. Some of the diseases may 
affect only spinal motor neurons (termed lower motor neurons), whereas
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others may affect both lower motor neurons and neurons that originate in 
higher regions of the brain (termed upper motor neurons), such as the 
neurons of the corticospinal tract.
Muscular atrophy is a characteristic change in muscles innervated by 
degenerating lower motor neurons. As a result of denervation, muscle 
fibres are seen to shrink and eventually disappear. The axons of surviving 
neurons may sprout and reinnervate some of these muscle fibres but if the 
effect on motor neurons is progressive and affects surviving motor neurons 
then atrophy will be observed in groups of adjacent muscle fibres that will 
also take on an angular morphology
Degeneration of all motor neurons is characterised by a number of changes 
to neuronal morphology. The cell body of the motor neuron may swell in 
size with the nucleus adopting an eccentric position. Nissl substance is 
observed at the margin of the cell body rather than around the nucleus as 
in normal cells. These changes to the morphology of the cell body are 
termed chromatolysis, and are a diagnostic feature of motor neuron 
degeneration. Additionally Wallerian degeneration may be observed in 
which the axon terminal and its distal segment degenerates leaves behind 
myelin debris.
Approximately 80% of hum an inherited motor neuron disease is due to 
mutation of the SMA locus on chromosome 5. SMA (spinal muscular 
atrophy) affects mostly the lower motor neurons and is subdivided into 
three classes based on the level of severity. All three classes manifest as 
muscular weakness and localise to the same region of hum an chromosome 
5, suggesting the involvement of a single gene with multiple alleles.
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Neuropathological studies of SMA patients reveal a paucity of spinal 
motor neurons, with those surviving exhibiting chromatolysis. More 
subtle changes are also widespread throughout the nervous system, such 
as chromatolysis in sensory neurons. It has long been thought that SMA 
primarily involved the cell soma of motor neurons but it has been 
suggested that the primary abnormality originates in the distal axons (for a 
review see [HO]).
A number of mouse motor neuron disease mutants have been identified in 
which the lower motor neurons are primarily affected and which might 
serve as useful models for SMA (see Table 4.2). Furthermore a number of 
these mutants such as pmn (progressive motor neuropathy) [111], mnd 
(motor neuron degeneration) [112] and mndl (motor neuron degeneration 
2) [113] exhibit features which are strongly reminiscent of those observed 
in Ann mutants such as small size, progressive paralysis and premature 
death. This could suggest that Ann represents a model for some form of 
lower motor neuron disease.
Undoubtedly the most well-known hum an motor neuron disease is 
Amyotrophic lateral sclerosis (ALS). This disorder can be either sporadic 
or inherited and involves the progressive degeneration of both upper and 
lower motor neurons. The weakness and paralysis observed is attributable 
to degeneration of lower motor neurons, whilst spasticity and 
hyperreflexia result from lesions of the upper motor neurons. The 
hereditary and sporadic forms of ALS are clinically indistinguishable, but 
only about 10% of cases are inherited [114]. Mutations of the C u /Z n  
superoxide dismutase 1 (SOD1) gene have been found as the cause of disease 
in approximately 20% of familial ALS (FALS) cases [115]. SOD1 is a
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Table 4.2. Mouse models of motor neuron disease
Mutant Gene Gross phenotyope Pathology
progressive motor 
neuropathy (pmn) [111]
Unknown Progressive atrophy and 
paralysis, firstly of the pelvic 
girdle and hindlimbs, followed 
by forelimbs. Mutants smaller 
than normal. Death at 6 to 7 
weeks of age.
Degeneration, mostly of 
lower motor neurons, 
originating at motor 
endplates and progressing 
proximally, causing 
atrophy of skeletal muscle.
motor neuron 
degeneration 2 (mndl) 
[113]
Unknown Unstable gait, hunched posture 
and loss of balance visible from 
between 21 and 24 days, gradual 
decline in mobility of mutants. 
Failure to gain weight and 
eventual death prior to 40 days.
Chromatolysis exclusively 
in lower motor neurons, 
and denervation atrophy 
of skeletal muscles
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Loss of motor neurons, 
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Generally motor dysfunction 
and weakness.
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Unknown Hindlimb weakness and ataxia 
between 5 and 11 months, 
progressing to severe spastic 
paralysis of all limbs and death 
by 9 to 14 months.
Degeneration of both 
upper and lower motor 
neurons.
Wobbler (wr) [119] Unknown Small size, fine head tremor and 
'high-stepping' unsteady gait 
from 3 weeks. Progressive 
weakness from the fourth or 
fifth week, more severe in the 
forelimbs and anterior of the 
body. Most mutants die by 2 or 
3 months.
Degeneration of motor 
nerve cells in the brainstem 
and spinal cord
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member of a family of metalloenzymes that have the ability to catalyse the 
conversion of 0 2' to H20 2 and 0 2. Transgenic mice expressing m utant forms 
of hum an [116] and mouse [120] SOD1 have been generated and exhibit 
several clinical signs of ALS such as progressive weakness, muscle atrophy 
and paralysis, whereas transgenics expressing wild-type SOD1 display no 
phenotype.
Several other mouse motor neuron disease mutants are known to display 
degeneration of both upper and lower motor neurons and thus bear 
similarities to ALS (see Table 4.2). A number share similar phenotypes to 
the Ann m utant, most notably the recessive wobbler (wr) m utant that 
exhibits degeneration of the motor nerve cells in the brainstem and spinal 
cord [119]. Homozygotes are identifiable from about 3 weeks of age, being 
smaller than normal littermates and exhibiting a fine tremor of the head 
and a 'high-stepping' unsteady gait. Progressive weakness is apparent 
from the fourth or fifth week and most mutants die by 2 or 3 months of 
age. To consider the Ann m utant as a possible motor neuron disease 
model it will be essential to look for the pathological changes, both in 
muscle and motor neurons, which characterise these diseases.
4.1.6 Ion channels and channelopathies
Present in all cells, ion channels are membrane-spanning glycoproteins that 
play a key role in the normal function of both nerves and muscles. Ion 
channels belong to one of two major classes according to the type of signals 
that modulate their activity. The binding of a biologically active molecule 
such as a hormone or neurotransmitter activates ligand-gated ion channels. 
This type of channel plays an important role in controlling ion flux in the 
postsynaptic regions of nerve and muscle cells. Regulated by changes in
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membrane polarity, voltage-gated ion channels are critical to the 
propagation of action potentials in nerve cells.
Channels of both classes have been associated with a variety of genetic 
disorders, with defects in voltage-gated ion channels being especially 
prevalent. Neurological abnormalities are common to mutations in a 
number of K+, Na+ and Ca2+ ion channel genes. Weakness, ataxia, myotonia 
and paralysis are characteristic features of such channelopathies (for 
review see [121]). The genes encoding numerous ion channel subunits 
belonging to a variety of types have been identified and the 
characterisation of a number of these subunits has been aided by the 
availability of a myriad of spontaneous and engineered mouse mutants in 
the corresponding genes (see Table 4.3). Again a number of mutants of 
different ion channel types display phenotypic similarities to Ann mutants, 
including small size and gait abnormalities.
Amongst these is the recessive weaver (wv) mouse, which results from the 
spontaneous mutation of the inwardly rectifying K+ channel gene, Kcnj6 
[122]. Wv homozygotes are identifiable from 2 weeks of age by their small 
size, unstable gait, weakness and hypotonia [123]. In this case the ion- 
channel defect results in developmental abnormalities in the cerebellum 
(discussed in section 4.1.8).
The leaner (la) Cacnala, Ca2+ channel m utant also exhibits cerebellar defects 
that are manifest as ataxia, stiffness and retarded motor activity from 8 to 
10 days of age [123]. Most la homozygotes die at weaning. Mutations in 
the hum an homologue of the Cacnala gene, CACNA1A1, result in the 
hum an hereditary ataxia spinocerebellar ataxia 6 [124].
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Multiple alleles of the Scn8a Na+ voltage-gated ion-channel a  subunit gene 
have been isolated in the mouse. Motor end-plate disease (med) is a 
spontaneous recessive mutation of the Scn8a gene [133] that is 
characterised by progressive weakness of skeletal muscle and is apparent 
from 8 to 10 days of age leading to eventual death within 2 weeks of onset. 
Muscular atrophy is accompanied by terminal sprouting of motor axons 
that also display slower than normal conduction velocities [132].
Conclusive identification of an ion channelopathy based on 
histopathological analysis alone is virtually impossible owing to the range 
of tissues and functions dependant upon different ion channel types (e.g. 
motor end plate through to higher brain regions). In this instance, some 
form of molecular data would be invaluable to conclusively prove 
mutation of an ion channel-encoding gene in the Ann mutant.
4.1.7 Myelination and related neuropathies
The majority of axons in the nervous system are encapsulated in a myelin 
sheath that acts as an insulating structure and facilitates the high-speed 
conduction of action potentials. The myelin sheath consists of repeated 
bimolecular layers of lipids interspersed between adjacent protein layers, 
and is derived from multiple wrappings of oligodendrocyte (in the CNS) or 
Schwann cell (in the PNS) processes around the axon. The majority of 
cytoplasm is extruded from these layers leaving a highly compacted and 
organised sheath structure.
The most common hum an neuropathies result from perturbation of myelin 
formation or maintenance and have the common characteristic of a 
reduction in nerve conduction velocity. Since both sensory and motor
102
axons are myelinated, myelinopathies may affect both motor and sensory 
functions. Loss of sensation and parasthesias may result from sensory 
impairment, whilst weakness and paralysis are typical signs of motor 
abnormalities. Most inherited myelinopathies result from mutations of the 
structural proteins of myelin and can lead to dysmyelination or 
demyelination in the PNS, CNS or both (for reviews see [134-136]).
A num ber of mouse mutants, both naturally occurring and engineered, are 
available as models for different types of myelinopathy (see Table 4.4). 
Again similarities with the Ann mutant, especially tremors and gait 
abnormalities, are notable in several of these mutants suggesting the Ann 
phenotype may result from a myelination defect. Amongst the 
myelination mutants which are outwardly similar to Ann are two mouse 
models of different hum an Charcot-Marie-Tooth-type peripheral 
neuropathies.
PMP-22 is a glycosylated membrane protein present in virtually all PNS 
myelinated fibres. The protein is expressed in Schwann cells and 
incorporated into the myelin sheath of PNS axons where it appears to play 
a structural role [137, 138]. The pmp22 gene is also expressed in the CNS 
but no protein is made there [136]. The trembler (Tr) mouse is an 
autosomal dominant pmp22 m utant that displays a severe peripheral 
neuropathy in which myelin sheaths in the PNS are thin or absent [139]. 
Trembler mutants are identifiable from 9 or 10 days of age owing to a rapid 
tremor. Affected animals suffer occasional seizures, a gait abnormality 
involving mainly the hindlimbs, and develop paralysis. Mortality is high 
between 3 and 4 weeks [140]. The trembler mouse represents a useful 
model for the hum an hereditary neuropathy Charcot-Marie-Tooth disease
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Table 4.4. Mouse myelination mutants
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changes.






type la  (CMTla) in which the genetic defect in some cases has been 
identified as a point mutation within the PMP22 gene [149].
Myelin protein zero (Mpz) is the most abundant protein in the myelin of 
the PNS [135]. It is a membrane glycoprotein that is thought to act as a 
homophilic adhesion molecule and is important in maintaining the IPL 
(Intraperiod line) of the myelin sheath. Mpz is expressed in Schwann cells 
at the time of myelin formation in the PNS [150]. Although no naturally 
occurring Mpz mouse mutants have been isolated, gene targeting has been 
used to engineer an Mpz null strain [146]. Knockout mice exhibit a 
heterogeneous pattern of dysmyelination with m any axons surrounded by 
abnormal myelin, due to incomplete compaction at the IPL. In some 
Schwann cell-axon units no myelin forms at all whereas in other units, 
morphologically normal, compact myelin is observed. Furthermore, many 
axons degenerate when associated with abnormal myelin in these mice. 
M utants develop an abnormal gait and tremors between 2 and 3 weeks of 
age, although the defect is not lethal.
Mutations in the Mpz gene are responsible for Charcot-Marie-Tooth disease 
type lb; a demyelinating disorder of the PNS [151], and also Dejerine- 
Sottas disease (DSS); a more severe disorder of the same type [152]. As 
with a putative myopathic or motor neuron disorder, a thorough 
histological analysis of myelin integrity in Ann mice would be required to 
test the possibility of a myelin defect in this strain.
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4.1.8 The cerebellum and cerebellar mutants.
The cerebellum is a highly organised, foliated structure that lies dorsal to 
the brain stem. It is involved in coordinating the planning, timing and 
patterning of muscular contractions during voluntary movements. It does 
this by receiving both internal feedback (from regions of the motor cortex) 
concerning the programming and execution of movement, and external 
feedback from the peripheral nervous system, allowing motor performance 
to be monitored. By comparing these internal and external feedbacks the 
cerebellum can adjust movement and posture by modulating the 
descending motor systems of the brain.
The cerebellum can be divided in a number of ways. It consists of an outer 
layer of grey matter; the cerebellar cortex, an internal layer of white matter, 
and three pairs of deep nuclei. The cerebellar cortex can itself be 
subdivided into three layers, the outermost molecular layer (ML) which 
contains mostly axons, the Purkinje cell layer (PCL) in which Purkinje cell 
bodies are arranged in a single layer, and the internal granular layer (IGL) 
containing mostly densely packed granule cells.
Disorders of the cerebellum lead to a number of characteristic symptoms 
depending upon the exact nature of the defect. The most common is 
ataxia, a term which encompasses a variety of abnormalities in the 
execution of voluntary movements including errors in the rate, regularity, 
range and force of movement. This is often manifest as an ataxic gait, in 
which the stance is wide and movement is hesitant and unsteady.
The single cell thick Purkinje cell layer is of param ount importance to 
normal cerebellar function in that it provides the sole output of the
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cerebellar cortex, through Purkinje cell axonal projections, to the 
underlying white matter (see Fig. 4.2). Purkinje cells receive their major 
afferent input from mossy fibres through synapses with granule cells. The 
number of small, densely-packed, neurons in the internal granular layer 
exceeds the total cell number in the cerebral cortex. Granule cells make 
important excitatory connections with Purkinje cells via their axons that 
extend to the outer molecular layer, where they become parallel fibres that 
synapse with the Purkinje cell dendrites. Purkinje cells and granule cells 
constitute the two major cell populations of the cerebellar cortex and in 
m any cerebellar disorders defects in either or both of these cell populations 
are apparent.
A number of mouse mutants exist which display some form of cerebellar 
dysfunction that often results from either the abnormal development or 
degeneration of one or more of the cerebellar cell populations (see Table 
4.5). An ataxic gait is a characteristic feature of cerebellar dysfunction 
which these mutants have in common. This may be accompanied by 
hypotonia and a tremor that is frequently apparent at the end of 
movement. Of the variety of neurological and neuromuscular mutants 
discussed in this chapter, the Ann m utant phenotype bears the strongest 
similarities in terms of clinical phenotype with mouse mutants affected by 
some form of cerebellar dysfunction. Therefore the m utants belonging to 




















Fig. 4.2. The laminar organisation of the cerebellar cortex.
Vertical section of a single cerebellar folium show ing both longitudinal and transverse 
planes. Figure adapted from Chapter 41 of Principles of Neural Science, [92].
Several classical cerebellar mutant strains are due to defects that 
intrinsically affect the Purkinje cell population leading to the degeneration 
of these cells. This can in turn produce effects on other cell types, most 
notably the granule cells, which fail to proliferate in the absence of Purkinje 
cells. This is true of two cerebellar mutants, the recessive staggerer (stg) 
[153] and semidominant lurcher (Lc) [154] strains. In both, intrinsic Purkinje
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Table 4.5. M ouse mutants displayping cerebellar dysfunction




Unknown Moderate ataxia, small 
size, normal life span, 
cerebellum slightly 
reduced in size.
Degeneration of Purkinje cells, 




- / -  : postnatal death
+/-: ataxia, small size,
viable.
Loss of Purkinje cells intrinsic 
to Purkinje cell population. 





staggering gait, hypotonia, 
tremor and small size. 
Death usual during forth 
week.
Deficiency of 60-90% Purkinje 
cells, intrinsic to this 
population. Remaining 
Purkinje cells unable to 
differentiate properly leading 
to secondary loss of granule 
cells.
stumbler (stu) [160] Unknown Stumbling, ataxic gait 
from 10 days, abnormal 
righting reflex, smaller 
than normal, death before 
weaning.
Cerebellar cortex reduced 
in size but retains its 
normal foliation.
Paucity of Purkinje and granule 
cells from 10 days, limited 
degeneration of Purkinje cells 
from 20 days, normal amounts 
of these cells types never 
produced.
wasted (wst) [161] Eefla2 [162] Tremor and 
uncoordinated body 
movements from 20 days 
of age, progressive 
paralysis and failure to 
gain weight leading to 
death by 30 days of age.
Degeneration of Purkinje cells 
and focal demyelination in the 
cerebellum.
nervous(nr) [163] Unknown Ataxic gait and small size 
from 2 to 3 weeks, 
mutants are viable but 
very poor breeders.
90% loss of Purkinje cells 
between 23 and 50 days due to 
inability of granule cells to 




See Table 4.3. See Table 4.3.
leaner{la) [123]
Cacnala
See Table 4.3. See Table 4.3.
reeler (rl) [140] Reelin [164] Tremors and a severely 
ataxic gait from 2 weeks of 
age. Mutants are inviable 
on inbred but viable on an 
outbred background.
Grossly abnormal organisation 
and lamination of cerebellar 
cortex, Purkinje and granule 
cell numbers reduced. Ectopia 




mDabl [166] As reeler except inviable 




cell defects result in the degeneration of this cell type and a subsequent 
reduction in granule cell numbers.
Alternatively, the granule cell population may not be affected by Purkinje 
cell loss, e.g. in the wasted (wst) m utant [161], whilst in the stumbler (stu) 
m utant normal numbers of both Purkinje and granule cells are never 
established [167]. Obviously the effects on cerebellar development are 
dependant on the function of the gene product that has been disrupted in 
these various mutants.
The development of the laminar structure of the cerebellum is dependant 
on highly choreographed neuronal migrations. Several mouse mutants 
have been identified in which defects in neuronal migration result in 
cerebella lacking the normal laminar structure. In the weaver (wv) and 
nervous (nr) mutants granule cell death and subsequent migration defects 
adversely affect the Purkinje cell population [168].
Alternatively in reeler (rl) and scrambler (scm), which are defective in a 
common signalling pathway [169], severe lamination defects result from 
abnormal Purkinje cell migration during cerebellar development [170-172].
Again, histopathological analysis of the morphology of the cerebellum and 
its associated cell types presents the most logical approach to investigating 
whether a cerebellar defect is the cause of the Ann m utant phenotype.
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4.2 Materials A nd Methods
4.2.1 Fixation of mouse tissues by perfusion
Perfusion fixation was performed with the assistance of Dr. J. Smith, 
(University of Birmingham). Mice were terminally anaesthetised by 
intraperitoneal injection with Ipg of Sagatal per gram of bodyweight. The 
abdominal cavity was cut open and the diaphragm cut away from the rib 
cage, the rib cage was then cut up either side and lifted to expose the heart. 
A cannula was then inserted through the base of the heart and manoeuvred 
into the aorta. Using fine plastic tubing the cannula was connected to a 
50ml syringe barrel and, by applying light pressure to the syringe plunger, 
the specimen was perfused firstly with approximately 30ml of sterile PBS 
containing 0.3ml of heparin (at a concentration of 5000 units/m l). The PBS 
was then substituted for 4% paraformaldehyde in PBS and approximately 
50ml of this solution was used to further perfuse the specimen until the 
upper limbs had visibly stiffened as a result of fixation. The mouse was 
then decapitated and the brain dissected into 4% paraformaldehyde in PBS, 
the upper spinal cord was also dissected into this fixative. Samples were 
postfixed for a further 12 hours prior to continuation of tissue processing.
4.2.2 Preparing Alcian blue/Alizaran red stained skeletons
Mice were killed by asphyxiation with COz, skinned, eviscerated and as 
much fat and muscle tissue removed as possible. Carcasses were fixed in 
100% ethanol for 5 days, rinsed in dHjO for a few minutes and then 
transferred to the staining solution (1 volume 0.3% alcian blue (Gurr) 
dissolved in 70% EtOH, 1 volume 0.1% alizaran red (Raymond Lamb) 
dissolved in 95% EtOH, 1 volume glacial acetic add , 17 volumes 70% 
EtOH) for 4 days. Following staining, spedm ens were washed in dH20  for 
a few minutes and then deared in 20% glycerol/1% KOH until the bones
I l l
became visible (over several weeks). Skeletons were transferred to 50% 
glycerol for 2 days and then stored in 100% glycerol indefinitely.
4.2.3 Cresyl violet staining of spinal cord sections
This was performed according to a standard protocol [82]. Slides prepared 
as described (section 2.2.23), were dewaxed in two 2 minute changes of 
Histoclear (National Diagnostics) then rehydrated by passing through 
100%, 100%, 95%, 90%, 70% and 50% EtOH for 2 minutes in each solution, 
followed by 1 minute in dH20 . After covering in 1% cresyl violet solution 
(acidified with 0.25% glacial acetic acid) for 30 minutes, slides were rinsed 
in dH20 . Slides were then passed through 96% EtOH (lminute) and rinsed 
in 100% EtOH for 2 minutes. Following a rinse in histoclear, slides were 
mounted under coverslips with DPX mountant.
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4.3 Results
4.3.1 Gross features of the Ann phenotype
Ann mutants were identifiable at around 12 days of age by a fine whole- 
body tremor. This persisted for a further 2 to 3 days before disappearing. 
From 13/14 days onwards mutants displayed difficulties with normal 
locomotion. Affected animals were unable to walk forward for more than 
2 or 3 paces without keeling over to one side. Once on their side mutants 
would frantically kick their legs until they managed to right themselves. 
By 16/17 days mutants would attempt to walk only infrequently and spent 
most of their time sitting still with a hunched posture (due to dorsal- 
ventral curvature of the spine).
Mutants did not increase in size from 12/13 days and became smaller than 
their littermates (see Fig. 4.3). By 17/18 days of age they had an emaciated 
appearance. Mutants died at around 21 days of age although some died as 
early as 19 days, whilst others survived to 24 days. None ever survived 
weaning for more than one day.
Mutants responded to visual, auditory and pain (tail pinch) stimuli, 
suggesting their sensory systems were functioning normally. When lifted 
by the tail, mutants did not clasp their rear paws, a behaviour that is 
common to several neurological mutants. The phenotype of mutants on 
both mixed C57BL/6J x CBA/Ca and inbred C57BL/6J genetic 
backgrounds were indistinguishable.
Fig. 4.3. Photograph of the Ann mutant.
Comparison of 21 day old Ann mutant (right) and w ild-type (left) siblings. Note the small 
size and hunched posture of the mutant animal.
Fig. 4.4. Ann skeletal preparations.
Alcian blue/alizarin red stained skeletal preparations from 21 day old w ild-type (above) 
and Ann mutant (below) siblings. Other than the obvious size differences, no gross 
skeletal abnormalities are apparent.
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4.3.2 Examination of Ann skeletons
To investigate the possibility of skeletal defects that might contribute to the 
Ann m utant phenotype, skeletons were prepared from 19 day old Ann 
wild-type and m utant animals. Skeletons were stained with Alcian red 
(stains bone) and Alizaran blue (stains cartilage) dyes. Comparison of both 
preparations confirms that, except for the obvious reduction in size, the 
skeleton of the Ann m utant bears no abnormalities (see Fig. 4.4).
4.3.3 Measurement of Ann mass over time
For a number of litters derived from Ann hemizygous intercrosses, pups 
were weighed daily from 8.5 days post partum  (when individuals could be 
marked by toe clipping) until 20.5 days (when mutants were normally 
killed). Mean wild-type and m utant mouse body mass values were 
plotted against age (measured as days post partum  see Fig. 4.5). Both wild- 
type and m utant mice gain mass steadily from 8.5 days, but whilst this 
increase continues in wild-type mice through to 20.5 days, in mutants body 
weight levels peak at 14.5 days and decrease thereafter. A significant 
difference in body mass between m utant and wild-type animals is apparent 
from 17.5 days onwards (as indicated by standard deviations see Fig 4.5.).
This failure to increase body mass beyond a certain level could result from 
an inability in mutants to compete with siblings for maternal nourishment. 
This would certainly be consistent with the locomotor abnormalities and 
emaciated appearance displayed by Ann mutants. An alternative 
possibility may be that a defect in the gastrointestinal tract of these mice 
may prevent them from obtaining sufficient nutrition. Both possibilities 
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Fig. 4.5. Ann vs w ild-type growth curve.
Growth curves show ing w ild-type and mutant m ouse body mass against days post 
partum. Data points represent mean body mass values for 38 (wild-type) and 19 (mutant) 
individuals
In addition to whole body mass measurements, at 20.5 days post partum, 
the mass of a variety of organs and tissues was measured to allow 
comparison between mutant and wild-type animals. The mean masses of a 
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Organ
Fig. 4.6. Relative organ mass.
Plot show ing mean organ mass as a percentage of mean body mass for both wild-type (wt) 
and mutant (mut) animals. Organs were heart, kidney and three different skeletal 
muscles: calf, quadricep (quad) and triceps brachii (tricep). Mean values obtained from 38 
w ild-type and 19 mutant animals at 21 days post partum. Standard deviations are 
represented by error bars.
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Fig. 4.7. Relative and absolute brain mass.
Plots show ing a) mean brain mass as a percentage of mean body mass and b) mean brain 
mass as an absolute value (in grams), for both w ild-type (wt) and mutant (mut) animals. 
Mean values obtained from 38 w ild-type and 19 mutant animals at 21 days post partum. 
Standard deviations are represented by error bars.
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With the exception of the brain, all organs weighed showed no significant 
differences in mass between m utant and wild-type animals when 
represented as a percentage of total body mass (as indicated by standard 
deviations in Fig. 4.6.). Average absolute brain mass was found to be 
greater in wild-type versus m utant mice but this trend was reversed when 
the average brain mass was calculated as a percentage of total body mass 
(see Fig. 4.7). Studies conducted on hum an sufferers of starvation have 
shown brain wastage to be much less dramatic than other organs. This is 
in keeping with our findings and reinforces the possibility that a failure to 
feed may be the cause of death in mutants.
4.3.4 Histological analysis of Ann muscle
To investigate the possibility of a myopathic disorder in Ann m utant mice 
a variety of muscle types were examined histologically. Transverse 
sections of biceps femoris and triceps brachii muscles from 19 day old wild- 
type and m utant mice were cut and stained with haematoxylin and eosin. 
As can be seen (Fig. 4.8) wild-type and m utant muscles displayed no 
obvious differences, with muscle fibres from both types of animal being 
regular in shape and size, and nuclei located at the periphery of each cell.
None of the pathological signs of muscular dystrophy diseases, such as 
centrally located nuclei and muscle fibre necrosis (see Fig. 4.8[E]), were 
observed in m utant muscle. Signs of musclar atrophy e.g. clusters of small, 
angular muscle fibres (see Fig. 4.8[F]), were also not apparent in mutant 
muscle sections.
118
Fig. 4.8. Ann vs w ild-type muscle.
Comparison of m uscle morphology of 21-day-old w ild-type and Ann mutant mice. 
Haematoxylin and eosin stained, transverse sections from w ild-type biceps femoris (A) and 
triceps brachii (C) muscles show ed no morphological differences from Ann mutant biceps 
femoris (B) and triceps brachii (D). N o abnormalities, such as those common to Muscular 
Dystrophy (E) or Muscular atrophy (F) type diseases were visible in mutant muscle 
sections. (E) and (F) obtained from [173]
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4.3.5 Histopathology of Ann brains
The possibility of central nervous system abnormalities in Ann mutants 
meant that examination of m utant brains was required. In addition to the 
overall reduction in brain size, it was apparent from visual examination 
that the cerebella of Ann mutants were much smaller than those of wild- 
type controls (see Fig. 4.9[A]). Histological analysis provided a further 
insight into the nature of the defect in these mice.
Most noticeable was the complete lack of foliation apparent in the wild-type 
cerebellum (see Figs. 4.9 and 4.10). Furthermore, the characteristic pattern of 
cerebellar lamination appeared to be disrupted. The relatively cell-free outer 
molecular layer was discemable despite being somewhat reduced in thickness, 
whereas the Purkinje cell layer was completely absent. Instead of being aligned in 
a single-cell thick row at the superficial aspect of the granule cell layer, Purkinje 
cells were scattered throughout and beneath a granule cell layer which was itself 
markedly reduced in size. Purkinje cells were also found together in clusters 
beneath the granule cell layer (see Fig. 4.10).
Examination of the cerebral cortex also revealed disruption to the normally 
laminated structure of this brain region. A co-ordinated ‘inside-out’ pattern of 
neuronal migration during cortical development generates a characteristic six- 
layered structure in the mammalian cerebral cortex. This classic pattern of 
lamination seems to be disrupted in Ann mice with large pyramidal cells and small 
granule cells being interspersed rather than segregated into disparate layers (see 
Fig. 4.11). This is most apparent in the marginal zone (layer I), which is located 
under the pial surface. Normally almost devoid of cell nuclei, in mutant brains this 
layer appears to have been infiltrated by neurons and as such becomes 
indistinguishable from the other layers.
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Fig. 4.9. Ann vs w ild-type brains.
Analysis of brains from 21 day old wild-type and Ann mutant littermates. A) Comparison 
of whole brains reveals a marked reduction in the size of the mutant cerebellum. These 
differences are even more apparent in Haematoxylin and eosin stained 7pm transverse 
sections taken from the midline of B) w ild-type and C) mutant cerebella. Comparison of 
Haematoxylin and eosin stained 7pm transverse sections taken from D) w ild-type and E) 
mutant hippocampi.
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Fig. 4.10. Ann vs w ild-type cerebellum /hippocam pus.
Comparison of cerebella and hippocampi of wild-type (A and B), hem izygous transgenic 
(C and D) and hom ozygous mutant (E and F) littermates. Cresyl violet staining was 
performed on 7|im thick sections taken from the midline of 21 day old m ouse brains. The 
arrow in A) denotes the single cell thick Purkinje cell layer whilst the arrow in E) denotes 
ectopic clustering of Purkinje cells beneath the granule cell layer.
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Abnormalities in the neuronal organisation of the hippocampus were also 
discovered. In the wild-type hippocampus the pyramidal neurons of the 
CA1 and CA3 regions, as well as the dentate gyrus, are arranged in clearly 
distinguishable, discrete rows. The m utant hippocampus lacks this 
organisation, with the pyramidal cells of these regions being almost 
randomly dispersed (see Fig. 4.8. and Fig. 4.10). Furthermore, the granule 
cells of the m utant Dentate Gyrus are also found to be scattered almost 
randomly.
4.3.6 Histological analysis of Ann spinal motor neurons
From an examination of transverse sections, it was apparent that the spinal 
cord as a whole exhibited no obvious differences to that of wild-type 
controls. Since this region has been implicated in a number of mouse 
mutants bearing phenotypic similarities to Ann, it was decided to examine 
the spinal motor neurons of mutants more closely. At higher 
magnification, individual motor neurons could be observed. Upon 
comparison with wild-type samples, no obvious abnormalities in the 
general morphology of these cells were discernable with both wild-type 
and m utant neurons exhibited the same general size, shape and staining 
intensities (see Fig. 4.11).
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Fig. 4.11. Ann vs w ild-type cerebral cortex/spinal motor neurons.
Comparison of cerebral cortex and spinal motor neurons of w ild-type (A and B), 
hem izygous transgenic (C and D) and hom ozygous mutant (E and F) littermates. Cresyl 
violet staining w as performed on 7pm thick sections taken from either the midline of the 
brain (A, C, E) or C2-C3 region of the spinal cord (B, D, F).
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4.4 Discussion
4.4.1 Ann mutants do not have a myopathic disorder
Although differences are apparent, Ann m utants do exhibit some notable 
similarities to a number of the muscular dystrophy mouse mutants. For 
example, the abnormal gait, reduced size and dorso-ventral curvature of 
the spine observed in the m dx/utrn '' mouse are all features that are 
apparent in Ann mutants [98] [99].
To investigate the possibility of a myopathic disorder in Ann m utant mice, 
a variety of muscle types were examined histologically. As can be seen in 
figure 4.6, transverse sections of m utant biceps femoris and triceps brachii 
muscles exhibited no obvious differences to those of wild-type littermates. 
Both wild-type and m utant muscle fibres were regular in shape and size 
and their nuclei were located at the periphery of the cell. Certainly none of 
the characteristic features of dystrophic muscle i.e. variations in fibre size, 
centrally located nuclei, necrotic fibres and infiltration by mononuclear 
cells [174], were observed. The absence of pathological features in Ann 
m utant muscle sections indicates clearly that the Ann phenotype is not that 
of a muscular dystrophy disease.
Atrophy of muscle fibres is most often caused by the loss of motor 
innervation and is characterised by a reduction in size and an angular 
morphology of groups of adjacent muscle fibres (see Fig. 4.8[F]). No 
atrophic regions were observed in Ann muscle sections, suggesting that 
innervation of skeletal muscle is normal. We could therefore tentatively 
conclude that the defect in Ann mutants does not involve the basic motor 
unit, and that skeletal muscle, the neuromuscular junction, and lower
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motor neurons are all functionally intact. As such it is improbable that the 
Ann m utant could serve as a model for the two commonest forms of motor 
neuron disease since lower motor neurons are affected in both ALS and 
SMA, and muscular atrophy is evident in both syndromes.
It should be stated that in a number of diseases affecting the lower motor 
neurons, denervation atrophy of skeletal muscles accompanies changes in 
these neurons. Such changes are absent though in diseases exclusively 
affecting the upper motor neurons. Thus the possibility that the Ann 
phenotype reflects an upper motor neuron defect or alternatively a 
myelination or ion channel disorder could not be negated at this stage. A 
study of neuronal morphology in the spinal cord revealed no gross 
abnormalities but more subtle changes (i.e. at the sub light microscopic 
level) may well have gone undetected.
4.4.2 Ann mutants display gross abnormalities of the cerebellum
The chance that a defect in some region of the CNS is responsible for the 
gross Ann phenotype necessitated an examination of the brain and spinal 
cord of mutants. A brief visual comparison of the brains of wild-type and 
m utant littermates immediately yielded insight into the possible cause of 
the Ann phenotype. Disregarding the overall size reduction of mutant 
brains, it was obvious that the cerebellum of mutants is disproportionately 
smaller than in wild-type mice. This size disparity was clearly visible in 
sagittal brain sections from 21 day old mice. The m utant cerebellum is 
severely hypoplastic, in addition the normal foliated structure of the 
cerebellar cortex is completely absent and the discrete cellular layers 
observed in the wild-type cerebellum are disrupted.
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The cerebellar cortex normally consists of three discrete layers: the outer 
molecular layer (OML), the Purkinje cell layer (PCL) and the internal 
granular layer (IGL). An IGL is present in Ann m utant brains but numbers 
of granule cells appear to be greatly reduced in comparison to wild-type. 
A cell-free OML is still located at the outside of the cerebellum but the 
Purkinje cell layer, normally found beneath, is almost completely absent. 
On closer inspection, clusters of large, darkly staining cells, which are most 
probably ectopically located Purkinje cells, can be found in locations 
beneath the IGL.
Development of the cerebellum (reviewed in D'arcangelo and Curran, 1998 
[175]) begins at embryonic day 11 in the mouse with tangential migration 
of granule cell precursors from the fourth ventricle to form the external 
germinal layer (EGL). Purkinje cell precursors are subsequently born at the 
ventricular surface and migrate outward along radial glial fibres, 
eventually forming the Purkinje cell layer just below the EGL. Granule 
cell precursors in the EGL then proliferate rapidly and, upon exit from the 
cell cycle, migrate inwards, again along radial fibres [176]. These cells cross 
the OML and PCL, to form the broad internal granule layer (see Fig. 4.2).
Although features of the Ann m utant cerebellum bear similarities with a 
number of the cerebellar mutants (discussed in the introduction to this 
chapter), the morphology observed is most highly reminiscent of that 
found in the reeler and scrambler classical mouse mutants (see Table 4.5.). 
Reeler and scrambler m utant cerebella are grossly abnormal, being much 
reduced in size and displaying an almost complete lack of foliation. As a 
result of a failure to migrate, the Purkinje cell layer is completely missing, 
w ith the majority of cells of this type found in deep clusters [170,172].
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Granule cells are much reduced in number and remain superficial to any 
Purkinje cells. The absence of Purkinje cells next to the EGL is thought to 
reduce the proliferation of granule cells, possibly due to the lack of a 
secreted mitogenic factor. In rl and scm, granule cells still migrate inward 
forming a much reduced granule cell layer and allowing the molecular 
layer to form. It is the paucity of granule cell numbers that results in the 
reduced size and lack of foliation of rl/scm  cerebella.
The molecular basis of these mutants is known to lie in a common 
signalling pathway that is essential to normal Purkinje cell migration. The 
cloning of the gene m utated in reeler mice; reelin, was facilitated by 
generation of another reeler allele (rllg) by transgene insertional mutagenesis 
[177]. The reelin gene product is a large extracellular protein secreted by 
granule cells in the outer molecular layer (OML) and the EGL of the 
developing cerebellum (see Fig. 4.12.) [178]. Secreted reelin was proposed 
to facilitate normal migration of Purkinje cells from the ventricular zone to 
their normal positions beneath the OML [175]. When the reelin signal is 
abolished, such as in rl mice, Purkinje cells do not migrate correctly and 
remain in deep, subcortical locations [172]. The reduction in granule cell 
numbers is secondary to the abnormal migration of Purkinje cells. Reeler 
homozygotes display tremors and a severely ataxic gait from around 2 
weeks of age [140]. Mutants are non-viable on inbred genetic backgrounds 
but may survive and breed on an outbred genetic background despite no 
apparent difference in cerebellar histopathology [179].
Abnormal expression of the mouse disabled 1 (mdabl) gene is responsible for 
scm [166, 180]. mdabl is an intracellular tyrosine kinase signalling adaptor 
molecule which functions downstream of reelin in the same pathway.
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High levels of mDabl protein are expressed by the Purkinje cell precursors 
that migrate from the fourth ventricle to positions directly beneath the EGL 
(see Fig. 4.12) [166, 169, 171]. Interaction of reelin with these Purkinje cell 
precursors is essential for their appropriate migration. The reelin signalling 
pathway is therefore required for the formation of the Purkinje cell layer. 
Exactly how reelin signalling achieves this outcome remains the subject of 
much speculation [181].
Fig. 4.12. Developm ent of the cerebellum in w ild-type and r l/scm  mice.
Cerebellar developm ent in w ild-type (A) and rl/scm  mutants (B). Beginning at around 
embryonic day 11, granule cells (represented by filled circles) migrate outwards from the 
fourth ventricle to form the EGL. Migration of m Dabl expressing Purkinje cells (shown as 
shaded circles w ith dendritic projections) to form the PCL (beside the Reelin expressing 
EGL) is follow ed by inward migration of granule cells to form the IGL (postnatal days 0 to 
14). In rl/scm , Purkinje cells do not migrate outwards and remain in deep sub-cortical 
locations w ith a resulting reduction in granule cell numbers. The cerebellum is therefore 
much smaller than normal as w ell as being structurally disorganised (figure adapted from  
D'Arcangelo and Curran, 1998 1175]).
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The almost identical morphological defects of the Ann and rl/scm  
cerebella suggests that the mutation in Ann may affect some component of 
the reelin signalling pathway. Alternatively the molecule disrupted in Ann 
may function independently of this pathway to influence Purkinje cell 
migration. Only the identification of the molecule disrupted in Ann will 
resolve these possibilities.
It seems reasonable to assume that the Ann ataxic phenotype could 
originate solely from the cerebellar abnormalities observed since in a 
number of mouse mutants displaying highly similar phenotypes only the 
cerebellum is affected (see Table 4.5.). As such, the Ann line could serve as 
a useful model of cerebellar ataxia in humans. How does Ann compare 
with these diseases? The hum an hereditary ataxias result from 
degeneration of the cerebellum and its efferent and afferent connections. 
Both autosomal dominant and autosomal recessive diseases are known and 
both types are often associated with trinucleotide repeat expansion at a 
specific locus.
Friedreich's ataxia (FA) is the most common form of autosomal recessive 
ataxia. Caused by trinucleotide repeat expansion of the Frataxin gene 
[182], this disease is characterised by progressive ataxia from puberty and 
can be associated with cardiomyopathy. Neuropathologically, the 
cerebellar cortex is generally unaffected and degeneration of the 
spinocerebellar, posterior column and pyramidal tracts of the spinal cord 
are the predom inant features [183].
Classification of the autosomal dominant ataxias on a neuropathological 
basis is complicated by extensive heterogeneity. As a result these diseases,
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including olivopontocerebellar atrophy (OPCA), familial cortical cerebellar 
atrophy (FCCA) and Machado Joseph disease (MJD) have been reclassified 
as the spinocerebellar ataxias numbers 1 to 7 (SCA1 -  SCA7), according to 
the genetic loci involved [184].
Olivopontocerebellar atrophy results from trinucleotide repeat expansion 
of either the ataxin 1 (SCA1) [185] or ataxin 2 (SCA2) [186] genes. 
Neuropathologically, OPCA exhibits severe atrophy of the cerebellum and 
basis pontis [183]. Cerebellar abnormalities are characterised by a loss of 
Purkinje cells and a reduction in the thickness of the molecular layer. Both 
the foliation and laminar structure of the cerebellum appear intact.
Machado Joseph disease (SCA3) is caused again by trinucleotide repeat 
expansion, this time in the ataxin 3 gene [185, 187]. In this form of 
hereditary ataxia the overall size of the cerebellum is reduced but the 
cerebellar cortex remains intact. Degeneration of the dentate nucleus and 
the dorsal columns of the spinal cord are responsible for the SCA3 
phenotype [183].
Finally, familial cortical cerebellar atrophy (SCA6) is also caused by an 
expansion of trinucleotide repeats, except that in this case a voltage gated 
Ca2+ channel gene, CACNA1A, is involved [124]. Purkinje cells in the 
cerebellum are reduced in number and have an abnormal morphology. As 
in OPCA, both the foliation and laminar structure of the cerebellum appear 
intact [183]. As mentioned previously, the tottering and leaner mice, in 
which the cacnala gene is mutated [130], represents a model for SCA6 and 
also presents a highly similar phenotype to that of the Ann m utant (see 
Table 4.3).
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4.4.3 The cerebral cortex of Ann mutants shows histopathological defects
Histological examination of the cerebral cortex in Ann mutants revealed a 
disruption to the normal laminar arrangement of this structure. The 
cerebral cortex is normally arranged in six well-defined layers based on the 
differing amounts of large pyramidal, small pyramidal and nonpyramidal 
cells in that region. Pyramidal cells are responsible for the transmission of 
efferent output from the cortex, whereas non-pyramidal cells primarily 
receive afferent inputs. The cortical layers are numbered sequentially from 
the surface next to the pia mater to the underlying white matter. Layer I is 
composed largely of axons and contains few cell bodies. Layers II, III, V 
and VI contain mostly pyramidal cells which provide the output from the 
cortex. Layer IV consists primarily of non-pyramidal cells and receives 
afferent input from the thalamus.
The increase in cell density of the region just beneath the pial surface 
provides the most obvious indication of the defects in the laminar structure 
of the m utant cerebral cortex. As a result, a clearly defined layer I is absent 
in the cerebral cortex of mutants. Rather than consisting of obvious layers 
in which one cell type predominates, in the remainder of the mutant 
cerebral cortex large pyramidal cells are scattered throughout and 
lamination is virtually undetectable. This is identical to the situation in the 
cerebral cortex of rl [188] and scm [169, 189] mutants in which a defect in 
neuronal migration during cerebral development results in an absence of 
lamination.
In the first stage of cortical development a pre-plate (also known as the 
primordial plexiform layer (PPL)), containing Cajal-Retzius and subplate 
neurons, forms just below the pial surface (see Fig. 4.13). Development
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proceeds with a series of neuronal migrations in which neurons at the 
ventricular zone stop dividing and migrate outwards along radial glial 
fibres [190]. These neurons must invade the preplate to reach their final 
destination where they displace subplate neurons and form the cortical 
plate (CP). Each neuronal migration goes beyond those that have 
previously taken place, in a classic 'inside-out' pattern. Therefore, cortical 
plate neurons which are 'bom ' (i.e. stop dividing and begin migrating) 
later, will end up in a more superficial location than those 'born ' earlier. 
This generates the laminar structure of the mature cortex that consists of 
six discrete neuronal layers in which the cortical plate neurons (layers II - 
VI) lie between the Cajal-Retzius containing marginal zone (MZ), and the 
subplate (SP) [190].
In rl and scm m utant mice, migrating cortical plate neurons fail to invade 
the preplate, which itself forms normally [169, 188, 189]. Additional 
migrating neurons are unable to bypass their predecessors and thus 
accumulate under the pre-plate in a disorganised fashion. As a result, the 
laminar structure of the normal cortex never forms (see Fig. 4.13). 
Furthermore, the failure of the preplate to split into the marginal zone and 
the subplate results in Cajal-Retzius and subplate cells remaining 
superficial to the cortical plate in a structure known as the superplate (SPP) 
[181].
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Fig. 4.13. Developm ent of the cerebral cortex in w ild-type and rl/scm  mice.
D evelopm ent of the cerebral cortex in w ild type (A&B) and rl/scm  mutants (A&C). The 
PPL, which contains reelin expressing Cajal-Retzius cells as w ell as subplate cells, is 
invaded by migrating neurons which express m dabl, splitting the PPL into the MZ and 
SP. These neurons travel from the fourth ventricle along radial glial fibres and stop 
migrating between the MZ and SP, forming the CP. The 'outside-in' pattern of neuronal 
migration generates the laminar structure of the cerebral cortex. In r l/scm  mutants, 
migrating neurons fail to split the PPL resulting in a disorganised cortical plate located 
beneath the resulting SPP (figure adapted from Rice and Curran, 1999 [181])
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During normal cortical development reelin is secreted by Cajal-Retzius 
neurons in the marginal zone [164, 178]. Migrating cortical plate neurons 
that bypass older cortical plate neurons and insert beneath the marginal 
zone express m Dabl [169]. As in the developing cerebellum, reelin 
secreting cells are closely apposed to cells expressing m Dabl, indicating 
that reelin signalling is important for appropriate neuronal migration. The 
exact role of reelin signalling in this process remains undefined. One 
possibility is that the reelin signal facilitates the penetration of the preplate 
by migrating cortical plate neurons, possibly through the modification of 
cell-cell interactions [191]. Another possibility is that reelin binding to 
cortical neurons could generate a signal for these cells to stop migrating, 
this however would not explain the failure of migrating cortical plate 
neurons to penetrate the preplate. Finally, reelin signalling could affect 
neuronal migration by modifying the interaction between migrating 
cortical plate neurons and radial glial fibres.
Essentially identical changes in the development of both the cerebellar 
cortex and the cerebral cortex in Ann m utant and rl/scm  mice provides 
strong evidence that the basis of the Ann phenotype rests with a defect in 
reelin signalling. Again, without having isolated the molecular basis of the 
Ann mutation one cannot progress beyond mere speculation as to the 
likelihood of this. Furthermore, it is not inconceivable that a molecule 
functioning outw ith this signalling pathway could be involved in neuronal 
migration during the development of both the cerebellum and the cerebral 
cortex and that a defect in this molecule could result in a phenotype that is 
difficult to distinguish from that of rl/scm  mice.
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The contribution of these cerebral defects to the overall Ann phenotype is 
difficult to discern since the cerebral cortex is involved in a variety of 
higher brain functions. These include somatic sensation, learning and 
memory as well as the control of movement [92]. The defects observed in 
the cerebellum could alone account for the Ann phenotype although it is 
possible that abnormal functioning of the motor cortex could in some way 
contribute to the movement disorder observed in mutants. Sensory defects 
resulting from abnormalities in the sensory cortex cannot be ruled out 
although touch, hearing and vision appear to function normally, as 
determined by admittedly rudimentary tests, in Ann mutants. In order to 
ascertain if m utant mice exhibit defects in learning and memory it would 
have been necessary to carry out a variety of behavioural tests. 
Considering the extreme locomotor disorder and short life span of mutants 
it is doubtful whether such tests would have provided any meaningful 
indication as to the presence of learning and memory defects in mutant 
mice.
Several human neuronal migration disorders exist in which the abnormal 
development of the cerebral cortex resembles that seen in the Ann mutant. 
Lissencephaly (meaning smooth brain) is a condition in which deficient 
neuronal migration results in either the absence of (agyria) or reduction in 
(pachygyria) of the surface convolutions, or gyri, of the cerebral 
hemispheres [192]. Additionally, the cortex is disorganised and lacks 
normal lamination. Lissencephaly results in profound mental retardation, 
intractable seizures, feeding problems and a shortened life-span [193]. 
Double cortex is a closely related abnormality in which defective neuronal 
migration results in the formation of an abnormal heterotopic band of 
neurons in the white matter, underlying what appears a normal cortex.
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The clinical manifestations of such an abnormality include epilepsy and 
mental retardation [194].
That cases of an X-linked form of lissencephaly and double cortex have 
been found within the same pedigree, suggested that some forms of these 
diseases could have a common, X-linked, genetic basis [195]. This was 
confirmed with the isolation of the doublecortin gene on the hum an X- 
chromosome [196]. The function of doublecortin is unknown but the 
protein does contain potential phosphorylation sites for a variety of kinases 
including the Abl tyrosine kinase [196]. This is interesting given that the 
m Dabl protein is known to interact with Abl during neuronal 
development in the mouse brain [197] (see section 6.4.2), suggesting a 
possible interaction between the m D abl/reelin  signalling pathway and 
doublecortin.
An autosomal gene involved in lissencephaly has also been isolated. The 
Lisl gene is located on chromosome 17 and encodes the platelet activating 
factor acetylhydrolase (31 subunit (PAFAH1B) [198, 199]. This protein 
contains eight WD40 subunits that have homology to p-subunits of 
heterotetrameric G-proteins. The fact that non-receptor tyrosine kinases, 
such as Abl, are known to phosphorylate the a-subunit of several such G- 
proteins, again presents a possible link between this protein and the 
m D abl/reelin  pathway [200].
Mutations in mouse Pafahlb have been generated with graded reductions 
in gene activity resulting in neuronal migration defects [201]. Furthermore, 
strong similarities in the overall lissencephaly phenotype of patients with 
X-linked lissencephaly and those in which the LIS1 gene is mutated
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suggests that doublecortin and Pafahlb may be involved in a common 
pathway controlling neuronal migration [202]. The possible involvement 
of such a pathway with m D abl/reelin  signalling must be resolved.
To date no hum an mutations in mDab or reelin have been identified. This 
coupled with the fact that Ann mutants exhibit none of the seizures 
associated with lissencephaly suggests that the Ann mouse may be of 
limited use as a possible model for hum an syndromes involving defective 
neuronal migration in the developing cerebral cortex.
4.4.4 Histopathology of the Ann Hippocampus suggests learning and memory 
defects
Given the identical pathologies of Ann and rl/scm  cerebellar and cerebral 
cortices an investigation into the possibility of additional similarities was 
deemed appropriate. A further region of the brain that is severely affected 
in rl/scm  mice is the hippocampus [189,203,204].
The hippocampus is a component of the limbic system and is involved in 
learning and memory functions. Like both the cerebellum and cerebral 
cortex, the hippocampus has a laminar organisation [175]. Development of 
one such laminar region in the hippocampus, the stratum  pyramidale (SP), 
is reminiscent of that of the cerebral cortex, with hippocampal pyramidal 
cells migrating along radial fibres in an 'inside-out' manner forming a 
compact layer. Conversely, during the development of the compact layers 
of the dentate gyrus (DG), granule cells migrate in an 'outside in ' fashion 
(see Fig. 4.14) [175].
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It is interesting to note the presence of reelin expressing Cajal-Retzius like 
cells in the outer marginal layer (OML) that separates the stratum 
pyramidale from the dentate gyrus [175, 205]. These cells are known to be 
important for correct neuronal migration during SP and DG development. 
Unsurprisingly, pyramidal cells express m Dabl as they migrate in the 
direction of the OML [169]. This is also true of migrating granule cells that 
express m Dabl as they themselves move toward reelin expressing cells.
In rl/scm  m utant mice, rather than forming a discrete structure, the 
pyramidal neurons of the stratum  pyramidale are split into two layers [165, 
189]. Similarly, the granule cells of the dentate gyrus are scattered 
randomly rather than being tightly packed as normal. Considering the 
respective expression patterns of rln and m Dabl, abnormalities in neuronal 
migration, akin to the situation in both the cerebellar and cerebral cortices, 
provides the likely explanation for such defects.
Given the role of the hippocampus, there is a strong possibility that the 
hippocampal pathology observed affects learning and memory functions in 
Ann mice. Again it would have been necessary to carry out a variety of 
behavioural tests in order to confirm this.
4.4.5 Ann mutants display no abnormalities of spinal motor neurons
It is reasonable to propose that an ion-channel or myelination defect could 
affect both the brain and the motor neurons. Furthermore, the phenotypes 
of several ion-channelopathy and myelinopathy mouse mutants, as well as 
those described as motor neuron disease mutants, bear a striking 
resemblance to Ann in a number of ways (see Table 4.2.). With this in mind, 
a superficial histological investigation of spinal motor neurons in the Ann
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Fig. 4.14. Developm ent of the hippocampus in w ild-type and r l/scm  mice.
Developm ent of the hippocampus in (A) wild-type and (B) rl/scm  mutants. The SP forms 
by migration of m D abl expressing, hippocampal pyramidal cells in an 'inside-out' fashion, 
whilst the DG forms by 'outside-in' migration of m D abl expressing, granule cells. The 
OML contains reelin-secreting, Cajal-Retzius-like cells. In rl/scm  mutants, migrating 
neurons do not form compact layers and cells of both the SP and DG become scattered. 
(Figure adapted from D'Arcangelo and Curran, 1998 [175])
Comparison with sections from age-matched control mice revealed no 
obvious morphological differences in spinal motor neurons in the ventral 
horns of the mutant spinal cord. Although only superficial in nature, these 
observations are suggestive that the Ann phenotype is derived solely from 
the brain defects identified. In order to state conclusively that mutant 
spinal motor neurons are morphologically normal an ultrastructural 
examination of these cells would be necessary. Furthermore it would also 
be desirable to investigate the neurons of the peripheral nervous system to 
eliminate their involvement.
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5.1.1 the need for a map position
In the m odem  era of molecular genetics the ability to define the position of 
a locus on a genetic map of one form or another provides an invaluable 
tool for use in both biological and medical research. Gene mapping can be 
utilised to advance from a genetic disease to the molecular cloning of the 
disease-causing gene. Conversely, mapping can be used to associate a 
genetic disease with a DNA clone of unknown function. With the human 
and mouse genome sequences soon to be realised, a high-resolution map 
position will potentially enable testing of all putative genes within the 
vicinity of a m utant lesion such as a transgene insertion. By providing a 
molecular handle on a genetic disease, gene mapping can contribute to the 
diagnosis, understanding and eventual treatment of the disease.
5.1.2 Linkage mapping
Genetic maps exist in a number of forms dependant upon the type of 
information contained within. Linkage mapping is a direct descendant of 
the classical genetics performed by Mendel and involves the analysis of 
transmission of genotypes and phenotypes from parents to offspring. 
Genes that are linked will only be separated by recombination during 
meiosis. Roughly speaking, recombination occurs at random  sites and it 
thus follows that the farther apart two linked genes are from each other the 
more likely they are to be separated by meiotic recombination. A relative 
value of genetic distance can therefore be provided by the frequency of 
recombination between two lod. Genetic distance is measured in 
centimorgans (cM), with lcM  equalling a recombination frequency 
between two lod  of 1%.
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Studying the segregation of gametes in mice requires the experimental 
breeding of animals that are genetically or molecularly defined at the loci 
of interest, and the analysis of offspring generated by such crosses. 
Additionally, linkage mapping can only be performed on lod  that are 
polymorphic, w ith two or more alleles. Originally genes were m apped by 
following the segregation of mutations that generated an easily identifiable 
phenotypic change e.g. coat colour mutations. This meant that only genes 
iper se, and not other non-phenotype determining genomic regions could be 
mapped. This situation changed with the dawn of the recombinant DNA 
era, which allowed the identification of polymorphisms at the nudeotide 
level. Now nudeic ad d  variations, from RFLPs (restriction fragment 
length polymorphisms) to SNPs (single nucleotide polymorphisms) are 
amongst the polymorphic markers whose segregation can be followed and 
can thus be linkage mapped. Of the wide variety of polymorphic genomic 
elements that have been identified and used in linkage mapping, the most 
useful to date has undoubtedly been the simple sequence length 
polymorphism (SSLP), or microsatellite. These can be either mono-, di-, tri, 
or tetrameric sequences repeated (several times) in tandem  [206].
Any linkage m apping exerdse requires the use of a panel of samples in 
which the segregation of the locus of interest can be followed. If this locus 
is defined only as a phenotypic mutation then the generation of such a 
panel will require the breeding of animals in which this phenotype can be 
tracked prior to DNA preparation for marker typing. Two breeding 
strategies can be utilised in order to generate such a panel and the use of 
either requires the existence of at least two alleles at the locus of interest 
and the ability to distinguish these alleles.
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The first stage of the outcross-backcross m apping protocol is the generation 
of an FI heterozygote. This is achieved by the so-called 'outcross' in which 
one animal, homozygous for the wild-type allele of the gene of interest, is 
crossed with another animal, homozygous for the m utant allele. Animals 
of the FI generation, which will all be heterozygous, are then bred against 
animals that are homozygous for the m utant allele, allowing the 
segregation of the wild-type allele to be followed easily in the N2 
generation (see Fig. 5.1). The advantage of such a strategy is that the 
backcross stage generates animals of only two genotypes (+ /m  and m /m ) 
in which recessive mutations can be differentiated phenotypically. The 
disadvantage is that since only one of the backcross parents is 
heterozygous, only meiotic recombination events in a single parent are 
informative.
The outcross-intercross strategy again involves an initial outcross step 
designed to generate FI heterozygote animals. The subsequent breeding 
step in this case involves the crossing of these FI animals against each 
other, thus creating an F2 generation with three possible genotypes (see 
Fig. 5.2.). This is the source of a major drawback in the use of such a 
strategy. When studying a recessive mutation it is impossible to 
distinguish + /+  from + /m  animals by phenotype alone and as a result 
these animals cannot be included in segregation analysis, meaning only 
25% of offspring will be scored. Unlike the outcross-backcross strategy, 
since both parents at the second breeding step are of the heterozygous FI 






Fig. 5.1. The outcross-backcross m apping protocol.
+ /+  animals (white) are hom ozygous for the w ild-type allele at the locus of interest, m /m  
animals (black) are hom ozygous for the recessive mutant allele, which does not effect 
viability or fertility, at this locus and + /-  animals (grey) are heterozygous. As a result of 
crossing FI animals against animals of the m /m  parental genotype N2 animals can be 
only one of two possible genotypes (+ /m  or m /m ) which can be distinguished  
phenotypically. Figure adapted from [1].
The breeding strategy used to map a phenotypically defined mutation 
depends greatly upon the nature of the mutation being studied. For 
example, if the mutation is recessive and deleterious then the backcross 
strategy will be unsuitable because the second breeding stage involves the
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crossing of an FI heterozygote against a homozygous mutant. In this case 
it would be necessary to utilise the intercross breeding strategy. Given the 
fact that, unlike the intercross regime, all N2 progeny derived from a 
backcross are informative, for non-deleterious recessive phenotypes the 
backcross represents the method of choice.




Fig. 5.2. The outcross-intercross mapping protocol.
+ /+  animals (white) are hom ozygous for the w ild-type allele at the locus of interest, m /m  
animals (black) are hom ozygous for the recessive mutant allele at this locus and + /-  
animals (grey) are heterozygous. In the F2 generation + /+  and + /m  animals cannot be 
distinguished phenotypically thus allowing only m /m  hom ozygous mutant animals to be 
used for linkage analysis. Figure adapted from [1].
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If the locus of interest can be defined on purely a molecular basis, then the 
need for mouse breeding may be superfluous. In this case it is possible to 
carry out the mapping exercise using a pre-existing panel of DNA samples 
derived from a prior breeding exercise.
A wide variety of mapping panels exist and all have associated advantages. 
Before microsatellite markers were available, the mapping panel of choice 
was one of those derived from the offspring of an interspecific backcross 
between two species, M. musculus and M. spretus [207]. A greater degree 
of evolutionary divergence meant that a larger number of RFLPs (which 
were the most polymorphic markers known at this stage) existed between 
these two species than between the inbred strains of laboratory mouse. 
With the discovery of microsatellite markers, other mapping panel types 
have largely superseded interspecific mapping panels. The high degree of 
polymorphism between microsatellites within inbred strains of laboratory 
mouse has facilitated the use of panels based on intercrosses between FI 
animals derived by outcrossing two different inbred strains [38]. Another 
resource which, despite having existed for a while, has found increased 
usage due to the discovery of microsatellites, is the recombinant inbred (Rl) 
mouse strains. These are generated by an initial outcross between two 
inbred strains, followed by at least twenty generations of inbreeding [208]. 
Through the application of microsatellite markers it has been possible to 
utilise these strains in a large number of linkage m apping exercises [38].
5.1.3 Chromosomal mapping
Whilst linkage mapping involves the ordering of lod  through 
recombinational distance, chromosome mapping is based around the 
assignment of a locus to a spedfic chromosome or chromosomal segment
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that makes up part of the organisms karyotype. This is made possible by 
the fact that individual chromosomes can be defined cytogenetically 
according to their size and discrete banding properties when stained with 
agents such as Giemsa [209].
When a locus-specific nucleic ad d  probe is available, then in-situ 
hybridisation (ISH) is often the method of choice for defining its 
chromosomal location. Chromosome preparations on microscope slides 
can be denatured, allowing sequence-spedfic hybridisation of the labelled 
probe to its target [210, 211]. Initially probes were labelled with 
radioisotopes, fadlitating visualisation of target-spedfic hybridisation 
through autoradiography. This methodology has been largely superseded 
by fluorescence in situ hybridisation (FISH) which uses probes labelled 
with fluorescent tags, providing greater resolution and ease of use [40].
The generation of somatic cell hybrid lines in culture provided a further 
means for assigning chromosomal locations to genes. These hybrid cells 
contain only a portion of a single mouse chromosome in combination with 
a complete hum an or hamster 'host' karyotype. Fully characterised panels 
of somatic cell hybrid lines, in which each line contains a different region of 
the mouse karyotype, can be used to assign chromosomal locations by 
correlating the presence or expression of a gene with a spedfic mouse 
chromosome or sub-chromosomal region [212].
Using somatic cell hybrids as starting material, radiation hybrid panels 
provide another gene mapping methodology that is as highly resolving as 
linkage mapping, without the requirement for mouse breeding [42]. 
Through X-ray irradiation of a somatic cell hybrid containing a single
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chromosome, followed by fusion of this line with a suitable host 
(commonly a hamster cell line), approximately 100 new hybrid clones can 
be generated, each containing a fragment of the mouse chromosome from 
the original hybrid line. Relying on the premise that DNA markers located 
close together are less likely to be separated by chromosome 
fragmentation, analysis of radiation hybrid cells can be used to generate a 
highly resolving genetic map based on physical rather than 
recombinational distance.
5.1.4 Physical mapping
Physical mapping bridges the gap between the linkage or chromosomal 
assignment of a marker and its actual molecular constitution. This is 
achieved by assigning a genetic marker to a genomic clone or DNA 
sequence. A much higher degree of mapping resolution is therefore 
attainable through physical mapping than the other mapping 
methodologies already discussed. Indeed, the nucleotide sequence of a 
genomic region could be considered as the form of map that provides the 
highest level of mapping resolution achievable. Physical maps are more 
often found as a contiguous series of overlapping DNA clones, known as a 
contig. Each clone can contain inserts as large as several hundred kilobases 
owing to the YAC (yeast artificial chromosome) [43], and more recently, 
BAC (bacterial artificial chromosome) and PAC (PI artificial chromosome) 
cloning vectors that are available [44].
Contigs can be generated by the end sequencing of individual clones and 
using the sequence generated to isolate overlapping clones from a genomic 
library [213-215]. By this means one can 'chromosome walk' from a clone 
identified as containing a marker of interest to further clones that may
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contain the gene shown to be linked to that marker. In this way it is 
possible to progress from the linkage mapping of a disease to its molecular 
basis. A number of methodologies exist for the identification of a gene from 
a large DNA clone (YAC, BAC or PAC). These include exon trapping [47], 
identification of CpG islands [48] and cross-species hybridisation of 
sequences [216]. Although laborious, such positional cloning exercises 
have yielded valuable successes e.g. the cloning of the gene mutated in 
Duchene Muscular Dystrophy; dystrophin [217].
5.1.5 Strategies for mapping an inserted transgene
A variety of strategies can be employed in order to map a transgene 
inserted into the genome randomly at a single location. Having only the 
transgene itself as a probe prevents the use of existing m apping panels 
since they will not contain the inserted transgene. This problem can be 
circumvented if the transgene is used as a handle in the cloning of genomic 
sequence flanking the site of transgene insertion. This endogenous 
sequence can then be applied to a mapping panel in the usual manner and 
a map location derived. Such a methodology may however be complicated 
by the initial cloning of flanking sequence, which can be difficult owing to 
the often unpredictable nature of transgene insertion site (see Chapter 7).
Mapping by ISH or FISH obviates the need for a cloning exercise since the 
transgene itself can be used as a probe. The level of m apping resolution 
attainable through such methodologies is less than that from linkage 
m apping and generally one cannot proceed directly from an ISH or FISH 
location to a positional cloning exercise. Such an assignment can still prove 
useful by facilitating a search of existing mutants with similar phenotypes 
that have a similar chromosomal location. In this way possible alleles of a
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transgene insertion m utant can often be identified. The recent 
development of novel in-situ protocols (e.g. fibre FISH [218]) does mean 
that much higher levels of m apping resolution can now be achieved.
A further strategy that does not necessitate the cloning of flanking genomic 
sequence is the generation of an intercross or backcross panel specific to the 
transgenic strain in question. This methodology does though involve the 
breeding of large numbers of animals, which can be both time-consuming 
and expensive, especially when full genome coverage is required.
5.1.6 Mapping the Ann transgene
In an effort to elucidate more about the molecular nature of the transgene 
insertional mutation in the Ann line it was decided to proceed with 
mapping of the transgene in this line.
Prior to commencing a mapping exercise it was deemed necessary to prove 
that the transgene and the m utant phenotype were associated allowing the 
inference to be made that the transgene insertion was causative of the 
phenotype.
Fluoresence in situ hybridisation of Ann metaphase chromosome spreads 
was used as a starting point in the mapping exercise since expertise in this 
technique was already available in the laboratory. This would allow a 
tentative chromosomal assignment that could then be confirmed with a 
small-scale linkage m apping exercise using microsatellite markers. At this 
stage possible candidate genes and mutation would become apparent and 
could be tested if possible. Further linkage m apping could also be carried
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out if required in order to gain a more detailed map position for the site of 
transgene insertion.
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5.2 Materials And Methods
5.2.1 Microsatellite primers
Using information from the mouse genome informatics (Jackson labs.) [219] 
and Whitehead Institute/M IT Centre for Genome Reasearch [79] databases, 
microsatellite primer pairs were selected based on a number of criteria. 
Primers were chosen for intercross m apping analysis based on their 
proximity to the site of transgene integration, such that the locations of the 
primers spanned the appropriate region as determined by FISH studies. 
Primers were selected from four candidate mouse chromosomes 
(Chromosomes 4, 6, 8 and 12) following FISH analysis (see section 5.3.2). 
For backcross mapping analysis, primers positioned at regular intervals 
flanking D4Mitl55 were selected. As these studies progressed, further 
primers were selected according to their proximity to the putative location 
of the transgene insertion determined by this mapping analysis.
For all mapping studies the existence of size polymorphism between the 
C57BL/6J and CBA/Ca inbred mouse strains was essential. Unfortunately 
the mouse genome informatics (Jackson labs.) and Whitehead 
Institute/M IT Centre for Genome Reasearch databases contained no 
information on the CBA/Ca strain, thus primers were selected based on a 
comparison of C57BL/6J information with that of the C3H inbred mouse 
strain that is closely related to CBA/Ca. The actual existence of a size 
polymorphism between strains was then determined by testing inbred 
C57BL/6J and CBA/Ca samples by PCR and product visualisation 
(described below) for each set of primers purchased.
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Chromosome Marker C57 size (bp) C3H size  (bp) C57/CBA
polym orphism ?
4 D4M itl5 279 329 N o
D 4m itl55 205 189 Yes
6 D6M itl6 152 145 Yes
D6Mit69 164 168 Yes
8 D8Mit73 172 166 Yes
D8Mit74 126 120 Yes
12
D12M itl4 130 146 Yes
D12Mit34 174 166 Yes
D 12M itll8 134 124 N o
Table 5.1. Microsatellite primers selected for intercross mapping.
Using the criteria detailed, for intercross mapping nine suitable primer 
pairs were purchased (Research Genetics inc. see Table 5.1.). Based upon 
the results of intercross and backcross mapping analysis a further eleven 
(chromosome 4 specific) microsatellite primer pairs were purchased. 
Microsatellite PCR reactions were performed as detailed in section 2.2.16.
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Marker cM Position C57 size (bp) C3H size (bp) C57/CBA
polym orphism ?
D4M itl53 45.50 122 112 N o
D4M itl76 46.50 140 146 No
D4M itl55 49.60 205 189 Yes
D4M itl68 50.80 125 125 N o
D4Mit331 50.80 124 118 Yes
D4Mit29 51.00 N o info. N o info. N o
D4Mit31 51.30 122 112 Yes
D4Mit43 51.40 114 110 Yes
D4Mit332 53.60 138 152 Yes
D4Mit334 57.00 126 108 Yes
D4Mit203 60.00 144 124 Yes
Table 5.2. Microsatellite primers selected for backcross mapping.
5.2.2 Small scale polyacrylamide gel electrophoresis
Non-denaturing 8% polyacrylamide gels were made using the Mini- 
Protean II (Bio-rad) system according to the manufacturers instructions. 
Gels were run for 2-3 hours, according to expected product size, at 100V 
constant voltage with lx TBE (made from 5x stock, 2.2M Tris base, 2.2M 
boric acid, lOmM EDTA pH8.0) in the upper buffer chamber and 0.5x TBE 
in the lower chamber. For the silver staining procedure used to visualise 
the PCR products (section 5.2.4), glass plates were carefully separated and 
the gel removed into a glass trough.
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5.2.3 Large scale polyacrylamide gel electrophoresis
Glass sequencing plates were prepared by firstly cleaning with soap and 
water and then with xylene. The notched plate was then treated with a 1ml 
coating of repel-silane (Sigma) followed by wiping the surface of the plate 
with IMS. The flat plate was similarly treated with a coating of bind silane 
(3pl bind silane (Sigma), 1ml IMS, 0.5% glacial acetic acid) followed by IMS. 
The plates were assembled using sequencing tape (Gibco) with spacers 
between. 50ml of a 6% acrylamide-urea gel mix was prepared using 21 g of 
urea, 5ml lOx TBE, 10ml 30% acrylamideibis-acrylamide (19:1) and 20ml 
H20). The urea was dissolved under the hot tap and then allowed to cool 
to room temperature. Following the addition of 250pl of 10% Ammonium 
Persulphate (Sigma) and 25pl TEMED (Sigma) the mixture was mixed and 
quickly poured using a 50ml syringe. After allowing to set for at least 2 
hours, the gel was inserted into the gel tank, both buffer chambers filled 
w ith lx  TBE and a 24 well shark-toothed comb inserted. The gel was then 
pre-run for at least 30 minutes with the power pack set at a constant power 
of 50 watts and constant temperature of 50°C. Following the addition of 3x 
STR formamide loading buffer (lOmM NAOH, 95% formamide, 0.05% 
bromophenol blue, 0.05% xylene cyanol), 5pl of each PCR reaction was 
denatured at 95°C for 2 minutes prior to loading. Samples were run at a 
constant power of 50 watts and constant tem perature of 50°C for at least 2 
hours (depending on product size). Further samples could be loaded at 10- 
30 minute intervals (again dependant upon product size). After a suitable 
running time, gels were removed from the apparatus and glass plates 
prized apart using a razor blade. The gel was then subjected to the silver- 
staining procedure in a plastic trough whilst still attached to the flat 
sequencing plate.
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5.2.4 Visualisation of PCR products by silver staining
After electrophoresis, gels were fixed in 40% methanol for at least 30 
minutes. Two 10 minute washes in 10% IMS, were followed by 5 minutes 
in lx  silver stain oxidiser concentrate (Bio-rad). Gels were then washed, 
usually for 3x 5minutes in dH20 ,  until the yellow colouration had been 
removed. Following a 20-minute wash in 0.1% A gN 03 and a short rinse in 
dH20 ,  gels bands were developed by washing in developing solution (2% 
Na2C 0 3/0.01% formaldehyde (both Sigma)). On appearance of a brown 
precipitate, developer was changed, until bands were clearly visible. Prior 
to analysis, gels were washed in dHJd and in the case of the small gels, 
dried down under vacuum, on 3mm paper (Whatman).
5.2.5 Analysis of backcross mapping data
Data obtained from backcross linkage analysis was processed using the 
Gene-link program  [220]. For both backcrosses performed, databases were 
created in which genotyping information for every animal tested could be 
entered. The program  was then able to automatically order lod  (this is 
done by maximum likelihood order analysis) and calculate linkage 
distances and the associated 95% confidence interval.
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5.3 Results
5.3.1 The transgene and phenotype are linked
Prior to embarking upon a detailed study of a mutant phenotype caused by 
transgene insertion, it is essential to demonstrate that the transgene is 
indeed the causative agent of the mutation. With a lack of conclusive 
molecular evidence, statistical analysis was used to establish that the 
mutant phenotype resulted from transgene insertion. A null hypothesis 
was proposed that there was no linkage association between the transgene 
and the mutant phenotype i.e. that these two traits segregate 
independently from one another, and the transgene was assigned as a 
dominant trait (i.e. both hemizygotes and homozygotes are identifiable as 
transgenic) and the phenotype as recessive (i.e. only homozygotes are 
affected and identifiable) then, using Mendelian genetics, and if there is no 
linkage, the following was expected: 9/16 wild-type and transgenic; 3/16 
Ann mutant and transgenic; 3/16 wild-type and non-transgenic and 1/16 
Ann mutant and non-transgenic. The data for 16 Ann litters (129 pups) can 






Table 5.3. Ann intercross breeding data
Expected and observed numbers from a total of 129 mice (16 litters). The values in the 
table are those observed and those in brackets are expected.
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Using these values, a %2 test was performed using the following formula:
C j
Where O is the observed value, E is the expected value and (O-E) is the 
absolute value of the difference between O and E.
X 2 =16.6
- for 3 degree of freedom this gives pcO.OOl
As the probability of the null hypothesis being correct is <0.05 this 
hypothesis can be rejected and it can be stated that there is a statistically 
significant likelihood that the two traits, the transgene and the Ann mutant 
phenotype, are linked (there is a chance of less than 1 in 1,000 that this 
assumption is incorrect). This strongly suggests that the insertion of the 
transgene is responsible for the Ann m utant phenotype.
5.3.2 Mapping the site of transgene insertion by FISH and G-banding
Having confirmed that the Ann phenotype and the inserted transgene were 
linked, it was decided to initiate studies to obtain a map position for the 
transgene to facilitate a search for possible candidate genes or provide a 
starting point for the cloning of the gene responsible for the Ann 
phenotype.
That the transgene itself was the only probe available at this stage limited 
the strategies that could be employed in m apping the site of transgene 
insertion. Chromosomal m apping by FISH, using the transgene as a probe, 
would provide a useful handle on the map position of insertion site and
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allow the identification of possible candidate genes. FISH was therefore 
selected as the method of choice for initial mapping studies. A 
methodology was employed whereby hybridisation of a biotinylated 
transgene probe to Ann metaphase chromosome spreads could be 
visualised using anti-biotin fluorescent antibodies. Prior G-banding of 
these spreads with Giemsa dye facilitated the identification of the 
transgene-specific chromosome by comparison with existing mouse 
karyotypes.
Metaphase Ann chromosome spreads subjected to FISH and G-banding are 
shown in Fig. 5.3. These images show that the integrated transgene 
(identifiable by red spots in the FISH images) has an approximate mid to 
distal location on a m edium to large sized chromosome. Comparison with 
existing mouse G-banded karyotypes provides further insight as to the 
possible identity of the transgene-specific chromosome (see Fig. 5.4.). Due 
to their acrocentric nature and, in many cases, similar banding patterns, it 
can be difficult to make a chromosome assignment unequivocally through 
G-banding. Chromosomes 4, 6, 8 and 12 were suggested as strong 
candidates owing to their size and banding patterns. Of these, 
Chromosome 4 was suggested as the most likely candidate by a mouse 
karyotyping expert (M. Lee personal communication).
Fig. 5.3. Ann FISH and G-banding.
Chromosomal mapping of the transgene insertion by FISH and G-banding o f Ann metaphase 
chromosome spreads. Fluorescence in situ hybridisation of Ann metaphase chromosome spreads 
using a transgene specific probe fragment, (A) and (C). The site o f transgene insertion is identified 
by a fluorescent spot on sister chromatids of the same chromosome (indicated by arrow). G- 





Fig. 5.4. Standard m ouse karyotypes.
These were used for comparison with Ann G-banding results. G-banded m ouse  
chrom osom es (A) and an iodiogram  illustrating G-banding patterns (B) were used to 
narrow dow n the chrom osom e of interest to one of four possibilities (Chromsome 4, 6, 8 
or 12). Karyotypes obtained from the University of W ashington, School of Pathology web  
site.
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5.3.3 Confirming the chromosomal location by small-scale intercross mapping
FISH and G-banding analysis on metaphase chromosome spreads from 
Ann hemizygous mice had suggested that chromosome 4, 6, 8 or 12 might 
harbour the transgene array. It was decided to utilise microsatellite 
markers in a linkage m apping exercise in order to confirm/eliminate these 
possibilities.
Transgenic founders had been generated using FI embryos derived from 
crossing C57BL/6J and CBA/Ca mice. Interbreeding of subsequent 
generations meant that all available transgenic mice had genetic 
backgrounds of a mixed C57 and CBA constitution. To be informative for 
possible intercross m apping analysis, it was essential for breeding mice to 
have suitable haplotypes for the microsatellite markers being tested. In 
order to identify suitable breeding mice, haplotype analysis of selected 
microsatellite markers from the four candidate chromosomes was initiated.
r
Two male and two female mice of breeding age were tested for 
microsatellite markers on chromosome 6 (D6Mitl6), 8 (D8Mit73) and 12 
(D12Mit34) (see Table 5.4.). According to the fragments amplified, 
mice were typed as being of C57 type, CBA type or FI type (both C57- 
specific and CBA-specific fragments).
Based on the FISH and G-banding data generated, microsatellite markers 
were likely to be positioned close to the inserted transgene array. Thus, 
excepting the possibility of recombination events, one would expect a 
marker from the correct chromosome to segregate with the transgene. 
Since the embryos used to generate founder transgenic mice were of 
F1(C57BL/6J, CBA/Ca) it was reasonable to suggest that the transgene was 
integrated on either a C57 or CBA chromosome. Therefore typing of a
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marker linked to the transgene should generate an FI pattern for 
hemizygous transgenic mice and C57 or CBA specific patterns for non- 
transgenic wild-type or homozygous-transgenic mutant mice, dependant 
upon into which chromosome the transgene has integrated.
3d 79 6d 99
D 6M itl6 CBA C57 CBA CBA
D6Mit69 CBA CBA CBA CBA
D8Mit73 FI C57 FI C57
D8Mit74 FI C57 C57 C57
D12M itl4 CBA CBA CBA CBA
D12Mit34 CBA CBA CBA CBA
Table 5.4. Microsatellite typing of breeding animals.
Genotyping of breeding animals using microsatellite markers specific to chromosomes 6, 8
and 12.
The results of markers for chromosomes 6 and 8 shown in Table 5.4. yield 
immediate insight into the possible identity of the transgene-specific 
chromosome. Since the mice typed were all hemizygous transgenic, and 
none of the markers analysed displayed an FI banding pattern for every 
mouse, it seems unlikely that any of these microsatellite markers are linked 
to the transgene array. The possibility of recombination events distorting 
segregation patterns in such numbers seems unlikely given the expected 
proximity between the markers selected and the transgene (based upon the 
relative position of the transgene along the chromosome as determined by 
FISH).
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To strengthen these suggestions it was decided to cross the mice that had 
been tested and type the offspring with microsatellites in order to 
investigate possible correlations between transgene and microsatellite 
segregation. The results confirm that the segregation of markers D6Mitl6 
and D8Mit73 bears no relationship with that of the transgene, allowing 
Chromosomes 6 and 8 to be eliminated from further investigation (see table 
5.5.)
Both Chromosome 12 markers yielded the same banding pattern (CBA/Ca) 
for all four breeding mice, meaning that testing of intercross litters with 
these markers would be uninformative. To overcome this, mouse 3d was 
m ated with a C57BL6/J inbred female, producing offspring that were all 
confirmed as being of the FI type for the D12Mitl4 and D12Mit 34 
microsatellite markers. Two sibling breeding pairs were set up from this 
outcross. Mice selected for breeding were also found to carry the FI 
haplotype for the more recently obtained Chromosome 4 marker 
D4Mitl55.
Intercross litters were generated and typed, firstly with D4Mitl55. Typing 
of the first two litters (15 mice) with this marker revealed a definite trend 
suggesting its co-segregation with the transgene. Typing of four further 
intercross litters was used to test wether the transgene and marker 
D4Mitl55 were indeed linked. Again, %2 analysis was performed using the 
results shown in Table 5.6. A probability of >0.0001 was calculated for the 
null hypothesis, that the two loci were unlinked, being correct. This was 
done using the special %2 equation for intercrossing outlined in the book 
Mouse Genetics [1]. Given this result, further testing of the Chromosome 12 
markers (D12Mitl4 and D12Mit34), was deemed to be unnecessary.
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Parents Litter
M ouse no. 3d 79 Id 2d 3d 4d 5d 6d 7d 89 99
Transgene T /w t T /w t T /w t w t/w t T /w t T /T T /w t T /T T /w t w t /w t w t/w t
D 6M itl6 CBA C57 FI FI FI FI FI FI FI FI FI
D8Mit73 FI C57 C57 C57 C57 FI C57 C57 FI C57 C57
Parents Litter
M ouse no. 6d 99 Id 29 39 49 59 69 79 89
Transgene T /w t T /w t T /w t w t/w t T /T T /T w t/T w t/T w t/T w t/T
D6M itl6 CBA CBA CBA CBA CBA CBA CBA CBA CBA CBA
D8Mit73 FI C57 FI C57 FI FI FI FI C57 C57
Table 5.5. Genotyping of parents and offspring for two microsatellite markers.
Genotyping of parents and offspring for two microsatellite markers (D6M itl6 and 
D8Mit73) reveals no correlation with the segregation of the transgene, allowing 
elimination of Chromosomes 6 and 8 as possible candidates.
Transgene status No. offspring D4M itl55
C57 FI CBA
w t/w t 21 21 0 0
T /w t 23 1 21 1
T /T 6 0 0 6
Table 5.6. Small scale intercross analysis.
Small scale intercross analysis show s possible co-segregation of the transgene and the 
Chromosome 4 microsatellite marker D4M itl55.
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5.3.4 Fine mapping using a backcross strategy
Having obtained a chromosomal assignment and a tentative map position 
through a small scale intercross study, it became possible to search the 
Mouse Genome Database for possible candidate genes and mutations 
located around the same region of mouse chromosome 4. Three good 
candidate genes were identified in this way allowing molecular studies on 
these genes to be initiated (see Chapter 6).
It was decided that the pursuit of a more exact map position would 
provide a stronger indication as to likely candidate genes located in this 
region. To do this a backcross m apping strategy was employed whereby 
four breeding harems were set up, each containing a single hemizygous 
transgenic male (confirmed as being of the FI haplotype for the 
microsatellite marker D4Mitl55) and four C57BL/6J inbred females. This 
was thought to be the best way to generate a useful amount of data in as 
short a period as possible. Each F2 pup born (representative of a single 
meiotic event) was typed with a number of microsatellite markers located 
near to D4Mitl55, as well as being tested for transgenicity by luciferase 
assay. Large numbers of animals could be quickly typed by running up to 
96 microsatellite PCR reactions on a single polyacrylamide gel (a typical 
example is shown in Fig. 5.5). All breeding males were tested for each new 
marker used to confirm an FI haplotype. As the analysis progressed and 
preliminary mapping data was generated further microsatellite markers 
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Fig. 5.5. Microsatellite marker typing o f backcross DNA samples.
A typical example of a large-scale polyacrylamide gel following electrophoresis of microsatellite 
PCR products (in this case D4Mit332 which gives a C57-specific product o f 138bp and a CBA- 
specific product o f 152 base pairs) and visualisation of products by silver staining. By having 
multiple loadings a large number of samples can be tested on a single gel (in this case 96: backcross 
samples 49-84 from one cross and 58-114 from another as well as C57, CBA and FI controls).
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Similar to the situation described in section 5.3.3, segregation of a linked 
microsatellite marker with the transgene in these crosses would be 
expected to result in non-transgenic offspring of the C57BL/6J haplotype 
for this marker, whilst transgenic hemizygotes would be of the FI 
haplotype. Any deviations must result from a meiotic recombination event 
taking place between the marker and the transgene in the paternal 
gametes.
Data was entered into a Gene-link 2.0 database that had been set up for this 
study. The haplotypes of each of the 237 F2 offspring for 7 microsatellite 
markers is shown in Fig. 5.6. (it should be noted that the markers D4Mit31 
and D4Mit43 gave identical results). Using this data, the Gene-link 
software was able to order the microsatellite markers in relation to each 
other and the transgene array. In addition, this program  calculated linkage 
distances between markers, including 95% confidence intervals (see Fig. 
5.7.). This data shows that the transgene is positioned between the markers 
D4Mitl55 and D4Mit331. Further typing using Mit microsatellite markers 
located between D4Mitl55 and D4Mit331 was prevented due to the 
absence of C57/CBA size polymorphism for all markers located in this 
region.
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D4Mitl55 | □ ■ □ ■ ■ □ ■  ■
Transgene | ■ □ □ ■ i n ■ □ ■ ■
D4Mit331 | ■ □ ■ □ □ ■ □
D 4M it31/43( ■ □ ■ □ ■ ■ □ ■  : n  ■
D4Mit332 | ■ □ ■ □ ■ □ □ ■  : D  ■
D4Mit334 | ■ □ ■ □ ■ □ ■ □  □
D4Mit203 | ■ □ ■ □ ■ ■ □ ■ □  ■
118 88 3 4 0 1 4 5 2 2 3 2 4 2
Fig. 5.6. Backcross linkage m apping haplotype diagram.
Backcross linkage mapping of the transgene against a number of chromosome 4 
microsatellite markers. The backcross involved the breeding of hem izygous transgenic 
male mice of the C57/CBA background at each of the markers w ith C57 females. The 
results of the 237 informative m eioses analysed are show n for each marker, black squares 
represent a CBA genotype whilst white squares represent a C57 genotype.
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(1.20-5.99) (0.01-2.33) (1.47-6.54) (0.46-4.26) (0.69-4.85) (0.93-5.43)
Fig. 5.7. A genetic map of the region surrounding the transgene insertion.
Numbers of recombinants beween the markers analysed are detailed. Using the 
information shown in Fig. 5.6. markers were ordered and map distances (in cM) with  
corresponding 95% confidence intervals (shown in brackets) calculated using the Gene- 
link 2.0 program.
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5.3.5 Differences from published recombination frequencies are strain specific
Comparison of the mapping data generated from our backcross analysis 
and the Chromosome 4 consensus map revealed marked differences in the 
linkage distances between markers located around the transgene 
integration site (see Fig. 5.8.). Linkage distances derived from the 
backcross analysis are much elevated between the markers D4Mitl55 and 
D4Mit331 and between D4Mit331 and D4Mit31, as compared to the 
consensus map.
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Fig. 5.8. Comparison of Ann and Chromosome 4 linkage maps.
Comparison of the linkage map constructed using the 237 m eiosis backcross analysis 
(above, as Fig. 5.7.) w ith the Chromosome 4 committee consensus map (below). Striking 
differences in map distances are apparent between the markers D4M itl55, D4Mit331 and 
D4Mit 31.
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To investigate the possibility that the transgene array was interfering with 
recombination in the surrounding genomic region, a backcross was set up 
between wild-type F1(C57/CBA) males and C57 inbred females. This cross 
mimics that used in previous backcross study except for the absence of the 
transgene in the breeding males. A total of sixty-seven F2 pups were 
genotyped for the transgene and the microsatellite markers D4Mitl55, 
D4Mit331 and D4Mit31. The haplotypes of these pups are shown in Fig. 
5.9.
D4Mitl55 ■ !I1 ■ □ ■
D4Mit31 ■ ■ ■
D4Mit331 ■ !■ ■
32 31
i
3 0 1 0
Fig. 5.9. Test backcross results.
Results of a test backcross between F1(C57/CBA) male and C57 females. Offspring were 
typed using the chromosome 4 microsatellite markers D4M itl55, D4Mit31 and D4Mit331. 
The results of the 65 informative m eioses analysed are show n for each marker, black 
squares represent a CBA genotype whilst white squares represent a C57 genotype.
Again, this data was entered into a Gene-link 2.0 database and linkage 
distances calculated. Comparison of linkage distances derived from both 
backcross experiments suggests that the transgene insertion has no 
significant effects upon recombination levels in the surrounding genomic
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region (see Fig. 5.10). Instead, differences observed in comparison with the 
Chromosome 4 committee consensus map are likely to be strain-specific.
























Fig. 5.10. Comparison of Ann and test backcross linkage maps.
Comparison of the linkage map constructed using the 65 m eiosis test backcross (middle) 
w ith that for the 237 meosis Ann backcross (below). Map distances between microsatellite 
markers are comparable w ith 95% confidence intervals (shown in brackets) clearly 
overlapping. The Chromosome 4 consensus map distances between the same markers are 
show n (above) for comparison.
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5.4 Discussion
5.4.1 The transgene maps close to the scrambler mutation on mouse 
chromosome 4
Through a combination of FISH and linkage mapping analysis the site of 
transgene integration was located on Chromosome 4 between the closely 
spaced microsatellite markers D4Mitl55 and D4Mit331. Examination of the 
Chromosome 4 committee consensus map reveals a number of genes and 
mutations known to map near to these microsatellite markers. Of these, 
one mutation that is located on the consensus map in a very similar 
position to the transgene (i.e. between D4Mit 155 and D4Mit331) is the 
scrambler (scm) classical mouse mutation[221] (see Fig. 5.11), which is 
described in detail in Chapter 6.
Two previous linkage-mapping studies have been conducted on scm. The 
first culminated in an intraspedfic intercross (between strains of a mixed 
DC/Le, C3HeB/FeJ background and BALB/cByJ) from which 118 meiotic 
events were typed for three Chromosome 4 microsatellite markers 
including D4Mitl76. No recombinants were observed between this 
particular marker and the scm mutation [221]. The second study was 
conducted on a larger m apping panel comprising 492 meiotic events 
(between the C57BL/KsJ-m+/+db and M A/M yJ strains) [180]. In this case 
the samples were ultimately typed for a number of microsatellite markers 
situated between D4Mitl76 and D4Mit31. No recombination was observed 
in this case between scm and the D4Mit29 microsatellite, which lies close to 
D4Mit331. The occurrence of a single recombination event between the 
transgene and the dosest microsatellite marker typed, D4Mit331, in the 
Ann backcross panel, may be attributable to strain spedfic differences in
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recombination between the Ann C57/CBA background and those detailed 
above.
The map positions of the scrambler mutation derived from both studies are 
found to be consistent when the 95% confidence intervals for these map 
positions are considered. This is also the case when considering the map 
position of the Ann transgene insertion (as derived from our study) 

















Chromosome committee Ann backcross
consensus map linkage map
Fig. 5.11. Comparing the map positions of the scm locus and the transgene.
Comparison of the chromosome 4 committee consensus map and the Ann linkage map
derived from a 237 m eoisis backcross analysis. The transgene is located between the
microsatellite markers D4M itl55 and D4Mit331 (as show n in the Ann linkage map) as is
the scrambler mutation (at offset 49.7, as show n in the consensus map).
3.0cM
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The gene m utated in scrambler was identified as the mouse disabled 
homologue, mdabl. In a separate study the chromosomal location of mdabl 
was m apped on mouse Chromosome 4 at offset 52.7 [197]. This map 
position differs somewhat from those of the scm mutation. In this case a 
Jax (Jackson Labs.) interspecific backcross-mapping panel (C57BL/6J x Mus 
spretus) FI x C57BL/6J)was analysed using a small number of markers.
These discrepancies highlight the difficulties encountered when comparing 
linkage maps compiled from separate studies. The validity of such 
comparisons depends largely on the number of meiotic events analysed 
(which dictates the confidence intervals for m apping distances) and the 
markers used. To gauge the map distance between two markers using 
information from separate studies, the presence of a marker common to 
both studies is imperative. This allows a valid comparison of map 
positions to be made. From our study it is also clear that strain-specific 
recombination differences influence map distances derived from different 
studies (see section 5.4.3).
Bearing in m ind possible differences in map locations it appeared 
pragmatic to examine the various linkage maps for other possible 
candidate genes located in the area of the transgene insertion on 
chromosome 4. Two other possible candidates were discovered, based 
upon a combination of their function and respective map positions. Both 
Glytl and faah map in the vicinity of the transgene insertion [222, 223], are 
expressed in the brain [224-226] and are known to play important roles in 
the normal function of the nervous system [227, 228]. In addition the 
clasper mouse m utant also maps nearby and exhibits a phenotype that, 
although not identical to Ann, is similar [229]. Despite this, owing to its
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map position and m utant phenotype (see chapter 4), mdabl/scm  still 
represents the most attractive candidate. Efforts to confirm or eliminate 
mdabl, Glytl and faah as candidate genes are presented in Chapter 6.
5.4.2 mdabl represents an attractive candidate for the Ann mutation
There are various reasons why the scrambler m utant represents an 
extremely promising candidate for the mutation in Ann. Firstly, as 
discussed, the map positions of both scm and the integrated transgene 
exhibit a strong correlation, more so than the other candidates mentioned 
(see Chapter 6, Fig 6.1.). Secondly, as outlined in Chapter 4, both the Ann 
and scrambler phenotypes show a marked resemblance in terms of clinical 
phenotype and brain histopathology. For these reasons, the molecular 
analysis of the mdabl gene in Ann mutants is of param ount importance.
5.4.3 Differences in recombination frequencies are strain specific and do not 
arise through chromosomal rearrangement
Comparison of the data generated from the Ann backcross m apping study 
with the Chromosome 4 committee consensus map reveals a disparity in 
the linkage distances separating three of the microsatellite markers 
flanking the integrated transgene in the Ann mouse
The map distance between markers D4Mitl55 and D4Mit31, as presented 
in the consensus map (i.e. 1.7cM), falls beneath the 95% confidence interval 
for the distance between the same markers, as found in the Ann backcross 
m apping study (i.e. 6.75 (3.91 -10.37))
Two explanations for this phenomenon seemed plausible. The first of these 
being that the presence of the integrated transgene array was somehow 
interfering with normal levels of recombination in this surrounding region.
177
Effects on genomic structure and chromatin stability around sites of 
transgene integration are well-documented (see Chapter 1) and alterations 
in map distances resulting form transgene-specific chromosomal changes 
have been seen. An increase in linkage distances between markers would 
though require the promotion of recombination events and no precedent 
for such a phenomenon exists. It is not though outwith the realms of 
possibility that the insertion of exogenous DNA at a site in the genome 
could somehow create a 'hot-spot' for recombination at that site.
Alternatively, differences in recombination frequency between inbred 
strains of laboratory mouse are also well known. Any discrepancies 
between our data and that used to generate the chromosome committee 
map could therefore rest with strain-specific differences in recombination 
for the mice used. Since the information used to generate the consensus 
map is derived from a variety of sources, including crosses involving 
different mouse strains, this seems a valid possibility.
The results of a test backcross involving identical strains to those used in 
the Ann backcross, except for the absence of the transgene, indicate that 
any differences from the consensus map are most probably due to strain- 
specific differences in recombination rates, and these are not significantly 
affected by the transgene insertion.
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CHAPTER 6: IDENTIFYING THE MOLECULAR 
BASIS OF THE ANN PHENOTYPE
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6.1 Introduction
6.1.1 The molecular basis of the Ann phenotype
In order to find a gene disrupted by transgene insertion it is invaluable to 
obtain genomic sequence flanking the transgene. The availability of such 
sequence allows the investigator to isolate nearby genes by providing a 
molecular probe for screening wild-type mouse genomic DNA libraries. A 
number of methods can then be employed to identify possible exons in the 
region, such as direct sequencing, zoo blots and exon trapping. Indeed 
such methodologies have been successfully applied to the cloning of novel 
genes m utated by transgene insertion including legless [230] and limb 
deformity [231].
Such a procedure would appear, in principle, to be straightforward but 
problems can arise for a number of reasons. For example, the cloning of 
genomic sequence can be complicated by the structure of the inserted 
transgene itself (see Chapter 7).
6.1.2 The candidate gene approach
W hen embarking upon such a study, possibility of allelism with an existing 
locus should be investigated. Such a statement becomes all the more 
pertinent when considering the number of insertional mutations that have 
been found to be allelic with existing genes or mutations.
In one previous systematic screen for visible insertional mutants in a large 
series of transgenic mice, amongst five lines identified as carrying visible 
mutations three were found to represent re-mutation of pre-existing 
classical lod  [26]. Indeed these findings agree with the global figures for
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visible insertional mutants for which just over 50% of mutants identified 
have been found to be allelic with existing mutations.
Obviously the efficiency in testing an insertional m utant for allelism with a 
candidate locus increases with the availability of good mapping data both 
for the candidate and for the transgene insertion. With reasonable 
mapping data in hand, and an ever expanding database of mouse mutant 
phenotypes and map positions, not to mention genomic DNA sequence, 
candidate loci can rapidly be tested for disruption in a new insertional 
m utant line.
The simplest way to perform such a test is by analysing expression of either 
the mRNA or protein of the candidate in homozygous m utant mice. Loss 
or reduction of expression of the candidate may well confirm this as the 
affected gene. Such results must be interpreted with caution. For example, 
reduction of gene expression in an anatomical structure could result as a 
consequence of loss of the structure concerned. In order to unequivocally 
test whether a mutation is allelic or not, a complementation test must be 
performed with an existing mutant. Unfortunately such tests can become 
cumbersome when m utant mice must be located and imported prior to 
breeding.
6.1.3 Finding and testing candidates for the Ann mutation
Successful FISH and intercross linkage mapping experiments confirmed 
that the transgene array in the Ann line had integrated in the mid-to-distal 
region of mouse chromosome 4 (see Chapter 5). Whilst fine backcross 
mapping of the transgene was in progress, it was decided to investigate the
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possibility of candidate genes for the Ann mutation localising to this 
region.
Analysis of the chromosome committee map for mouse chromosome 4 in 
the area harbouring the transgene reveals the presence of a number of 
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Fig. 6.1. Candidate genes on Chromosome 4.
Chromosome 4 linkage map showing Ann candidate genes located in the vicinity of the 
Ann transgene. The transgene was mapped between the microsatellite markers D4M itl55 
and D4Mit331.
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For each candidate gene (mdabl, Faah and Glytl) a cDNA clone was 
obtained from which a probe fragment specific for the gene of interest 
could be derived. These probes were utilised in the investigation of both 
structural integrity and expression levels of the gene in wild-type, 
hemizygous transgenic and homozygous transgenic mice in order to 
elucidate any possible involvement in the Ann m utant phenotype.
6.1.4 The glycine transporter type 1 (Glytl) gene as a candidate
The glycine transporter type 1 gene, Glytl, had previously been m apped to 
the central region of mouse chromosome 4 (chromosome committee map, 
offset 52.0, see Fig 6.1) [222]. Neurotransmitter transporters such as GlyTl 
are essential for the re-uptake of neurotransmitters at the presynaptic 
membrane and on surrounding glial cells. Termination of synaptic 
transmission and the replenishment of transmitter pools in the presynaptic 
nerve terminal is dependent upon such re-uptake [228].
In keeping with such a role, the two isoforms of GlyTl (GlyTla and 
GlyTlb) have been shown to be expressed in the central nervous system of 
developing rat embryos, and in several regions of the adult rat and mouse 
CNS including the Purkinje cell layer of the cerebellum [224, 225]. In situ 
hybridisation studies on adult rat sections have shown this CNS specific 
expression to be of glial cell origin [232].
Glycine transporters work in tandem with glycine receptors. These 
receptors have been implicated in the pathogenesis of spactidty [233, 234] 
and the loss of motor control [235,236] associated with the hum an diseases 
Amyotrophic Lateral Sclerosis and Parkinson's disease. The suggestion 
that perturbation of glycine signalling at the synaptic cleft could be
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involved in such a diseases, coupled with an appropriate map location, 
presents the Glytl gene as a good candidate for that disrupted in Ann 
m utant mice. As such, it was decided to look for any abnormalities in the 
expression of the Glytl gene in Ann transgenic mice.
6.1.5 The fatty acid amide hydrolase (Faah) gene as a candidate
Another reasonable candidate for the Ann mutation is the fatty-acid amide 
hydrolase (Faah) gene. This had been m apped to the centro-distal region of 
chromosome 4, concordant with the Mpl gene (at offset 56.5 of the 
chromosome committee map, see Fig. 6.1) [223]. Faah is a membrane bound 
enzyme involved in the degradation of fatty acid amides, including the 
neuromodulatory signalling molecules oleamide and anandamide [237, 
238].
W idespread distribution of Faah mRNA in neuronal cells in the rat CNS 
was demonstrated by in situ hybridisation [226]. Furthermore, anandamide 
has been shown to induce motor deficits in mice [227]. This has led to 
speculation that defects in Faah activity could potentially cause inheritable 
neurological disorders in humans.
Indeed such speculation prom pted one study in which Faah was evaluated 
as a candidate for the classical neurological mouse mutation clasper [223], 
which itself maps to the mid-region of chromosome 4 [229]. Clasper mice 
exhibit an abnormal gait and whole-body tremor and are found to clasp 
both forefeet and hindfeet on suspension by the tail. Whilst Faah was 
eliminated as the genetic basis of the clasper mutation it still represents an 
attractive candidate gene for the Ann mutation.
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6.1.6 The disabled-1 {mdabl) gene/scrambler mutant as a candidate
As demonstrated in Chapter 5, the employment of a larger scale backcross 
mapping study provided a more precise map location for the transgene. 
Comparison of this more accurate map position w ith the chromosome 
committee consensus map revealed that scrambler maps extremely close to 
the site of transgene insertion (between microsatellite markers D4Mitl55 
and D4Mit331, see Fig. 6.1). This, coupled with the strong phenotypic 
correlation between the Ann and scrambler m utant phenotypes makes 
scrambler the strongest candidate of those considered. As such, the 
structure and expression of the mdabl gene responsible for the scrambler 
mutation was investigated for anomalies in Ann m utant mice.
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6.2 Materials And Methods
6.2.4 cDNA probes
All probe fragments were digested with the suitable restriction 
endonucleases and gel purified following electrophoresis on a 1% agarose 
gel (see section 2.2.9).
A construct representing 1.7kb of the Faah cDNA cloned into the pcDNA3 
vector (Invitrogen) was obtained [239]. The probe fragment was isolated 
by restriction endonuclease digestion with EcoRI and Notl
A  Glytl I.M.A.G.E Consortium clone (ref no. 420070) was obtained 
consisting of 1.3kb of the Glytl cDNA sequence cloned into the pT7T3D- 
Pac vector (Amersham pharmacia). The probe fragment was isolated by 
endonuclease digestion with Notl and Xhol.
The mdabl 555 cDNA clone consists of 1.7kb of sequence that encodes the 
mDabl 555 protein isoform cloned in the pBS (Stratagene) vector[197]. The 
probe fragment was isolated by restriction endonuclease digestion with 
EcoRI.
6.2.5 Reverse transcriptase PCR
Reagents used were all obtained from the Promega reverse transcriptase kit 
(Promega). lp g  of RNA sample was added to 500ng of random  hexamer 
primers and the volume made up to lOpl with DEPC-treated HzO. This 
was incubated at 75°C for 10 minutes and then allowed to cool at room 
temperature for a further 10 minutes. The tube was spun briefly to collect 
the sample at the bottom and then 4pl of 5x reaction buffer, 2pl of lOOmM 
DTT, 2pl of 5mM dNTPs (GATC) and 200 units of reverse transcriptase
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added. The tube was mixed and spun briefly and then incubated at room 
temperature for 5 minutes prior to 60min at 37°C. Following incubation, 
l|iil of reaction mixture was added to a 20pl PCR reaction (as described in 
section 2.2.16). With the SoxlO control primers the PCR mixture was the 
same as for all other PCR reactions but thermocycling conditions differed. 
SoxlO reactions were denatured at 94°C for 2 minutes, followed by 40 
cycles each comprising of 40 seconds at 94°C, 30 seconds at 55°C and 2 
minutes at 68°C, followed by a final extension for 7 minutes at 68°C and 
cooling to 4°C. PCR products were analysed by electrophoresis of 5|xl of 
the reaction mixture on a 1.5% agarose g e l .
6.2.6 Primers
For reverse transcriptase PCR reactions either mdabl or SoxlO control 
primers were used. The mdabl primers had been used in a previous study 
[180] and were 20-mers specific to positions 177-196 (m dabl.1) and 626-607 
(m dabl.2) of the mdabl 555 published cDNA sequence:
m dabl.1 5'-AGGGAGGAGCCTTTCTCTTG-3'
m dabl.2 5'-TGTGATGTCCTTCGCAATGT-3'
For PCR reactions with this primer pair an annealing temperature of 60°C 
was used and the Mg2+ concentration of the reaction mixture was 3.0mM.





For PCR reactions with this primer pair an annealing tem perature of 55°C 
was used and the Mg2+ concentration of the reaction mixture was 3.0mM.
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6.3 Results
6.3.1 Analysis of Glytl and Faah genomic structure
Genomic DNA from wild-type and Ann m utant mice on an inbred 
C57BL/6J genetic background (resulting from 10 generations of 
brother/sister mating) was digested with a variety of restriction 
endonucleases and separated by electrophoresis. Following Southern 
blotting, hybridisation of the filter to radiolabelled cDNA probes was 
carried out.
A 1.3kb Glytl cDNA fragment was used to compare the structure of this 
gene in wild-type and m utant animals. The identical restriction patterns of 
both types indicated that the transgene had not detectably interrupted the 
Glytl genomic region covered by the cDNA probe (see Fig. 6.2). This in 
itself does not eliminate Glytl as a candidate since the expression of the 
gene may still be compromised without any detectable disruption of the 
structural gene itself. For example, disruption of a regulatory region may 
affect Glytl expression without being detectable using a cDNA probe on a 
genomic Southern blot. It was therefore decided to further investigate 
Glytl as a candidate by examining its expression in wild-type, hemizygous 
transgenic and homozygous m utant transgenic mice (see section 6.3.2).
The same genomic DNA filter was stripped and re-probed with a 1.7kb 
Faah cDNA probe. Again no difference in restriction pattern between wild- 
type and m utant samples was detected, indicating no disruption to the 
region of the Faah genomic region covered by this probe (see Fig. 6.3). 
Again it was decided to further investigate the expression of this gene in
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Fig. 6.2. Southern blot probed with G ly tl.
Southern blot of C57BL6/J Ann hom ozygous mutant and w ild-type D N A  digested with a
variety of restriction endonucleases and hybridised with a 1.3Kb G ly tl cDNA probe. 
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Fig. 6.3. Southern blot probed with Faah.
Southern blot of C57BL6/J Ann hom ozygous mutant and w ild-type D N A  digested with 
various restriction endonucleases and hybridised with a 1.7Kb Faah cD N A  probe.
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wild-type, hemizygous transgenic and homozygous m utant transgenic 
mice (see section 6.3.2).
6.3.2 Analysis of Glytl and Faah expression
Total brain RNA was extracted from 17.5 day old mice derived from an 
Ann hemizygous intercross. All offspring had previously been genotyped 
by luciferase assay. RNA was quantified and concentration-matched 
duplicate samples from wild-type, hemizygous transgenic and 
homozygous m utant mice electrophoresed. Following Northern blotting, 
hybridisation to filters of radiolabelled cDNA probes was undertaken.
The Glytl cDNA fragment was used to investigate the levels of Glytl 
expression in brains of the three mouse types. Strong expression of a 3.2kb 
Glytl transcript had previously been described in a variety of regions in the 
adult mouse brain [225].
Expression of this 3.2kb Glytl transcript was detectable in the brains of Ann 
homozygous m utants as well as in hemizygous and non-transgenic mice 
(see Fig. 6.4). Closer inspection revealed quantitative differences between 
transcripts in m utant mice and those of the other two classes. This feature 
will be discussed in section 6.4.1.
The same filter was stripped of radionucleotide and re-hybridised with the 
Faah cDNA fragment probe. Strong Faah expression had previously been 
demonstrated in both hum an [239] and adult rat [238] brains. A transcript 
of approximately 2.5kb was detectable at comparable levels in all three 
mouse types (see Fig. 6.4).
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Fig. 6.4. Northern blot probed with Glytl and Faah.
Northern blot of total brain RNA from 17.5 day old C57BL/6J Ann hemizygous transgenic, 
homozygous mutant and non-transgenic wild-type whole brains. The blot was hybridised with an 
mGap cDNA probe to control for loading o f RNA, stripped and probed with a 1.3kb Glytl cDNA 
probe and then stripped again prior to re-probing with a 1 7kb Faah cDNA probe. Autoradiographs 
were exposed overnight for each probe.
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Fig. 6.5. Southern blot probed with mdabl.
Southern blot of C57BL/6J Ann homozygous mutant and wild-type genomic DNA digested with a 
variety o f restriction endonucleases. The blot was hybridised with a 1.7kb mdabl 555 cDNA probe 
and the autoradiograph exposed overnight.
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6.3.3 Lack of polymorphism in a large section of the mdabl coding region
In order to investigate the possibility of transgene insertion at the mdabl 
locus the Southern blot filter used previously was stripped and re­
hybridised with the mdabl 555 cDNA probe. No readily detectable 
differences in banding patterns between m utant and wild-type genomic 
DNA were identifiable (see Fig. 6.5), appearing to eliminate a large section 
of the mdabl coding region from harbouring the inserted transgene. This, 
though, does not exclude the possibility that transgene insertion is affecting 
the expression of mdabl (discussed in section 6.4.1).
6.3.4 Analysis of mdabl transcript reveals loss of expression in Ann mutant 
mice
The presence of a 5.5kb transcript in total brain RNA extracts had been 
reported in adult mice. Two smaller transcripts (4.0kb and 1.8kb) had also 
been detected, but only in poly A-selected RNA samples [180,240].
A further Northern blot was hybridised with a radiolabelled mdabl 555 
cDNA fragment. Strong expression of the 5.5kb mdabl species was 
observed in the non-transgenic samples (see Fig. 6.6). This same band 
appeared to be completely absent in m utant samples, indicating that 
expression of the mdabl 5.5kb species was ablated in Ann m utant mice. 
Samples from Ann hemizygote mice showed levels of the same transcript 
at approximately half that observed in wild-type mice. A longer exposure 
of this filter revealed a weak band of around 5.5kb in size in the mutant 
samples (see Fig. 6.6). This band could represent a residual level of mdabl 













Fig. 6.6. Northern blot probed with mdabl.
Northern blot of total brain RNA from 17.5 day old C57BL/6J Ann non-transgenic wild-type, 
homozygous mutant and hemizygous transgenic whole brains. The blot was hybridised with an 
mGap cDNA probe to control for loading of RNA (bottom panel), stripped and probed with a 1.7kb 












Fig. 6.7. mdabl RT-PCR.
RT-PCR products from total RNA extracted from 17.5 day old C57BL/6J Ann non-transgenic wild- 
type, hemizygous transgenic and homozygous mutant whole brains. Primers complementary to 
positions 177-196 and 626-607 of the mdabl 555 published cDNA sequence were used to generate 
the mdabl products, whilst primers specific to the mouse SoxlO gene were used to confirm the 
success o f each reverse transcriptase reaction.
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The two smaller mdabl transcripts identified in other studies were visible at 
low levels in wild-type and hemizygous samples, but not in m utant (result 
not shown).
6.3.5 Reverse transcriptase PCR reveals no abnormally sized transcripts
Despite the lack of a polymorphism in a large section of the mdabl coding 
region, several possibilities remain whereby expression of the mdabl gene 
could be (almost completely) ablated by transgene insertional mutation.
Both the scrambler and yotari classical mutants result from alteration in 
mdabl 555 transcript at nucleotide position 570 [240, 241]. These abnormal 
RNA species are incapable of allowing production of sufficient (scrambler), 
or any (yotari), functional mDabl protein. The existence of two 
independent mutants of this nature suggests this nucleotide position might 
be a highly mutable site in the mdabl gene. A similar type of mutation at 
this position in the Ann line therefore presented one possibility that 
required consideration.
As demonstrated, a faint band was detectable at around 5.5kb following 
long term exposure of mdabl Northern blots. Although no large scale size 
difference was noticeable, this band could represent low levels of an 
aberrant transcript. Abnormalities in this mRNA species at nucleotide 570 
were investigated by means of reverse transcriptase PCR (RT-PCR) using 
mdabl specific primers flanking this position. A transcript detectable on a 
N orthern blot should be readily amplified by the more sensitive RT-PCR 
technique and any abnormally sized bands produced in transgenic samples 
would indicate an aberrant mdabl transcript.
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Primers used to amplify across this region in a previous study were 
obtained and utilised in RT-PCR experiments on wild-type, hemizygous 
transgenic and homozygous m utant brain, total RNA samples. Bands of 
the expected size (430bp) were generated from both wild-type and 
hemizygote samples, but no band was observed in m utant (see Fig. 6.7). 
Successful amplification from the same reverse transcriptase reactions with 
SoxlO control primers demonstrated the viability of the samples and 
indicated the lack of RT-PCR-detectable mdabl transcript in Ann mutants. 
The mouse SoxlO gene encodes a transcription factor that is known to be 




6.4.1 The Ann mutant is a likely allele of mdabl/scrambler
Three candidate genes were investigated as the source of the Ann mutant 
phenotype by comparing their expression levels in wild-type, hemizygous 
transgenic and homozygous m utant animals, at 17.5 days post partum  
when the ataxic phenotype in mutants is approaching its most profound. It 
m ust be noted that a failure to detect abnormal gene expression in mutant 
animals does not necessarily eliminate a candidate, since post-translational 
defects remain a possibility as the cause of the mutation. It is though 
unlikely that the integration of a large, multicopy transgene array into the 
genome would cause a subtle mutation in which a normal sized transcript 
is still detectable. Therefore it seems rational to look for a dramatic effect 
on gene expression, at least as a starting point in the analysis of candidates.
On Northern blots, complete, or almost complete, ablation of mdabl 
message was apparent. A longer exposure of the Northern blot did reveal 
a faint band of about the correct size for the mdabl mRNA and the source of 
this remains unclear (see below).
Again it must be stated that even this dramatic effect does not absolutely 
confirm mdabl as the source of the Ann mutation. To prove this beyond 
doubt a transgene rescue experiment or complementation test using an 
existing mdabl mutant, would have to be performed. With the weight of 
evidence provided from the expression analysis, linkage mapping and 
phenotypic data, we can say within a reasonable degree of certainty that 
the Ann mutation did result from an anomaly in the mdabl gene.
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No quantitative differences in Faah mRNA levels were observed between 
the three mouse types, making it the least likely candidate gene at this 
stage.
The situation with Glytl was rather more complex given the reduction in 
expression levels in homozygous transgenic as compared w ith hemizygous 
transgenic and wild-type mice. This gene is known to be heavily expressed 
in the cerebellum of adult mice, and as we have seen (Chapter 4), this brain 
structure is dramatically reduced in size in m utant mice. With this in mind 
it was reasoned that the small reductions in Glytl expression observed in 
mutants could be due to the hypoplasia of the cerebellum rather than 
through a direct affect on the Glytl gene. Furthermore, if the transgene 
was affecting Glytl expression, it was reasoned that a more dramatic effect 
would be expected. That a much smaller number of mouse phenotypic 
mutants result from haploinsufficiency as compared to complete loss of 
gene expression would appear to support this rationale.
To identify the physical basis of the mdabl defect, Southern blotting was 
performed to look for polymorphisms in the gene. Hybridisation with the 
mdabl 555 cDNA probe fragment will reveal polymorphisms in a region of 
the mdabl coding region and in the 3' or 5' untranslated regions, dependant 
upon the positions of endonuclease restriction sites relative to the probe. 
No novel restriction fragments were visible in samples digested with a 
variety of restriction endonucleases suggesting that the transgene array has 
not integrated into the region of mdabl spanned by the probe that was 
used.
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Another possible source of perturbation to the expression of mdabl is the 
highly mutable region affected in both the scrambler and yotari classical 
mdabl mutants. Separate defects at nucleotide position 570 of the mdabl 
coding region are the basis for both of these mutants, and as such it was 
deemed prudent to exclude this site as the basis for the mutation in Ann. 
RT-PCR reactions, using primers spanning this position, generated normal 
sized products from both wild-type and hemizygous transgenic brain total 
RNA samples, but no product from mutants. This eliminates the existence 
of an abnormal mdabl transcript, similar to those found in scrambler and 
yotari, although smaller size differences may have been undetectable. The 
source of the faint band detectable on longer exposure of the mdabl 
N othem  blot may be explained by this result. A residual level of mdabl 
transcript detectable by Northern blot should also be picked-up by the 
more sensitive RT-PCR technique. That it is not questions the authenticity 
of this band as representing a true mdabl transcript. Alternative 
explanations exist, such as contamination of the m utant RNA samples used 
for the Northern blot with wild-type RNA, or even hybridisation of the 
probe to an mdabl-like transcript. Indeed an mdabl related gene, mdab2, 
has been identified [242].
6.4.2 Mouse disabled 1 is a cytoplasmic adaptor protein
A yeast two-hybrid screen for proteins interacting with the Src 
nonreceptor protein tyrosine kinase (PTK) revealed the existence of a 
mouse homologue of the Drosophila dab (disabled) gene [197]. The dab gene 
was itself originally identified in Drosophila via its interaction with another 
nonreceptor PTK, dAbl [243]. Mutation of dab was found to exacerbate the 
dAbX1' phenotype and as such belonged to a group of genes termed HDA 
(haploinsuffident, dependent upon dAbl).
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The mdabl gene encodes a cytosolic protein and is alternatively spliced to 
generate at least three different mRNAs encoding protein isoforms of 555, 
271 and 217 amino acid residues [197]. These isoforms have a common 
amino terminus which contains a protein interaction/phosphotyrosine 
binding (PI/PTB) domain known to bind the tetra-peptide; Asn-Pro-x-Tyr 
(NPxY) motif [244]. Proteins with PI/PTB domains can bind to NPxY 
motifs in either a phosphotyrosine dependent (e.g. She binding of IRS1 
[245]) or independent (e.g. Fe65 binding of APP [246]) manner. The PTB 
domain has been shown to mediate docking functions in a number of 
cytoplasmic adaptor proteins including mDabl [247].
A second mechanism by which mDabl can interact with other proteins is 
through binding to the SH2 domains of the nonreceptor PTKs Src, Fyn and 
Abl [197]. These interactions are facilitated by tyrosine phosphorylation of 
m Dabl protein, and suggest a role for m Dabl in intracellular signalling 
cascades. m Dabl has been shown to be expressed in the developing CNS 
of mouse embryos and furthermore, was determined as being tyrosine 
phosphorylated during this period. Thus m Dabl was postulated to be 
involved in the development of the mammalian CNS, probably through 
some involvement in signal transduction cascades.
6.4.3 The mdabl knockout is an ataxic mutant
The exact role of mDabl in mouse CNS development became more 
apparent upon the generation of mdabl null m utants by gene targeting 
[240]. Mice homozygous for a disruption of the first 47 codons of the 
PI/PTB domain exhibited a severe ataxic phenotype. Clearly identifiable 
by 15 days; mutants have an unstable gait, whole body tremor and are 
smaller than their siblings. They generally die between 20 and 30 days old.
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The brains of mdabl knockout mice have severe defects in a number of 
regions.
6.4.4 Mutations in mdabl are responsible for scrambler and yotari
Generation of the mdabl knockout mouse facilitated the elucidation of the 
molecular basis of two existing classical mutants. Scrambler and yotari, both 
of which exhibit almost identical phenotypes to the mdabl knockout, were 
identified as arising from mutations in the mdabl gene [180,241].
The scrambler m utant arose spontaneously in the dancer (DC/Le) mouse 
strain and displays a similar, if less severe phenotype to the mdabl 
knockout, having a normal lifespan (thought to result through differences 
in genetic background) [229]. The mutation was m apped to Chromosome 
4, close to the mdabl map position. The appearance of the mdabl knockout 
allowed investigators attempting to positionally clone the gene responsible 
for scrambler to focus on mdabl and look for mutations in this gene in 
scrambler mice [241].
W ith a phenotype identical to scrambler, the yotari m utant arose during the 
targeted disruption of the inositol 1,4,5 trisphosphate gene [248]. This 
m utant was m apped to the same site as scrambler. Analysis of mdabl 
expression revealed anomalies in both m utant strains. In scrambler, levels 
of the normal 5.5kb mdabl transcript were greatly reduced, accompanied 
by the appearance of an abnormal transcript of approximately 7kb. Yotari 
mice expressed only a shorter (approximately 5.2kb) transcript at wild-type 
levels. Further investigation revealed that both strains, somewhat 
incredibly, expressed abnormal mdabl transcripts that were mutated at 
exactly the same nucleotide position. The abnormally large transcript
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detected in scrambler was generated by the aberrant splicing of a mouse 
intracisternal-A particle (IAP) element to nucleotide 570 of the mdabl 
mRNA. Present at around 1000 copies per haploid mouse genome [249, 
250], LAPs are retrovirus related transposable elements and have been 
identified as causing insertional mutations in a number of other cases in the 
mouse(e.g. the Albany allele of reeler RelnrM/b2)[251].
Insertion of the IAP in the mdabl transcript in scrambler creates a severely 
truncated form of the protein that is undetectable on Western blots, and 
therefore must be rapidly degraded. Only a trace level of normal protein is 
detectable in scrambler, probably originating from the residual level of 
normal sized message expressed in mutants.
The lesion in the yotari strain was found to be a deletion of 375 bases 
of mdabl coding sequence, again originating at nucleotide 570. The 
open reading frame is maintained in this m utant transcript, but again no 
normal protein is detectable, and any polypeptide generated must be 
unstable.
6.4.5 mdabl mutant mice have defects in cerebellar, cerebral and hippocampal 
development
As discussed in Chapter 4, neuropathological studies of scm mice indicated 
that loss of m Dabl activity during development leads to severe 
abnormalities in a variety of different brain regions. In the cerebellar 
cortex, defective migration of Purkinje cells results in the almost total loss 
of the Purkinje cell layer and a subsequent reduction in number of granule 
cells in the internal granule cell layer. As a result, the cerebellum is much 
reduced in size and completely lacks foliation [240, 252]. In the developing
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cerebral cortex, the classic 'inside-out' pattern of neuronal migration, which 
generates a characteristic layered structure, is disrupted and migrating 
neurons are unable to bypass their predecessors and reach their 
appropriate locations. Hence, the normal layering is abolished and 
different cell types are largely intermingled [189, 240, 253]. Finally, in the 
hippocampal formation, the pyramidal neurons of the hippocampus and 
the granule cells of the dentate gyrus are randomly scattered rather than 
forming discrete structures. Again, defective neuronal migration is 
responsible for these abnormalities [206,242],
6.4.6 mDabl is a key component in reelin signalling during brain development
First described in 1951 [254], reeler is another classical mouse m utant that 
displays an almost identical phenotype to the mdabl mutants. Reeler mice 
are ataxic, their cerebellums are hypoplastic and lack foliation, and 
furthermore, laminated brain structures such as the cerebral cortex and 
hippocampal formation exibit neuronal ectopia.
The generation of a reeler allele rltg by transgene insertion [255], facilitated 
the cloning of the reeler gene [164], which was named reelin (rein). It was 
found to be a large secreted protein of 3,461 amino-acid residues and was 
proposed to be involved in neuronal migration in various tissues of the 
developing brain, probably by acting as an extracellular signalling 
molecule.
The almost identical phenotypes of reinh and mdabl''' mice immediately 
suggested that these molecules were part of a common signalling pathway. 
This idea was strengthened by the observation that levels of m Dabl protein 
are increased in reeler brains [253], demonstrating the existence of a
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biochemical link between Rein and mDabl. Furthermore, application of 
Rein protein to neuronal cultures causes an increase in tyrosine 
phosphorylation of m Dabl, this phosphorylation decreased in developing 
brains of reeler mutants as compared with normal mice [256].
Additional support for a common signalling pathway comes from the 
expression patterns of these proteins being spatially and temporally 
juxtaposed in the brain structures affected in both m utants [253]. In the 
developing cerebral cortex Rein is secreted by the Cajal-Retzius neurons of 
the preplate, whilst migrating cortical plate neurons are found to express 
m Dabl at the time they invade this structure.
A similar pattern is observed in the developing cerebellum in which 
granule cell precursors in the EGL express Rein and purkinje cell 
precursors, which migrate from the ventricular zone towards this region, 
express high levels of mDabl. Migrating pyramidal cells in the developing 
stratum  pyramidale of the hippocampus express m Dabl as they migrate 
toward the Rein-expressing, Cajal-Retzius-like cells in the outer molecular 
layer. Similarly, during neuronal positioning to form a compact layer in 
the dentate gyrus, mDabl expressing granule cells migrate toward Rein 
secreting cells.
6.4.7 Members of the LDL receptor family transmit the Reelin signal to 
mDabl
The mechanisms of Rein signalling were further elucidated with the 
identification of Reelin binding, transmembrane receptor molecules that 
could transmit a signal to mDabl.
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The interaction of the mDabl PI/PTB domain with NPxY motifs has been 
discussed (see 6.4.2). Such motifs are present in the cytoplasmic tails of 
proteins belonging to the low density lipoprotein (LDL) receptor family 
[257] of which there are five known members. The LDL receptor (LDLR), 
LDL receptor-related protein (LRP), Megalin, very low density receptor 
(VLDLR) and apolipoprotein E receptor 2 (ApoER2) are structurally 
related, multifunctional cell-surface receptors that mediate endocytosis of 
extracellular ligands [258].
The mDabl protein was shown to interact with several neuronally 
expressed transmembrane proteins, including several members of this gene 
family [247]. Generation of vldlr'/'/  apoERl'/’ double mutants produced 
mice that displayed behavioural and neuroanatomical defects almost 
identical to those found in both rein'' and mdabl'1' mice [259]. Again 
cerebellar, cerebral cortex and hippocampal abnormalities, suggestive of 
abnormal neuronal migration, were observed. Disruption of either gene 
alone produced more subtle phenotypes, suggesting a level of redundancy 
between the two receptors.
Expression of both VLDLR and ApoER2 is high in the same subset of 
neuronal cells that express mDabl during brain development, namely the 
cortical plate neuron precursors in the cerebral cortex, purkinje cell 
precursors in the cerebellum, and the granule and pyramidal cells of the 
hippocampal formation. This is indicative of a role for these receptors in 
transmitting the Rein signal to intracellular m Dabl. An upregulation of 
m Dabl levels in apoERZ1'/v ld lf /  brains, just as in the rein'1' mutant, further 
alludes to this hypothesis. The establishment of Rein as a ligand for both
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ApoER2 and VLDLR places, Rein, VLDLR, ApoER2 and mDabl on a 
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Fig. 6.8. The postulated Reelin signalling pathway.
Either direct or indirect interaction of Reelin with VLDLR or ApoER2 results in binding of 
m D abl to the cytoplasmic NpxY motif of these receptors and its subsequent 
phosphorylation, possibly through a Reelin activated membrane tyrosine kinase. The 
signal is further propagated via the binding and activation by m D abl of non-receptor 
tyrosine kinases, and may ultimately lead to changes in cell shape and migration.
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Since m Dabl becomes phosphorylated during Reelin signalling, but the 
lipoprotein receptors posses no inherent tyrosine kinase activity, it is 
probable that mDabl phosphorylation is affected by association of the 
protein with tyrosine kinases upon receptor binding of Rein. 
Phosphorylated mDabl could then recruit intracellular signalling 
molecules containing SH2 domains, setting up signalling cascades that 
could alter gene expression to bring about changes in cell shape and 
migration. Changes to cytoskeletal organisation could also be affected by 
such signalling, and indeed mutants in p35 and Cdk5, two molecules 
known to regulate cytoskeletal proteins, exhibit similarities to the rein 
mdabT/' and vldlrm/~/apoERZ/m mutants [261,262].
The overall effects of Rein signalling on neuronal migration still remain 
unclear. One possibility is that Rein acts as a stop signal for migrating 
neurons, thus facilitating migration to the correct positions. In the absence 
of this signalling (as in rein1', mdabl'1' and vld lf1'/ dpoERZ1' mutants) 
neurons will not receive the correct positional cues and will thus migrate to 
ectopic sites. A second hypothesis is that Rein could be present in a 
concentration gradient that would induce neurons to migrate past those 
born at an earlier stage. Again defects in this signalling pathw ay would 
result in ectopic neuronal positioning. Alternatively, Rein signalling could 
act in the developing cerebral cortex to split the cortical preplate, allowing 
invasion of migrating cortical neurons. Failure of the preplate to split 
would prevent this invasion resulting in ectopic positioning of neurons 
beneath the preplate.
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6.4.8 The Ann mutant contributes to an existing allelic series
Resulting from a deficiency in gene expression, the Ann m utant is not the 
first mdabl allele to be discovered. As we have seen, three alleles of this 
gene are already in existence. Scrambler results from the aberrant splicing 
of mdabl mRNA, whilst in yotari 375 nucleotides are deleted from the 
mdabl coding sequence, with the lesion occurring at the same position as in 
scrambler. An mdabl knockout mouse was also generated by the deletion of 
the first 47 codons of the PI/PTB domain.
Although the precise nature of the molecular lesion in Ann m utants has not 
been determined, a large section of the mdabl coding region seems not to 
have been disrupted by the inserted transgene. Furthermore, 
abnormalities at the nucleotide position disrupted in both scrambler and 
yotari are undetectable by RT-PCR in Ann.
Amongst the possibilities remaining as to the nature of the Ann mutation, 
disruption to either the mdabl 5' or 3' untranslated regions, or to an mdabl 
regulatory region represent the most likely explanations. If any of these 
possibilities turns out to be correct, the value of the Ann mouse to further 
studies on mdabl regulation and function should not be underestimated. 
The generation of allelic series in the mouse, usually by gene targeting or 
chemical mutagenesis strategies has become an essential tool in the 
accurate dissection of domains important in protein function [263] (e.g. 
dilute [264, 265]), or elements involved in regulating gene expression (e.g. 
short ear [266]). As a novel allele of mdabl, the Ann m utant contributes to 
an existing allelic series and therefore has the potential for use in the future 
analysis of mdabl gene expression and the regulatory elements involved.
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CHAPTER 7: MOLECULAR ANALYSIS OF 




7.1.1 Transgenes insert into the genome at a single site, often in multiple 
copies
Disruption of the function of an endogenous gene by transgene insertion 
often prom pts further investigation of the nature of the mutation in 
molecular, as well as phenotypic, terms. The presence of known transgene 
sequence incorporated into the genome provides a useful handle for 
molecular studies of transgene integration. Normally this involves the 
cloning of genomic sequence flanking the integrated transgene. This 
sequence can then be used in efforts to isolate the gene m utated by the 
transgene insertion.
The isolation of flanking sequence can be complicated by several features 
of microinjected transgene DNA integration into the host genome. Firstly, 
as stated in Chapter 1, transgenes often integrate as multiple copy arrays. 
Within such arrays, single transgene copies are usually orientated in a 
'head-to-tail' fashion [58, 59] although 'head-to-head' and 'tail-to-tail' 
orientations have been reported. Elucidation of the transgene array 
structure is often a pre-requisite for the cloning of sequences flanking 
multiple copy arrays. The convoluted nature of many transgene arrays can 
make this extremely difficult, often creating a considerable impediment to 
the development of a suitable cloning strategy.
In addition, cloning flanking sequence using a PCR-based method often 
involves amplifying outwards from a transgene sequence known, or at 
least assumed, to be in juxtaposition to the surrounding genome. The 
arrangement of transgene copies within an array in 'head-to-head' or 'tail-
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to-tail' orientations could conceivably result in the preferential 
amplification of sequences internal to the array, at the junction of the 
transgene copies arranged in this manner.
Chromosomal rearrangements, which are often found at the site of 
transgene insertion (see Chapter 1) [62-64], whilst not interfering with 
efforts to clone flanking sequence, can create difficulties in isolating the 
mutated gene. For example, a genomic rearrangement near the site of 
integration could result in the displacement of the gene of interest from its 
normal position to a position either closer to, or further away from, the 
inserted transgene. Either scenario would be likely to create confusion 
when cloned flanking sequence is used as a probe to isolate clones from a 
wild-type genomic DNA library, as is often the approach in such studies.
7.1.2 Cloning genomic sequence flanking the transgene
When investigating a m utant phenotype caused by the effects of transgene 
integration upon an endogenous gene, isolation of the flanking sequence 
can facilitate the identification of the disrupted gene in a number of ways.
Flanking sequence provides a useful tool for linkage mapping the site of 
transgene integration into the genome. Obtaining endogenous sequence 
allows the use of an existing mapping panel for linkage mapping studies 
and circumvents the need to generate a panel that is specific to the 
transgenic line being studied. As discussed in Chapter 5, knowing the map 
position of the transgene facilitates a search for possible candidate genes. 
This, in turn, may obviate the need to isolate the affected gene by 
molecular means.
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The requirement for flanking sequence is especially great in cases where 
the endogenous gene is one that has not previously been isolated. In this 
situation a candidate approach cannot be utilised to identify the gene. 
Instead it is necessary to progress from the transgene insertion site to the 
molecular cloning of the gene itself. To do this, the cloning of sequence 
flanking the transgene is essential. This sequence provides the starting 
point for a chromosome walk from the transgene to the affected gene. If 
the transgene has disrupted the function of a gene by integrating within the 
gene itself then such a walk could be relatively facile. Alternatively, the 
transgene integration could provoke an effect by disrupting an enhancer 
element of the gene. In this case the transgene could be located 100's of 
kilobases upstream  of the gene, making a chromosome walk much less 
trivial.
It should be noted that the majority of transgene insertional mutagenesis 
studies originate by chance from transgenesis exercises instigated for a 
completely separate reason. In addition to facilitating the isolation of novel 
genes or new alleles of previously identified genes, transgenic mice can be 
used to elucidate the mechanisms by which foreign DNA integrates into 
the mouse genome [267]. In this instance, flanking sequence can provide a 
useful tool for investigating the nature of the genomic region into which 
the transgene has integrated and the effects that integration has on the 
constitution of this region.
The means of cloning transgene flanking sequence can often depend upon 
the nature of the transgene array and the insertion event itself. As 
mentioned, the often complex nature of many transgenic insertions can 
complicate the isolation of endogenous sequence and necessitate the use of
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cloning strategies that can be highly inventive. Regardless of complexity, 
such cloning exercises are generally either library or PCR based.
7.1.3 Cloning flanking sequence by PCR
A major limitation of conventional PCR technology is its ability to allow 
only the amplification of DNA fragments between two regions of known 
sequence. Isolation of transgene flanking regions by PCR does though 
depend upon the amplification of unknown sequence. Furthermore, in this 
case only transgene-specific primers are available. A panopoly of 
strategies have been developed to allow PCR amplification of unknown 
sequence adjacent to a known region. In general these methods can be 
divided into those that involve a prior ligation step and those that utilise 
non-specific or unknown sequence.
One PCR technique involving a prior ligation step is Inverse PCR (I-PCR) 
[268]. In this case, primers are used that are specific to the known sequence 
(i.e. the inserted transgene) but which prime DNA synthesis in opposite 
directions. These primers are able to successfully amplify flanking 
sequence through the inversion of the known sequence in the region 
between the primers. This is achieved by restriction endonuclease 
digestion at suitable sites (at least one of which must be in the flanking 
region) and subsequent ligation, followed by digestion in the known region 
between the primers. Prior knowledge of the transgene array structure is 
essential for the selection of suitable restriction sites.
A number of other PCR strategies involve the ligation of linker 
oligonucleotides to the termini of junction fragments generated by
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restriction enzyme digestion. These linkers provide sites for primer 
annealing, thus facilitating the amplification of unkown flanking sequence. 
Specificity to sequence flanking the known region is maintained through 
the use of primers that amplify out from this region (multiple 
amplifications with nested primers are often used). One such method is 
Capture PCR [269], which involves restriction digestion and ligation of a 
primer-specific double-stranded oligonucleotide linker prior to PCR 
amplification.
A similar, but more advanced method is Vectorette PCR [270]. This 
technique involves the ligation of linkers to restriction digested DNA to 
generate a 'Vectorette-library'. The duplex Vectorette linker contains a 
non-homologous central region. Amplification from a vectorette primer, 
specific to this region, can only proceed after the synthesis of a 
complimentary strand originating from the known (i.e. transgene-spedfic) 
sequence. Vectorette PCR has successfully been used to isolate transgene 
flanking sequence [271]. Like I-PCR, the success of a linker-based PCR 
technique may depend on knowledge of the transgene array structure in 
order to select suitable sites for restriction digestion prior to linker ligation.
Circumventing the requirement for restriction digestion/ligation prior to 
amplification, are a variety of techniques based upon the use of primers 
that can amplify directly from the unkown flanking sequence. In perhaps 
the most straightforward case, essentially aribitrary primers have been 
used to successfully prime DNA synthesis of unknown sequence flanking a 
known region. This technique, termed 'targeted gene walking' [270] is 
based upon the observation that even primers containing large numbers of 
mismatches (as much as 60%) can fadlitate amplification as long as partial
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homology at the 3' end of the primer exists, and there is correct base 
pairing of the last two nucleotides at this end. A drawback of this 
technique is that such arbitrary priming generates non-target molecules 
that can constitute the bulk of the final product.
Thermal Asymmetric Interlaced PCR (TAIL PCR) [272] addresses this 
problem through the use of primers of different lengths in conjunction with 
advanced PCR cycling conditions. High annealing temperatures are 
known to favour primers of longer length, whilst lower temperatures allow 
both long and short primers to function almost equivalently. By using long 
primers specific to the known sequence and a short, degenerate primer to 
amplify from the unknown sequence, in combination with interspersed 
PCR cycles of high and low stringency, amplification of products flanking 
the region of known sequence is favoured. Use of sequence-specific, nested 
primers in further PCR cycles can eliminate virtually all products that are 
not specific to the flanking sequence.
A number of other PCR protocols exist that do not rely on a prior 
restriction/ligation step, but also are not dependant on random  or near­
random  priming from unknown flanking sequence. Instead these 
protocols are dependant upon the fact that well characterised genomic 
regions may be positioned close to the region of known sequence, allowing 
amplification of the intervening region. One such method is Restriction 
Site PCR (RS PCR) [273]. This technique uses primers specific to restriction 
enzyme recognition sequences (RSOs) in conjunction with primers specific 
to the known sequence, to facilitate the amplification of flanking regions. 
Such a technique is based upon the assumption that at least one RSO 
specific to the primers being used, will be positioned close enough to the
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known sequence to allow successful amplification. To increase the chances 
of this, it is therefore desirable to use primers specific to a number of RSOs.
Other techniques have been developed which utilise repetitive genomic 
sequences, rather than RSOs, to provide a site for primer annealing. A 
variety of repeat sequences are dispersed throughout the mouse genome 
such as Alu repeats, which have successfully been used in such PCR 
methodologies [274].
7.1.4 Cloning flanking sequence by library based methods
The majority of PCR-based techniques described depend heavily upon 
some prior knowledge of the structure of the transgene array. With this in 
mind, insertion of a completely intact transgene copy into the genome 
without any accompanying genomic rearrangements provides the most 
straightforward scenario for the cloning of transgene-flanking sequence by 
a PCR method. This is also true for the cloning of flanking sequence by 
library-based methods. Cloning flanking sequence using a library-based 
approach could simply involve digestion of genomic DNA with a suitable 
restriction endonuclease that does not cut within the transgene but does cut 
closely enough in the flanking regions to allow the cloning of a fragment 
containing the complete transgene and both 5' and 3' flanking sequence in 
a plasmid or phagemid vector (depending upon the size of the fragment). 
A genomic library could be generated and the desired clone isolated by 
screening with a transgene-specific probe. Cloning of both 5' and 3' 
flanking sequence is often desirable since it allows the identification of any 
genomic rearrangements at the site of insertion and facilitates a possible 
chromosome walk both upstream and downstream from the transgene.
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In at least one case, cloning of genomic sequence flanking a single copy 
transgene insertion was facilitated by the fact that the transgene itself 
contained a complete plasmid vector sequence [275]. This negated the 
requirement for the generation and screening of a genomic library, since 
any successfully transformed clones were obviously derived from the 
transgene.
If the transgene is found in a multi-copy array, cloning of the complete 
array could still be suitable depending upon the size of the DNA fragment 
in question. The development of BAC (Bacterial Artificial Chromosome), 
PAC (PI Artificial Chromosome) and YAC (Yeast Artificial Chromosome) 
vectors mean that DNA fragments of 10's and 100's of kilobases can now be 
cloned [43,44]. Unfortunately the ease of handling libraries generated with 
such vectors can often be much less than plasmid or phagemid libraries.
If one is not attempting to clone the entire transgene array then generation 
of a genomic library must involve restriction endonuclease digestion of 
genomic DNA with an enzyme that cuts within the transgene. In a 
multiple copy transgene array this will generate fragments consisting of 
only transgene sequence, as well as those that include flanking sequence. 
Generation of a library from genomic DNA digested with such an 
endonuclease, followed by screening with a transgene-specific probe, will 
isolate clones carrying transgene sequence with or w ithout accompanying 
flanking sequence.
Methods can be employed to prevent cloning and screening of transgene- 
only clones. If the sizes of the various transgene-containing fragments are 
known then a size-restricted library can be generated using genomic
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fragments of a certain size that will include those in which the transgene 
sequence is accompanied by flanking sequence but not those containing 
only transgene sequence. Size separation of genomic fragments can be 
achieved in a variety of ways, e.g. sucrose gradient, gel 
electrophoresis/fragment purification. Transgene-positive clones isolated 
from a library constructed in this manner are much more likely to contain 
flanking sequence. The feasibility of such a cloning strategy is dependant 
upon whether fragments containing flanking sequence can be 
distinguished and subsequently size-separated from those that do not. 
Thus, the elucidation of the transgene array structure is essential prior to 
attempting such a cloning exercise.
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7.2 Materials and Methods
7.2.1 Producing a restricted genomic library from Ann DNA
Ann genomic DNA was purified as in section 2.2.5 and four aliquots of 
approximately lOpg each digested, overnight at 37°C, with 10 units of Kpnl 
restriction endonuclease. Digested DNA was separated by electrophoresis 
on a 1% agarose gel and the gel section containing fragments of the 3 to 5 
kb size range, excised. DNA was purified from the gel section using the 
QIAquick Gel Extraction Kit (Qiagen), according to the manufacturers 
instructions, and pooled. One seventh of the purified DNA was retained 
for use in Southern blot analysis, whilst the remainder was split into three 
equal parts that were subsequently digested each with 10 units of either 
Apal, BamYQ. or Hmdlll restriction endonuclease (Promega), overnight at 
37°C. The following day, reactions were heat inactivated at 65°C for 10 
minutes. Half of each digested sample was separated by electrophoresis on 
a 1% agarose gel and Southern blotting performed (as in section 2.2.10). 
The blotted membrane was hybridised with a a 32P-dCTP-labelled H19 5' 
probe fragment with the analysis of the resulting autoradiograph 
prom pting the use of the Apal/Kpnl digested aliquot of genomic DNA in 
the construction of a plasmid library, ljug of pBluescript K S11+ (pBSKSII+) 
plasmid DNA (Stratagene) was digested overnight with 10 units of both 
Apal and Kpnl restriction endonucleases and fragments separated by 
electrophoresis on a 1% agarose gel. The section of gel containing the DNA 
fragment of approximately 3kb in length (corresponding to the linearised 
plasmid) was excised and DNA purified again using the QIAquick Gel 
Extraction Kit. Ligation reactions containing lOng of linearised pBSKSII+ 
DNA and either lOng of the A pal/K pnl digested sample, or an equivalent 
volume of dHjO, were set up. Reactions also contained 1 unit of DNA
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ligase (Promega) and an appropriate volume of DNA ligase buffer 
(Promega). Ligation reactions were incubated overnight at room 
temperature and the following day I j l l I  was used to transform 
electrocompetent DH5a E. coli (as described in sections 2.2.1 and 2.2.2). 
Cells were plated on 10cm diameter, LB agar (containing 20pg/ml 
ampicillin with IPTG (20pg/ml LB agar)/X-gal (15pg/ml LB agar)) plates, 
and cultured overnight at 37°C. Numbers of blue and white colonies were 
counted the following day. The remainder of the ligation reaction, 
containing insert, was then transformed into electrocompetent DH5a E. 
coli, in lp l aliquots. All of the transformed cells were plated together on 
two 22cmx 22cm square, LB agar (20pg/ml ampicillin) plates and grown 
overnight at 37°C. The next day, the number of colonies on each plate was 
counted and the plates incubated at 4°C until required.
7.2.2 Library screening
Hybond-N (Amersham) membranes were prepared for hybridisation with 
the H19 5' probe fragment by performing colony lifts on each of the two 
bacterial library plates essentially as described in the Hybond-N protocols 
booklet. Briefly, Hybond-N membranes were cut to fit neatly on the 
surface of the 22x 22cm plates. Membranes were carefully lowered onto 
the surface of the plate and removed 60 seconds later, using forceps, onto a 
sheet of 3MM paper (Whatman) soaked in 10% (w /v) SDS (colony side up). 
After 3 minutes, membranes were transferred to 3MM paper soaked in 
denaturation buffer (1.5M NaCl/0.5N NaOH) for 5 minutes. Membranes 
were then placed on 3MM paper soaked in neutralisation buffer (1.5M 
NaCl/1.5M Tris(pH 7.4)) for two periods of 3 minutes each. Following 
vigorous washing in 2x SSC (on a shaking platform), membranes were 
allowed to air dry on 3MM paper prior to crosslinking (see section 2.2.10).
220
Membranes were then suitable for hybridisation with radiolabelled DNA 
probes (as sections 2.2.14 and 2.2.15).
Following incubation of agar plates for approximately 4 hours at 37°C, 
positive colonies were picked by excising the surrounding area of agar 
using the wide end of a 1ml pipette tip and placing the agar plug in an 
1.5ml polypropylene tube (Sarstedt) containing 1ml of LB medium. After 
brief agitation, lOOpl of medium was plated on a 10cm diameter LB 
agar /A m p plate that was then incubated overnight.
Colony lifts were performed on 10cm diameter petri dishes, for secondary 
screening, as described for 22cmx22cm square plates.
7.2.3 Analysis of genomic clones
Small-scale purification of plasmid DNA was performed on colonies as 
described (section 2.2.3). Clones were analysed by restriction endonuclease 
digestion of plasmid DNA using Apal/Kpnl restriction enzymes (section 
2.2.8) followed by electrophoresis on a 1% agarose gel.
Selected clones were sent for automated sequencing using the pBSKSII+ - 
specific M13 -40 or Reverse primers. Automated sequencing was 
performed using the Perkin Elmer automated sequencer according to 
manufacturers instructions. Sequence data was analysed using the GCG 
Wisconsin package.
7.2.4 DNA probes
The Lux 5' probe was prepared by Hmdlll/EcoRI endonuclease digestion 
of plasmid pl47al4  and gel purification (see section 2.2.9) of the 0.6kb
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fragment. The Lux 3' probe was purified from the same reaction by gel 
purifcation of the 1.2kb fragment generated.
The H19 5' probe was purified by digestion of plasmid pl766a2 with Xbal 
and gel purification of the l.Okb fragment produced. The H19 3' probe was 
purified by digestion of the same plasmid with PstI, again a l.Okb fragment 
was gel purified for radio-labelling (as described in section 2.2.14).
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7.3 Results
7.3.1 Elucidation of the Ann transgene array structure
Early Southern blot experiments carried out on the Ann line (for 
genotyping purposes) suggested that the transgene array contained 
multiple transgene copies, most probably arranged in a 'head-to-tail' 
orientation. This was suggested by the presence of multiple, transgene- 
specific bands, of which at least one had a much higher level of intensity 
(suggestive of multiple copies). This created a problem when constructing 
and screening genomic libraries, in that using transgene sequence as a 
probe is at least as likely, if not more likely, to isolate clones containing 
only sequence internal to the transgene array and not flanking it.
To assist w ith attempts to clone genomic sequence flanking the inserted 
transgene it was decided to elucidate the structure of the transgene array 
by Southern blotting and hybridisation with a variety of transgene-specific 
probes. Transgenic and wild-type (control) DNA was digested with a 
variety of common restriction enzymes, which have sites within the 
transgene sequence, and Southern blotted. The same blot was probed 
serially with each of four probes recognising different parts of the 
transgene construct (see Fig. 7.1) and the probe completely removed 
following hybridisation with each one. From the examination of these 
blots (see Fig. 7.2) it was clear that the structure of the transgene array was 
likely to be extremely complex.
In each track one or more strong bands (depending on the position of 
restriction sites in relation to the hybridising probe) were present 
corresponding to the repeated units of a multiple copy, 'head-to-tail*
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transgene array (Fig. 7.3.). Probes specific to the H19 enhancer element 
found in the transgene also hybridised to at least one endogenous 
fragment. It was thought that any other bands present could correspond to 
fragments at the junction of the transgene and the surrounding genome 
(termed junction fragments).
Probing an EcoRI digest with the 5' Lux probe reveals the presence of a 
band of approximately 1.9kb. This same band was present in samples 
digested with EcoRI and either Kpnl, NheI or Pstl, but was ablated when 
samples were digested with EcoRI and Xbal or Hmdlll (Fig. 7.4). The 'A' 
construct sequence indicates the presence of single Xbal and Hindlll sites 
downstream of the most 5' EcoRI site. No Kpnl, Nhel or Psfl sites are found 














Fig. 7.1. 'A' transgene probes.
Segments of transgene constructs used as probes for hybridisation to Southern blots. 5' 
and 3' Lux probes consist of sequence specific to the firefly (Photinus pyralis) luciferase gene 
whilst the 5' and 3' H19 probes consist of sequence specific to the murine H19 enhancer 
element.
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Fig. 7.2. Ann Southern blots probed with transgene fragments.
Southern blot autoradiographs showing restriction endonuclese digested Ann transgenic and wild- 
type control genomic DNA samples digested with a variety of restriction endonucleases prior to 
blotting and hybridisation with radiolabelled A) Lux 5’ probe. The same blot was then stripped and 
reprobed consecutively with B) Lux 3’, C) H19 5’ and D) H19 3’ radiolabelled probes.
Fig. 7.3. A multiple copy transgene array.
A diagrammatic representation of a multiple A  transgene copy, 'head-to-tail' array. The 
dotted line represents flanking genomic DNA, open boxes represent the P3 promoter, 
arrows represent the Luciferase reporter gene, filled boxes represent the H19 enhancer. 
The 5' Lux probe is also shown.
If two 'A' transgene copies were orientated with their 5' most ends abutting 
(in a head-to-head arrangement), one would expect an EcoRI band of 
approximately 1.8kb on hybridisation with the 5' Lux probe only (Fig. 7.5). 
This band would be ablated on double digestion with Xbal and Hmdlll 
(producing a variety of smaller fragments), but not Kpnl, NheI or Pstl. We 
can thus have a certain degree of confidence that such an arrangement does 
exist within the transgene array.
Two small bands (a l.Okb and l.lkb  doublet) were observed in EcoRI 
digested samples, again probed with the 5' Lux probe. This doublet was 
also present in samples digested with EcoRI and EcoRI with either Kpnl, 
Nhe I or Pstl, but was ablated with Xbal. Digestion with EcoRI and Hmdlll 
removed the larger (approximately l.lkb) band, but left the smaller 
(approximately l.Okb) band intact (Fig.7.4).
Such results appear hard to reconcile, but one possibility does provide a 
suitable explanation. The small size of these bands would appear to limit 
the possibility of both, or at least one of them, being a 'junction fragment', 
whilst their persistence/disappearance upon double digestion suggests 
another 'head-to-head' arrangement. This would be possible if a stretch of
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sequence containing at least one EcoRI site was situated between two 'head- 
to-head' transgene copies, resulting in l.Okb and l.lkb  bands on 5' Lux 
probed EcoRI digests (see Fig.7.6).
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Fig. 7.4. Southern blot suggesting a 'head-to-head' transgene arrangement.
Overnight exposure of Southern blot autoradiograph show ing restriction endonuclease 
digested Ann transgenic genomic DN A  samples (plus w ild-type control sample). DNA  
sam ples were digested with a variety of restriction endonucleases prior to blotting and 
hybridisation with radiolabelled Lux 5' probe. The band present in som e of the samples at 
approximately 1.9kb represents a putative 'head-to-head transgene fragment whilst the 
doublet at approximately l.O k b /l.lk b  represents another putative 'head-to-head' fragment 
with intervening sequence.
1.8kb
£ ™ RI Xbal Xbal
Hindlll
Fig. 7.5. Diagram of a putative 'head-to-head' transgene arrangement.
Such an arrangement may be present within the Ann m ulticopy transgene array. EcoRI 
digestion w ould produce a fragment of approximately 1.8kb, which w ould itself be cut 
into smaller fragments upon restriction endonuclease digestion w ith either Xbal or Hmdlll.
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The persistance of such bands upon double digestion with Kpnl, Nhel or 
Pstl would agree with this model, as would the ablation of both bands on 
digestion with EcoRI and Xbal. The loss of the l.lkb  band but not the l.Okb 
band on EcoRI/Hmdlll double digestion can be explained by loss of the 5' 
most end of one of these transgene copies from a point somewhere 
between the Xbal and Hmdlll sites. In support of this, the 1.9kb (EcoRI 
digested) 'head-to-head' array band appears to have greater intensity 
(perhaps double) than the l.Okb and the l.lkb  bands. This would be 
expected in this case since the 1.9kb band represents hybridisation of two 
probe units per fragment whereas only one probe unit hybridises per l.Okb 
or l.lkb  fragment.
Extension of the above hypotheses leads one to resolve that at least one 
'tail-to-tail' transgene copy arrangement must exist within the multiple 
copy array. For two 'head-to-head' arrangements to exist within one 





Fig. 7.6. Diagram of a modified putative 'head-to-head' transgene arrangement.
This may be present within the Ann multicopy transgene array. O w ing to the presence of 
an EcoRI site between transgene copies, digestion w ith this restriction endonuclease would  
give fragments of approximately l.Okb and l.lk b . Both fragments w ould be digested  
further w ith Xbal treatment, but further digestion w ith H m dlll w ould only cut the l.lk b  
fragment leaving the smaller fragment intact.
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Although the majority of bands on Southern blots can be explained as 
transgene repeats, 'head-to-tail', 'tail-to-tail' or endogenous DNA 
fragments, this still leaves the question of which fragments are candidate 
junction fragments. The fact that a majority of digests, on Southern 
blotting and hybridisation, still present more than one band which cannot 
be assigned to one of the above types, could suggest that some other 
transgene arrangement is present in the array.
Alternatively, if one or both of the terminal transgene copies was not 
completely intact this could allow the same probe to hybridise to both 
junction fragments on the same restriction digest, thus producing more 
than one junction fragment band on a Southern blot.
Thus far, there remains no way to conclusively distinguish between these 
possibilities. This creates a problem when attempting to isolate junction 
fragments away from other fragments internal to the transgene array in 
order to produce, for example, a size-restricted genomic library. The 
cloning of these fragments with such strategies remains a problem.
7.3.2 The array contains multiple transgene copies arranged ‘head-to-tail’
An alternative to specifically isolating junction fragments, would be to 
clone the entire transgene array, including both junctions. Given the 
multiple copy nature of the transgene array, the probable size of the 
fragment one would need to clone would seem to exclude the use of a 
plasmid or bacteriophage X library. It is more likely that either a cosmid, 
PAC, BAC or YAC library would be more suitable. Before deciding upon 
the most suitable cloning vector to use for library construction it is essential 
to elucidate the size of the transgene array fragment to be cloned. With this
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in mind, it was decided to calculate the number of transgene copies 
arranged 'head-to-tail', which from existing Southern blot evidence, one 
would presume makes up the majority of the transgene array.
This was done by a copy number titration method, using Kpnl digested 
(hemizygous) transgenic DNA, Southern blotting and hybridisation with 
the 5' H19 probe. By comparing the endogenous band of a test sample of 
known concentration with a transgene repeat specific band of a variety of 
dilutions of the same sample, the dilution factor which gives the 
endogenous, and transgene specific, bands the same intensity was 
estimated. Since the endogenous band is known to represent two gene 
copies, and the DNA used was from hemizygous transgenic mice, 
multiplication of this dilution factor by two gives an approximate value for 
the number of copies in a single transgene array. Dilution factors were 
calculated which gave a transgene-specific band corresponding to 5 to 20 
transgene copies when equivalent to the endogenous band of the undiluted 
test sample (see Fig. 7.7).
The transgene array seemed to contain approximately 11 to 13 'head-to-tail' 
copies, although some difficulty in distinguishing bands in more dilute 
samples resulted from using smaller volumes of DNA. A more precise 
approach would have been to use identical volumes of serially diluted 
samples in order to minimise pipetting errors. Nevertheless, since the size 
of a single "A" transgene unit is approximately 5.6kb, a transgene array 
containing at least 11 "head-to-tail' copies would be a minimum of 
approximately 60kb in length. If, as postulated, "head-to-head" and "tail-to- 
tail" transgene arrangements are also included, the array might be 
considerably larger. To clone a complete array of this nature, including
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flanking sequences, a PAC, BAC or YAC library would have to be 
constructed. Such an operation requires considerably more expertise than 
that involved in making a plasmid or bacteriophage library. Furthermore, 
to unambiguously identify the size of fragment one would have to clone in 
order to obtain the complete transgene array and accompanying flanking 
sequence, it would be necessary to carry out Southern blotting on genomic 
DNA digested with a restriction endonuclease which does not cut within 
the transgene. Given its large size, it is probable that such a fragment 
would have to be separated by Pulsed Feld Gel Electrophoresis (PFGE).
Fig. 7.7. Transgene copy number titration.
Copy number titration of 'head-to-tail' transgene copy number in the Ann transgene 
array. 48 hour exposure of Southern blot autoradiograph show ing restriction 
endonuclease digested Ann hem izygote genomic D N A  samples (plus w ild-type control). 
D N A  samples were digested with Kpnl prior to blotting and hybridisation w ith P32 labelled 
H 19 5' probe. An indication of the number of copies can be obtained by comparing the 
5.3kb endogenous H19 band in the undiluted lane w ith the 3.3kb transgene specific band 
in the diluted sample lanes.
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7.3.3 Attempts to clone genomic sequence flanking the transgene array were 
unsuccessful
Both PCR and library-based options for cloning the junctions between the 
transgene array and flanking genomic sequence were considered. A PCR 
approach was ruled out because the possible existence of 'head-to-head' 
and 'tail-to-tail' transgene arrangements within the array could result in 
the preferential amplification of internal sequence from the transgene- 
specific primer alone.
The most attractive alternative was that of a library from which junction- 
containing clones could be isolated in preference to those containing 
internal sequence. This precluded the use of a conventional library made 
from Ann total genomic DNA, since the majority of transgene-positive 
clones would carry only sequence internal to the multi-copy array. Instead 
it was decided to construct a size-restricted library in which the proportion 
of junction-containing clones was enriched. In this approach restriction 
digestion and Southern blotting of Ann genomic DNA was carried out to 
identify junction fragments of a suitable size for use in a plasmid library 
(between 2Kb and 5Kb was deemed to be an optimal trade-off between 
cloning efficiency and sequence length). Suitably digested DNA of the 
correct size range could then be purified and this used as insert material for 
cloning into an appropriate plasmid vector (pBluescript KS 11+ (pBSKSII+) 
was chosen). Screening of this library with the same probe used to identify 
the junction fragment would be expected to yield a significant number of 
positive clones, especially since the library should be highly enriched for 
this fragment.
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Endonuclease digestion was carried out on purified Ann transgenic and 
wild-type genomic DNAs, followed by Southern blotting and probing with 
a fragment specific to the 5' end of the H19 sequence used in the 'A ' 
construct. A fragment of approximately 4kb, present in the KpnI-digested 
sample, was identified as being suitable for isolation from a library 
enriched for Kpnl fragments of this size (see Fig. 7.2.). With this in mind it 
was decided to purify Kpnl-digested Ann genomic DNA of the 3 to 5kb size 
range for use as insert in generating a pBSKSII+ plasmid library which 
could then be screened using the H I9 5' fragment as a probe.
The first attem pt at generating this library proved unsuccessful since a high 
proportion of the plasmids purified from surviving colonies (grown on 
Amp selective plates) were found to contain no insert (blue colonies on X- 
gal/IPTG). This is indicative of self-ligation of the pBSKS 11+ plasmid.
To circumvent this problem it was decided to use plasmid vector digested 
with two endonucleases, rather than one. The 4kb Kpnl putative junction 
fragment was still used as the basis for the fragment to be isolated except 
on this occasion XpnI-digested, Ann genomic DNA, in the 3 to 5kb size 
range was purified and then each of three aliquots re-digested with the 
restriction endonucleases Apal, BamHl and Hmdlll. Half of each double­
digested sample was separated by gel electrophoresis, Southern blotted 
and hybridised with the H19 5' probe fragment (see Fig. 7.8.). Following 
Kpnl, additional digestion with BamHl or Hmdlll had no effect on the sizes 
of fragments identified by Southern blotting. In the sample subjected to 
additional digestion with Apal, the 4kb putative junction fragment, as well 
as the 5.3kb endogenous H19 band and the 3.3kb transgene-repeat band,
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had all disappeared to be replaced by new bands of approximately 3kb, 
2kb, 1.7kb and 1.5kb.
Comparison with a Southern blot performed on Apal digested Ann 
transgenic and wild-type genomic DNA, hybridised with the H19 5' 
fragment (Fig. 7.8), revealed that the 1.5kb band corresponded to the 
transgene repeat/H19  endogenous fragment generated by Apal. 
Furthermore, bands of approximately 1.7kb and 2.0kb were present in this 
blot. Whether these are identical in size to those seen in Figure 7.8. is 
difficult to discern. It is possible that in the Apal/Kpnl digested sample, the 
bands of these sizes are generated purely by Apal or alternatively these 
could be bona fide Apal/Kpnl fragments, differing slightly in size from those 
seen in Fig. 7.8. If so, the cloning of these fragments into pBSKSII+, 
linearised with these enzymes, would be possible.
The band of approximately 3.0kb observed in the A pal/K pnl digested 
sample is not present in that digested with Apal alone, making it likely that 
this fragment is generated only through digestion with both 
endonucleases. Again, this fragment is suitable for cloning into Apal/Kpnl 
digested pBSKSII+.
Having considered the possible origins of the fragments generated by the 
additional digestion of the purified Kpnl sample with Apal, it was decided 
to attem pt the generation of a pBSKSII+ library using the Apal/Kpnl 
digested Ann DNA sample. A test transformation was carried out using 
approximately 1/10* of a ligation reaction containing both lOng of plasmid 
and insert DNA. Three quarters of the colonies surviving ampicillin
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1.5 to 3.5kb (as revealed by A pal/K pnl digestion of miniprep DNA from 20 
colonies picked).
x =
Fig. 7.8. Restricted library Southern blot.
Southern analysis of endonuclease digested Ann genomic D N A  sam ples, purified for use 
in library construction. Kpnl digested Ann DNA of the 3 to 5kB size range w as purified 
and redigested with either BamHl, H in d ll or Apal and samples. Hybridisation w ith the 
H19 5' probe revealed novel fragments in only the A p a l/K p n l digested sample that were 
also not present in Ann genomic D N A  digested with A pal alone.
The complete library was then transformed into electrocompetent DH5a E. 
coli and a total of 40,000 colonies plated. Of these, approximately 75% (as 
estimated from the test transformation), or 30,000 colonies, were predicted
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to carry pBSKSII+ plasmid vector containing an insert in the desired size 
range. This library was screened using the H19 5' probe fragment, 
identifying 12 positive colonies. Each of these was picked and re-plated to 
allow a second round of screening to be carried out using the same probe 
fragment
Four colonies were found to be positive in both rounds of screening. 
Plasmid DNA was purified from each clone and subjected to restriction 
digestion with Apal/Kpnl. The results of this restriction analysis was 
somewhat surprising; instead of yielding two fragments: one of 2.9kb 
(corresponding to pBSKSII+) and another in the 1.5kb and 3.5kb 
(corresponding to genomic sequence), as would be expected, four bands 
were produced from each clone. This immediately suggested the presence 
of Apal or Kpnl sites internal to the cloned genomic fragment. The positive 
clones could be separated into two groups depending upon the banding 
pattern produced by Apal/Kpnl endonuclease digestion. Three of the 
clones belonged to group 1, in which bands of approximately 2.9kb, 1.4kb, 
0.6kb and 0.2kb were present. Digestion of the remaining clone (group 2) 
yielded bands of 3kb, 1.4kb, 0.9kb and 0.2kb.
Nucleotide sequencing of the cloning junctions of a single clone from each 
of the two groups revealed that both inserts were derived entirely from the 
transgene itself, and contained no unknown sequence. The insert in the 
group 1 clones was an approximately 2.2kb fragment of the H19 region 
found in the 'A ' construct (see Fig. 7.9.) For this DNA fragment to be 
present in the purified Apal/Kpnl digested genomic DNA sample, no 
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Fig. 7.9. Trartsgene fragments cloned by library screening.
Diagram outlining the regions present in the inserts of clones isolated by screening the 
Ann genomic library enriched for putative junction fragments. Inserts of both the group 1 
and 2 types consisted only of sequence derived from the 'A ' construct. In both cases Apal 
sites present w ithin the HI 9 region resisted cleavage by this endonuclease.
The insert in the group 2 clone was a fragment of approximately 2.5Kb, 
again internal to the transgene array, except this time containing both H19 
sequence and the SV40 small t intron/polyadenylation signal present in the 
'A' transgene construct. Again, to produce this DNA species in the 
purified A pal/K pn l sample, no digestion must have taken place at two 
Apal sites in the H19 region (in this case Apal* and Apal**).
At this stage, owing to the difficulties encountered in generating a suitable 
genomic library from which junction fragments could be isolated and 
taking into account the progress achieved in other studies through 
studying the location of the transgene array in the mouse genome (see 
Chapter 5), it was decided to abandon further attempts at that stage to 
clone genomic sequence flanking the transgene array.
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7.4 Discussion
7.4.1 The nature of the transgene array made the cloning of flanking sequence 
difficult
The cloning of genomic sequence flanking the site of transgene integration 
can be of param ount importance, especially when a m utant phenotype 
results from the disruption of an endogenous gene's function by the 
transgene. In this case, isolation of flanking sequence is often the first step 
towards the identification of the gene involved.
A variety of strategies exist for the cloning of flanking sequence. In cases 
where multiple transgene copies are arranged in an array, a number of 
these strategies require prior knowledge of the structure of the array in 
order to allow the preferential isolation of flanking sequence rather than 
sequence internal to the array.
Southern blot analysis of endonuclease digested Ann genomic DNA, using 
transgene-specific DNA probes, indicated that the transgene in this line 
was present in multiple copies, and also that the structure of this multi­
copy array might be extremely complicated.
One or more strongly hybridising bands were identified in each 
endonuclease digested sample, of a size which indicated that multiple 
transgene copies, arranged in a 'head-to-head' fashion, were present in the 
array, as is often the case in transgenic mouse lines [55]. Through a copy 
number titration, it was elucidated that at least 11 transgene copies were 
orientated in this fashion.
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Further analysis and interpretation of bands present on Southern blots 
allowed us to elucidate that at least two 'head-to-head' and one 'tail-to-tail' 
transgene arrangements were likely to be present in the array. Despite this 
a large proportion of the bands present on the various Southern blots 
remained unaccounted for, although it was thought probable that a 
number of these bands represented junction fragments containing flanking 
genomic DNA.
The highly complex nature of the Ann transgene array, as revealed by 
Southern blotting, made selection of a strategy for isolating flanking 
sequence difficult. It was decided to construct a genomic DNA library in 
which the proportion of fragments, identified as containing flanking 
sequence, would be highly enriched. In this way the isolation of clones 
containing flanking sequence, rather than only sequence internal to the 
transgene array, should be highly favoured.
To do this, endonuclease digestion with a suitable enzyme was performed 
and DNA species of a specific size range, previously identified by Southern 
blotting as containing a putative junction fragment, were purified. This 
DNA sample was then further digested with another endonuclease, 
generating junction fragments with different end sequences, thus 
facilitating 'sticky-end' cloning and minimising self-ligation of plasmid 
vector. This library was then screened using a transgene-specific probe 
and positive clones were identified.
Unfortunately the insert sequences of all of the clones isolated were found 
to be internal to the transgene array, and did not contain any flanking 
genomic sequence. Furthermore, it was discovered that these inserts
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contained Apal restriction endonuclease target sites that escaped digestion 
during the preparation of the insert DNA. The reason for incomplete 
digestion of genomic DNA at these sites probably lies with a resistance of 
these specific sites to endonuclease digestion. This is a commonly observed 
phenomenon wherein specific endonucleases do not digest genomic DNA 
at 100% of their specific target sites. Indeed the Apal restriction 
endonuclease is known to be sensitive to CpG methylation in certain 
cirumstances.
The identification of a number of restriction sites present in the transgene 
that are resistant to endonuclease cleavage poses as serious problem in the 
interpretation of the Southern blots used to elucidate the structure of the 
transgene array. Bands that cannot be attributed to either a transgene 
repeat or endogenous H19 sequence could be either a junction fragment or 
may derive from incomplete digestion of genomic DNA, distinguishing 
these possibilities could be either impossible or at best extremely difficult 
and uncertain.
The substantial difficulities encountered in attempting to clone transgene 
flanking sequence was considered in relation to the progress achieved in 
studying the location of the transgene array in the mouse genome (see 
Chapter 5), it was thus decided to abandon further attempts to clone 
genomic sequence flanking the transgene array.
7.4.2 Alternative strategies could have been used to clone flanking sequence
That the transgene is present in the genome in a multiple-copy array and 
the structure of this array appears to be extremely complex ruled out a
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number of possible strategies for isolating genomic sequence flanking the 
site of transgene insertion.
Owing to further uncertainties as to the nature of genomic fragments 
originally thought to contain flanking sequence, as revealed by our 
unsuccessful cloning attempts, it appears that PCR and library based 
methodologies that specifically target junction fragments and eliminate 
internal transgene sequence may well be inherently flawed. The successful 
isolation of such fragments may, rather than providing unknown flanking 
sequence, merely reveal that this fragment is generated through 
unsuccessful restriction digestion of internal transgene sequence.
Alternative strategies may provide a more straightforward route to the 
isolation of flanking sequence. For example the cloning of the complete 
array, including flanking regions, may be possible through the construction 
of either a PAC, BAC or YAC library. This would allow the isolation of 
both junctions that would be advantageous, for example, in elucidating 
whether any genomic sequence has been deleted at the site of transgene 
integration or by providing startpoints for chromosome walks out from the 
transgene in both directions.
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CHAPTER 8: A PUTATIVE MALE STERILITY 




8.1.1 An overview of spermatogenesis
The production of germ cells in the male, by the process of 
spermatogenesis, takes place in its entirety in the seminiferous tubules of 
the testes. Spermatogenesis can be divided into a number of stages 
essentially involving three distinct germ cell types: the spermatogonia, 
spermocytes and spermatids, with each cell type found concurrently but 
occupying a distinct position in the tubule (reviewed in [275]).
Found at the periphery of each seminiferous tubule are the spermatogonia. 
This is the earliest germ cell type and can itself be subdivided into three 
types: stem cells, mitotically dividing cells and cells undergoing 
differentiation. Formed by the differentiation of mature spermatogonia 
that have replicated their DNA, primary spermatocytes are located toward 
the lumen of the seminiferous tubule. Secondary spermatocytes are 
generated by meiotic division, a further round of which gives rise to the 
haploid round spermatids. This third germ cell type is found at the 
lumenal aspect of the tubule. Round spermatids differentiate into 
elongated spermatids and finally spermatozoa through the process of 
spermiogenesis, in which the genome is re-packaged with protamines.
A variety of somatic cell types are found in the testes and are im portant in 
spermatogenesis, including the Sertoli cells that reside towards the 
periphery of the seminiferous tubule. These cells play an im portant role in 
regulating spermatogenesis through paracrine interactions with germ cells 
[276].
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8.1.2 Male infertility in humans
It has been estimated that 10% of couples are affected by infertility, with 
approximately half of all cases attributable to the male partner [277]. 
Infertility in males arises through a variety of mechanisms but it is often 
associated with a complete absence of sperm (azoospermia), a gross 
reduction in sperm numbers (oligozoospermia), or a loss of motility 
(asthenozoospermia). A high proportion of azoospermic, oligozoospermic 
and asthenozoospermic cases are said to be idiopathic, in that no obvious 
cause has been identified. Increasingly it is being found that many such 
cases can be attributed to genetic defects [278].
These findings take on an elevated level of importance given the advent of 
the intracytoplasmic sperm injection (ISCI) method for assisted 
reproduction, since this method may facilitate transmission of a genetically 
determined infertility trait to a male offspring [279].
8.1.3 Genetic causes of infertility in man
Recently, genetic abnormalities have been increasingly implicated in 
spermatogenic defects. Often, abnormal spermatogenesis is only one of a 
cohort of abnormalities associated with a particular genetic disease (e.g. 
Cystic fibrosis [280]) but in other cases this may be the sole phenotype. The 
genetic basis of such defects can involve either chromosomal aberrations or 
the mutation of a single gene.
Chromosomal defects both in number and in structure have been found to 
be involved in male sterility. Usually with such defects more than simply 
the fertility of the individual is abnormal. This is unsurprising given that 
chromosomal abnormalities often involve multiple genes. Illustrating the
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fact that defects in both chromosomal number and structure can interfere 
with spermatogenesis, approximately 5% of azoospermic and 15% of 
oligozoospermic males exhibit an abnormal karyotype [281].
Numerical chromosomal disorders involving either polyploidy or 
aneuploidy are responsible for a number of syndromes in which male 
infertility is one of several abnormalities observed. Most such syndromes 
involve the sex chromosomes although a number involving only 
autosomes have been identified [282].
The most common chromosomal abnormality observed in azoospermic 
men (affecting 7 to 13% of the azoospermic population) is Klinefelters 
syndrome in which an XXY karyotype is classically seen [283]. Amongst 
the variety of abnormalities observed in these patients are sclerosis and 
hyalinization of the seminiferous tubules, an absence of spermatogenesis 
and a predomination of sertoli cells.
An example of an autosomal aneuploidy affecting spermatogenesis is 
Down's Syndrome in which male patients are almost always sterile. 
Histopathological defects include spermatogenic arrest, a reduction in 
germ cell numbers and hyalinized tubules [284].
Robertsonian translocations are the most common structural chromosomal 
abnormality found in infertile males, with an approximately ten-fold 
higher incidence in this subset of the population. In addition, paracentric 
and pericentric inversions are observed at an eight-fold higher incidence 
and reciprocal translocations at a five-fold higher incidence in infertile 
males as compared with normal individuals [282].
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Deletions on the long arm of the Y chromosome have been associated with 
approximately 15% of azoospermic and 10% of oligozoospermic men [285]. 
The absence of genetic recombination (outwith the pseudoautosomal 
region) on the Y chromosome has meant that gene mapping in this region 
has relied upon cytogenetic analysis rather than linkage data [286, 287]. 
Cytogenetically-defined deletions identified in infertile men have been 
refined using Y-specific Southern blot probes and PCR-amplified STSs 
(sequence-tagged sites) [288], to show that rather than a single crucial 
locus, at least three regions of the hum an Y chromosome, and several genes 
therein, are essential for normal spermatogenesis [289]. These regions are 
termed AZFa, AZFb and AZFc and candidate spermatogenesis genes have 
been identified in both the AZFb and AZFc loci.
Located within the AZFc region is a gene family named DAZ/SPGY, and is 
the sequence most frequently deleted in azoospermic and oligozoospermic 
men [285, 290, 291]. As such, DAZ/SPGY appears a strong candidate for 
the gene located within the AZFc that is essential for normal 
spermatogenesis.
Amongst the genes located within the AZFb region are sequences 
belonging to the RBM gene family, with deletions of this region preventing 
the expression of the RBM protein [292, 293]. Strikingly, RBM and 
DAZ/SPGY both encode proteins that contain an RNA recognition motif 
(RRM) and are therefore likely to bind RNA [294]. It has thus been 
proposed that both proteins are involved in the processing of RNAs 
essential for spermatogenesis [295]. In support of this hypothesis, RBM 
protein is present in all transcriptionally active germ cell types, with levels 
peaking in spermatocytes [293] (the cellular location of DAZ has not been
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described). Whether the two proteins are involved in the same process 
remains to be determined since the biological functions of both are 
unknown.
The DAZLA gene is an autosomally located DAZ/SPGY homologue and 
has a gonad-specific expression pattern [296]. No mutations in this gene 
have yet been identified in either man or mouse and as such the possible 
role of the DAZLA protein in spermatogenesis, although likely, remains 
unknown. In addition, RBM is closely related to the autosomal hnRNPG 
gene that is a member of the hnRNP protein family. Interestingly, these 
proteins are known to bind polyadenylated RNA in the nucleus and 
sometimes during nucleocytoplasmic transport [297]. It thus appears that 
the control of RNA metabolism could be extremely important in 
spermatogenesis and that a group of several proteins are likely to be 
involved in this process.
8.1.4 Using the laboratory mouse to investigate male infertility
The identification of genes important in spermatogenesis has been greatly 
aided by the availability of both spontaneous and targeted mouse mutants. 
The roles in hum an spermatogenesis of most of the genes identified in this 
way remains unknown, but the fact that these genes can now be tested for 
m utation in males suffering idiopathic infertility represents a significant 
advance in tackling this condition.
Similar to the situation in humans, a number of regions have been 
identified on the mouse Y Chromosome that are essential for 
spermatogenesis. Again, these regions have been m apped using mice 
bearing Y chromosome deletions and rearrangements [298].
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Two critical regions have been defined, Spy and Smy, w ith the deletion of 
either leading to infertility as a result of abnormal spermatogenesis. The 
Spy region is required for spermatogonial proliferation and has been 
accurately mapped on the small arm of the mouse Y chromosome using an 
informative transposition event [298-300]. Although no Spy genes have 
been isolated, several good candidates have been identified. These include 
Ubely, which encodes a ubiquitin-activating enzyme that may be involved 
in degrading histones during postmeiotic chromosome condensation in 
round spermatids [301,302].
The Smy region, again defined by Y chromosome breakpoints, is required 
for normal sperm head morphology [303]. In mice lacking this region 
spermatogenesis does proceed through the meiotic stages but the animals 
are infertile due to the abnormality of sperm heads. In this case a 
candidate gene (Ssty), present in several copies in the Smy region, has been 
isolated [304].
A homologue of the human DAZ/SPY gene has not been identified on the 
murine Y chromosome, although an autosomal Dazla has been described 
[305, 306]. As with all mammalian species, including man, the mouse Y 
Chromosome contains the Rbm gene family, although its expression pattern 
in mice differs to that in man, suggesting possible different roles [307].
The fact that Y chromosome deletions have only been identified in 8 -  13% 
of idiopathic infertility cases suggests that the mutation of autosomal genes 
may make a significant contribution to the remainder of cases [288]. 
Descriptions of autosomal genes implicated in idiopathic male infertility 
however, remain limited to date. This is largely due to the fact that genetic
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mutations causing male infertility are unlikely to be inherited and also 
because small family sizes make detailed genetic analysis of such 
mutations difficult.
Much has already been learned about the biological processes that are 
important to spermatogenesis and although a wide variety of gene 
products have been implicated in male sterility, many of which are 
involved in highly disparate biochemical pathways, it has become clear 
that certain pathways in particular (including, as described, the control of 
RNA metabolism) are critical at different stages of spermatogenesis in the 
mouse.
Meiosis is one of the key processes taking place during spermatogenesis 
and a number of processes exist that are specific to meisosis as opposed to 
mitosis. Spermatogenic defects arising from the targeted mutation of genes 
involved specifically in meiosis is therefore unsurprising. That the 
mutation of a number of meiosis-specific genes affects only 
spermatogenesis and not oogenesis [308, 309], is though rather more 
surprising and suggests sex-specific differences in meiosis.
Furthermore, a number of genes that are expressed outwith the testes have 
been m utated by gene targeting and male null mice found to be infertile 
due to defective meiosis. Included in this group are the DNA mismatch 
repair genes Pms-2 [308] and Mlhl [309]. This suggests that although such 
genes are important in both germ cells and somatic cells, genetic 
redundancy may limit any phenotype only to meiosis.
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As mentioned, the Ubely gene, which encodes a ubiquitin-activating 
enzyme, represents a candidate for the Y Chromosome-specific Spy gene 
[301, 302]. Mice bearing a targeted deletion of the mHR6B gene are 
defective in postmeiotic chromosome condensation [310]. mHR6B is 
known to ubiquitinylate histones [311] and is thought to be involved in 
replacing histones with transition proteins prior to genome repackaging in 
round spermatids. That a number of other proteins involved in the 
ubiquitin pathway may be essential for spermatogenesis seems very 
probable.
A number of molecules involved in cell signalling pathways have been 
found to be essential to spermatogenesis, again through the generation of 
gene knockouts. Many of these molecules are expressed by the somatic 
sertoli cells but exert effects on the germ cell lineage. These include the 
signalling molecules BMP8B [312] and DHH[313] which, like the DNA 
mismatch genes, have widespread expression patterns but their deletion 
only affects spermatogenesis.
That the targeted deletion of a number of autosomal genes in the mouse 
affects only spermatogenesis reinforces the suggestion that a high 
proportion of idiopathic infertility cases in the hum an population may 
have a genetic basis. Such mouse mutants may prove to be invaluable 
mouse models for hum an infertility in man whilst also contributing to our 
understanding of the processes underlying spermatogenesis. The 
identification of further genes essential for spermatogenesis in this way 
also provides targets for mutational screening in infertile men.
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8.1.5 A putative male sterility mutant identified from the screen for insertional 
mutants
Amongst the plethora of bone fide and putative transgene insertion mutants 
identified by the large scale screening programme (detailed in Chapter 3) 
were two lines, Ob and Grace in which the breeding of male homozygous 
transgenics proved impossible and it seems possible that homozygous 
transgenic males are infertile in these lines.
Studies to confirm male sterility in these lines has concentrated on Ob, with 
further breeding data reinforcing this suggestion. This chapter details 
these data and additional investigations carried out to further characterise 
both the molecular and physiological basis of the phenotype observed in 
this line.
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8.2 Materials And Methods
8.2.1 Interphase FISH
Interphase FISH was carried out essentially in the same manner as FISH on 
metaphase chromosome spreads (as described in sections 2.2.18-2.2.22) 
except that the Giemsa banding stage was omitted. Additionally, 
interphase (rather than metaphase) chromosome spreads were chosen for 
image capture following FISH. Interphase spreads are always more 
abundant on slides generated by the method used.
8.2.2 Histological analysis
Histological analysis of mouse testis was carried out by W.R. Bennet, A. 
Ward, A. Melidou and N. Ridouta in the manner described in sections 
2.2.23-2.2.25.
8.2.3 Linkage mappimg
Linkage mapping was carried out by A. W ard using the microsatellite 
markers D4Mit31, D6Mitl6, D8Mit74 and D12Mitl4 (described in section 
5.2.1) and PCR conditions detailed in section 2.2.16. Samples were 
analysed by large-scale polyacrylamide gel electrophoresis (section 5.2.3) 
followed by silver staining (section 5.2.5).
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8.3 Results
8.3.1 No Ob homozygous males have bred successfully
As discussed in Chapter 3, a two-step breeding strategy was adopted in 
order to screen for recessive mutations generated by transgene insertional 
mutagenesis. Intercrossing of hemizygous transgenic mice facilitated the 
generation of animals that were homozygous for the transgene whilst a 
second step involving backcrossing of transgenic offspring against a non- 
transgenic F1(C57/CBA) allowed the exact genotype of the transgenic 
parent (hemizygous or homozygous transgenic) to be identified. 
Confirmation of homozygosity required a transgenic animal, upon 
backcrossing against an F1(C57/CBA) partner, to produce at least 11 
transgenic pups without any non-transgenics (p=0.001, using the %2 test). 
The identification of at least one homozygous mouse of each sex bearing no 
detectable phenotype was deemed enough to eliminate this line from 
further testing.
In the case of the Ob line, a homozygous female mouse was identified 
through backcrossing, whereas, despite the identification of 23 hemizygous 
males, no homozygotes successfully bred (see Table 8.1.). Interestingly, a 
further 13 male animals set up for backcrossing (36% of the total set up) 
failed to breed. Each of these non-breeding males did though succesfully 
mate with females as evidenced by the observation of copulation plugs. 
This immediately suggested male sterility, rather than a sex-linked 




T/T T /w t T/T T /w t
0 23 1 7
Table 8.1. Ob breeding data.
Breeding data for Ob transgenic mice tested for genotype by backcrossing. T /T  = 
hom ozygous transgenic, T /w t = hemizygote.
According to Mendelian genetics, one would expect 2 /3  of all transgenic 
males generated by intercrossing of transgenic hemizygotes, to themselves 
be hemizygous and 1/3 to be homozygous. The probability of generating 
no homozygous male mice from intercrossing by chance was calculated as 
less the 1 in 1000 (%2 = 11.50 -for 1 degree of freedom this gives a p<0.001). 
In other words there is less than a 1 in 1000 chance that the failure to 
generate homozygous transgenic Ob null males by hemizygous 
intercrossing is not associated with their genotype.
8.3.2 Interphase FISH shows non-breeding males to be homozygous for the 
transgene
Despite statistical evidence that the inability to identify Ob homozygous 
males was not through chance, and even though 13 transgenic males (36% 
of the total set up) failed to breed, there was no solid evidence to support 
the hypothesis that this was due to male sterility rather than, for example, 
sex-linked embryonic lethality.
It was decided to confirm that the non-breeding Ob transgenic males were 
homozygous for the transgene by hybridisation of a transgene-specific 
probe to interphase chromosome spreads generated from these mice. In
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the case of a homozygous transgenic mouse, one would expect to observe 
two transgene specific signals per chromosome spread as compared to one 
in spreads from hemizygous control mice (see Fig 8.1.).
Analysis of two non-breeding males in this manner confirmed that both 
were homozygous for the transgene. This not only proves that Ob male 
homozygotes are viable but also adds support to the hypothesis that such 
mice are sterile especially since the the hemizygous transgenic control 
animals were fertile.
8.3.3 Quantitative and histopathological analysis of non-breeding Ob males 
reveals a reduction in abundance of specific spermatogenic cell types
Testis from non-breeding (putative homozygous transgenic) and fertile 
(hemizygous transgenic) littermates were weighed and vas deferens 
squeezed in order to detect the presence of mature sperm (work carried out 
by W.R. Bennett, A. Melidou, N. Ridout and A. Ward). It was found that 
testis from two non-breeding (putative homozygous transgenic) animals 
examined were much reduced in mass (less than half that of fertile 
hemizygous transgenic littermates) and furthermore that mature sperm 
were either absent or present at very low levels in comparison to fertile 
hemizygous transgenic littermates.
A histological analysis was carried out on haematoxylin and eosin stained, 
transverse testis sections (work carried out by W.R. Bennett, A. Melidou, N. 
Ridout and A. Ward). Briefly, all spermatogenic cell types (spermatogonia, 
spermatocyctes, spermatids and spermatozoa) were identified although
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Fig. 8.1. Ob interphase FISH.
Interphase chromosome spreads from fertile Ob transgenic hemizygous males (A and B) and non­
breeding transgenic littermates (C and D). An inserted transgene is identified by a fluorescent spot 
(indicated by an arrow) and is present on sister chromatids in spreads from non-breeding males but 
on only a single chromatid in spreads from the fertile transgenic animals.
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ily :
Fig. 8.2. H and E stained sections from w ild-type (A and C) and mutant (B and D) Ob 
testis at 400x (A and B) and lOOOx (C and D) magnification. Although a number of 
tubules from the mutant anim als appear normal, a proportion display morphological 
abnormalities in the form o f extracellular spaces as well as deficiencies in a variety 
spermatogenic cell-types.
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some morphological abnormalities, in the form of numerous extracellular 
spaces, were observed (see Fig. 8.2.). In those tubules more severely 
affected, the organisation of spermatogenic cells was poor.
A variety of measurements were taken from the testis sections. In sterile 
males seminiferous tubule diameter was significantly reduced in 
comparison to sterile (hemizygous transgenic) littermates. Quantification 
of spermatogenic cell types (subdivided into four easily distinguishable 
classes: spermatogonia, spermatocytes, early spermatids and mature 
spermatozoa) identified a significant reduction in the total number of 
spermatogenic cells per tubule in sterile males as compared to wild-type 
littermates with a reduction in each of the four cell classes. Furthermore, 
when represented as a percentage of the total cell number, there was found 
to be a significant reduction in the relative abundance of spermatids and 
especially mature spermatozoa (with an accompanying increase in the 
relative abundance of the other two cell types).
8.3.4 Mapping the location of the transgene in the Ob line by G-banding and 
FISH
Given the strong likelihood that the spermatogenic defects and male 
sterility observed in the Ob line results from transgene insertional 
mutagenesis of an endogenous gene, it was decided to attempt mapping 
the site of transgene integration. Successful identification of a map position 
would allow an assessment to be made on possible candidate genes located 
around the site of transgene insertion.
A chromosomal mapping strategy was pursued using fluorescence in-situ 
hybridisation of Ob metaphase chromosome spreads with a transgene-
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specific DNA probe fragment. This, carried out alongside karyotyping by 
G-banding, would allow a tentative identification of the chromosome and 
the particular chromosomal region into which the transgene had 
integrated. Production of metaphase chromosome spreads, G-banding and 
FISH was carried out as described in sections 2.2.18 -  2.2.22. A DNA probe 
containing the P3 Lux/CCD regions used in the 'O' construct was used for 
FISH.
Successful G-banding and FISH showed that in the Ob line, the 'O ' 
construct had integrated slightly to the centomeric side of the middle third 
of a medium sized chromosome (see Fig. 8.3.). This chromosome appeared 
to have either one thick or two darkly staining bands in its centre and 
another located in its telomeric third. Comparison with standard mouse 
karyotypes and karyotype ideograms (see Fig. 5.4.) allowed the transgene- 
specific chromosome to be narrowed down to one of four strong 
possibilities: chromosomes 4 ,6 ,8  and 12.
8.3.5. Microsatellite linkage mapping confirms chromosome 8 as harbouring 
the transgene
In order to identify which of chromosomes 4, 6, 8 and 12 the transgene had 
integrated (if any) a linkage mapping strategy, using microsatellite 
markers, was employed. Microsatellite markers (D4Mit31, D6Mitl6, 
D8Mit73 and D12Mitl4) located on the central region of each of the four 
candidate chromosomes were selected. These markers had already been 
confirmed as size-polymorphic between the two founder strains as part of 
studies conducted on the Ann transgenic line (see section 5.2.1).
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Fig. 8.3. Ob FISH and G-banding.
Chromosomal mapping o f the transgene insertion by FISH and G-banding of Ob metaphase 
chromosome spreads. Fluorescence in situ hybridisation o f Ob metaphase chromosome spreads 
using a transgene specific probe fragment, (A) and (C). The site o f transgene insertion is identified 
by a fluorescent spot on sister chromatids o f the same chromosome (indicated by arrow). G- 
banding of the same spreads is shown in (B) and (D), again the site o f transgene insertion is 
indicated.
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Transgenic founders had been generated using FI embryos derived from 
crossing C57BL/6J and CBA/Ca mice. Interbreeding of subsequent 
generations meant that all available transgenic mice had genetic 
backgrounds of a mixed C57 and CBA constitution. To be informative for 
possible intercross mapping analysis, it was essential for breeding mice to 
have suitable haplotypes for the microsatellite markers being tested. Such 
mice were identified by marker typing and crosses set up. Transgenic 
parents confirmed as being of the F1(C57/CBA) haplotype for the marker 
being tested, were bred with non-transgenic parents, again of the 
F1(C57/CBA) haplotype for the marker (marker typing of parents and 
offspring was carried out by W.R. Bennett, A. Melidou, N. Ridout and A. 
Ward).
For the markers D4Mit31 and D12Mit74, not enough informative offspring 
were generated to allow statistical analysis to be conducted. The fact that 
hemizygous transgenic mice of both the C57/C57 and CBA/CBA 
haplotypes for each marker were identified within the small number of 
samples analysed, does though strongly suggest that these markers are not 
linked with the transgene. The possibility of partial linkage cannot be 
discounted but seems unlikely since the chromosomal position of the 
transgene (as determined by FISH) and the markers should correlate 
reasonably well.
Enough informative offspring were generated for the microsatellite 
markers D6Mitl6 and D8Mit73 to allow a statistical analysis to be carried 
out. In the case of D6Mitl6 a %2 value of 0.92 was calculated for the null 
hypothesis that this marker and the transgene are unlinked. This is less 
than the critical value at the p=0.05 level (critical value = 11.1, with 5
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degrees of freedom), confirming there is no significant difference between 
the observed and expected values for non-linkage. We can thus conclude 
that the transgene and marker D6Mitl6 are unlinked.
In the case of D8Mit73, using the observed and expected values for the null 
hypothesis of non-linkage with the transgene (following the Mendelian 
ratio of 1:2:1, see table 8=2.) a *£ value of 53.8 was calculated using the 
special %2 equation for intercrossing outlined in the book Mouse Genetics [1]. 
This suggests that the probability of non-linkage between the transgene 
and this microsatelite is <0.0001. We can therefore conclude that the 
transgene is linked with D8Mit73 and therefore that the transgene is 
located in the central portion of mouse chromosome 8.
Transgene status No. offspring D8Mit73
C57 FI CBA
w t/w t 11 11 0 0
T /w t 4 0 4 0
Table 8.2. Ob intercross mapping data.
Small scale intercross analysis shows possible co-segregation of the transgene and the 
chromosome 8 microsatellite marker D8Mit73.
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8.4 Discussion
8.4.1 Ob: a recessive male sterility mutant caused by transgene insertional 
mutagenesis
During the large-scale screening programme for insertional mutant 
phenotypes conducted on a group of transgenic mouse lines one line was 
identified in which male homozygous transgenic mice could never be 
identified by backcross breeding analysis. Sufficient numbers of Ob 
transgenic males were generated by hemizygous intercrossing to confirm 
that this lack of homozygotes was significant. The fact that 38% of 
transgenic males, set up for backcrossing mated successfully (as evidenced 
by coital plugs) but produced no offspring, strongly suggested that the 
failure to identify male homozygotes rested with their inability to breed, 
rather than a sex-linked lethality. In support of this hypothesis, two non­
breeding male transgenics were genotyped by interphase FISH analysis 
that confirmed these mice as homozygous transgenics. In two other non­
breeding males the testis mass was less than half that of fertile, hemizygous 
siblings, and mature sperm were either absent or found in very low 
numbers in the vas deferens of these non-breeding males. Thus the Ob line 
most likely represents a recessive male sterility phenotype caused by 
transgene insertional mutagenesis.
8.4.2 Histological analysis of Ob testis suggests a defect in spermatogenesis
A histological analysis was conducted on testis from infertile transgenic 
males. It was observed that the seminiferous tubules of infertile mice were 
not only significantly smaller in diameter than in their fertile siblings (a 
trait which has been associated with male sterility in the weaver mutant), 
but that they also exhibited a significant difference in the relative 
abundance of the various spermatogenic cell-types. Mature spermatozoa,
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and to a lesser extent early spermatids, were found in much reduced 
numbers, relative to total spermatogenic cell numbers, when compared 
with fertile litter-mates. This suggests that the defect present in Ob 
homozygote transgenics may be specifically involved with the transition of 
immature spermatogenic cells, such as the spermatogonia or 
spermatocytes, to the more mature cell types found towards the lumen of 
the seminiferous tubule (i.e. the spermatids and spermatocytes).
As discussed in the introduction to this Chapter, the causes of male 
sterility, as identified through studies on m utant mice, often belong to 
specific processes which are of paramount importance to spermatogenesis 
and the m aturation of spermatogenic cells. One such process is meiosis, 
which is actively occurring in the spermatocytic cell population. A number 
of male sterile mice have been identified which display defects in meiosis 
as a result of disruption to genes involved in this process (i.e the DNA 
missmatch repair genes Pms-2 [308] and Mlh-1 [309]). A disruption to 
meiotic divison could well be responsible for the reduction in post-meiotic 
spermatogenic cell types observed in Ob homozygous males.
Alternatively a defect in post-meiotic chromatin condensation, which takes 
place in the round spermatid cells, may be the source of the Ob phenotype. 
Indeed one noteable male-sterile line, m utated in the mHR6B gene 
(involved in the ubiquitinylation of histones) displays defects in this 
process [310].
The unexplained extracellular spaces observed in the seminiferous tubules 
of Ob mutant mice could result from the degeneration (and subsequent 
phagocytosis by Sertoli cells) of spermatogenic cells which cannot progress
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to the next stage of spermatogenesis (e.g. due to meiotic arrest). That 
similar such extracellular spaces are also observed in ageing mice [314] 
means that studies must be carried out in Ob mice of a variety of ages to 
eliminate an age-related effect.
One realistic alternative to a spermatogenic-cell-specific defect in Ob 
homozygotes is the possibility that the phenotype may arise from an 
abnormality in Sertoli cell function. These cells are essential for 
spermatogenic cell survival and many cases of defective spermatogenesis 
have been associated with defects in the Sertoli cell population (e.g. the 
weaver mouse m utant [315]). Further such studies should therefore include 
an analysis of Sertoli cell numbers which would be aided through the use 
of Sertoli cell-specifc staining or antibodies (preliminary data has been 
obtained using an anti-WTl antibody that reveals a normal number of 
Sertoli cells).
8.4.2 The transgene in Ob mice maps to the central region of Chromosome 8
Through a combination of FISH mapping on metaphase chromosome 
spreads, and linkage mapping using microsatellite markers, the location of 
the integrated transgene in the Ob line was identified as the central third of 
Chromosome 8.
Inspection of the mouse chromosome committee consensus map for this 
chromosome [219] reveals one obvious candidate. The calmegin gene maps 
at offset 38.0cM, in the central third of Chromosome 8 [316], and encodes a 
testis-specific endoplasmic reticular (ER) protein that is homologous to the 
ubiquitous ER chaperone calnexin [317]. Calmegin has itself been shown to 
bind to nascent polypeptides during spermatogenesis [318] and is
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expressed in early pachytene spermatocytes and round and elongating 
spermatids [319]. Expression of Calmegin is undetectable from the 
spermatid maturation phase. Such an expression pattern would not be 
incompatible with the cell types affected in Ob mutants i.e. spermatid 
stages onwards.
Calmegin function has been disrupted by gene targeting and was found to 
be required for sperm fertility, with homozygous null males displaying 
reduced fertility [318]. Spermatogenesis in these mutants though, is 
morphologically normal, which is not in keeping with our observations of 
Ob mutants. The specific defect in Calmegin null mice was found to be one 
of adherance to the zona pellucida of the egg, suggesting that this protein 
acts as a chaperone for sperm-surface proteins which mediate interactions 
between sperm and egg.
Although the map position and expression pattern of the calmegin gene is 
compatible with it being the gene m utated in Ob mice, when m utated the 
resulting phenotype does not correlate strongly with that observed in Ob 
mutants. Despite this, testing of this gene as an Ob candidate by, for 
example, Northern analysis still seems warranted.
Elimination of calmegin as the gene mutated in Ob and the lack of other 
strong candidates in the region of Chromosome 8 to which the Ob 
transgene maps may indicate that a hitherto unidentified gene has been 
disrupted in this line. In this case, the isolation of genomic DNA flanking 
the site of transgene integration will be of param ount importance for the 
identifiction of the gene m utated in this line.
CHAPTER 9: DISCUSSION
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A screen of 74 transgenic mouse lines for visible m utant phenotypes, 
resulting from transgene insertion, has been described. To date, four bona 
fide insertional mutants have been identified and characterised at both the 
phenotypic and molecular levels.
That at least three of these mutants represent new allelic forms of 
previously identified genes/m utations may provide an indication as to the 
percentage of mouse genes, that have already been discovered, which can 
be m utated to give a visible phenotype.
Additional putative insertional mutants, identified by the screen, are 
awaiting confirmation. Furthermore, the screen cannot be considered as 
exhaustive, since it is possible that subtle or partially-penetrant phenotypes 
might have eluded detection. Thus, the number of insertional mutants 
identified to date (currently at 5.4%) is unlikely to be final.
Homozygous transgenic Ann mutants were identified at an early age due 
to their sevre ataxic phenotype. Expression of the mouse disabled 1 (mdabl) 
gene is ablated in these mutants as a result of transgene insertion. mDabl 
is a cytosolic adaptor protein that functions as part of the reelin signalling 
pathw ay in the developing CNS. This pathway is essential for correct 
neuronal m igration/positioning during the development of the 
cerebellum, cerebral cortex and hippocampus. Gross abnormalities of 
neural patterning in these brain structures are apparent in Ann mutants.
That mdabl m utant mice have already been described (scrambler, yotari and 
a gene-targeted mutation) means that the discovery of a novel mutation of 
this gene contributes to a pre-exisiting allelic series. A failure to detect any
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disruption to a large section of the mdabl gene structure suggests that a 
prom oter/enhancer sequence may be disrupted in the Ann line. This 
m utant could therefore serve as a useful tool in dissecting how the 
expression of this gene is controlled.
The identification and characterisation of a second insertional m utant line, 
Ob, has been described. Homozygous transgenic males of this line are 
found to be sterile. Testicular histology suggests that a reduction in 
numbers of a subset of spermatogenic cell-types may be responsible. The 
transgene insertion has been m apped to the centre of Chromosome 8.
One possible candidate gene, calmegin, located in this region, must be 
tested. Failure to identify any abnormalities in the expression of the 
calmegin gene orits corresponding protein may indicate that the Ob line 
represents a mutation of an, as yet, unidentified gene. Such a discovery 
would provide an important contribution to studies being conducted on 
the genetic basis of hum an infertility.
Systematic screening programmes of large numbers of transgenic mice for 
insertional m utation events, such as that described, can make a useful 
contribution to the array of mouse m utation/gene identification methods 
currently in use. The value of these methods in helping to elucidate the 
genetic basis of hum an development and disease cannot be understated.
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